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ABSTRACT
Seminal plasma is reported to suppress a number of in vitro and
jjl vivo parameters of immune cell function. This is believed to be
fundamental to the process of reproduction, preventing sens itisat ion
of the female to sperm antigen during coitus.
The mechanism of action of human seminal plasma (SP) mediated
immunosuppression is poorly documented, and characterisatIon studies
have been hampered by the complexity of the material. In this study
in vitro models of T-cell, Natural killer (NK) cell and monocyte
function were used to study inhibitory mechanisms of SP, and to test
the contribution of major seminal plasma constituents to
immunosuppression.
SP at concentrations from 0.5-4.0$ final volume In culture
suppressed the peripheral blood mononuclear cell (PBMC) response to
phytohaemagglutinin (PHA) in a dose dependent manner. Suppression was
most effective at suboptimal concentrations of mitogen and was not
due to cytotoxicity or cold target inhibition. Suppression was not
achieved if PBMC were preactivated for 24 hours before addition of
SP, or if PBMC were pre incubated in SP for 4 hours before culture
- with PHA. Suppression was related to decreased interleukin 2 (IL—2)
receptor expression, and suppression by 1$ SP was overcome by
10 U/ml recombinant IL—2.
NK cell mediated cytotoxicity against K562 target cells was also
inhibited in a dose dependent manner. However, preincubation of
monocytes with 1$ SP before washing and culture with IIpopolysacchar-
ide(LPS)resulted in increased interleukin 1 (IL-1) production.
Seminal plasma components were characterised using a variety of
techniques. A reverse phase high pressure liquid chromatography
x
(HPLC) separation of SP revealed 2 peaks of suppressive activity in
the NK cell and proliferation assays, and these coincided with the
peaks of prostaglandin E (PGE) and 19-OH-prostagI and in E (19-OH-PGE)
activity. Delipidation of SP by absorption chromatography removed all
NK suppressive activity, 70? of proliferation suppressive activity,
and 90? of the E series prostaglandins. SP was desalted using a
Sephadex G25 column, and excluded proteins separated on a DEAE HPLC
column. Fractions suppressing proliferation and NK cell mediated
cytotoxicity correlated with those with peak PGE activity, suggesting
that some of the seminal prostaglandins were binding to seminal
proteins.
Standard preparations of prostaglandins were examined at
concentrations similar to those found in SP. PGE2 (10 ® to
10 9M) and 19-OH-PGE^ (10 ®to 10 7M) suppressed proliferation.
Suppression was highest at suboptimal mitogen concentration, could
not be achieved with activated cells, was reversible, was replaced
with rlL-2 and correlated with decreased IL—2 receptor expression.
PGE2 (10~6 to 10~9 M) and 19-0H-PGE1 (10~6 to 10-9 M) also
inhibited NK cell mediated cytotoxicity. 19-OH-prostagI andin F1
(19-OH-PGF^) had little effect on proliferation or on NK cell
cytotoxicity. Pure preparations of zinc and the polyamine spermidine
were also examined. Zinc had little effect on proliferation when
~5 -8
used at 10 to 10 M in culture, but spermidine (6 to 12 jug/ml)
had a small but significant suppressive activity.
In conclusion, the study delineates some of the mechanisms of SP
mediated immunosuppression, and suggests that the E series






Semen is composed of spermatozoa, cells and a suspending fluid
which is termed the seminal plasma (SP). Seminal plasma comprises
80-90$ of the ejaculate and is a confluence of secretions from the
prostate, seminal vesicles, epididymis, urethal and bulbourethral
glands (Mann 1964). Chemical analysis of the fluid over the last
century has led to the discovery and identification of a wide range of
components, some of which are unique, or unique in their concentration,
to semen (Table 1).
Seminal plasma is a natural diluent and transport vehicle for
sperm and a number of its components have well defined roles. For
example, the proteolytic enzymes play a decisive role in semen
coagulation and liquefaction (Mann 1964), and high levels of fructose
provide spermatozoa with the metabolic energy required for mobility
and survival (Mann 1946). The physiological role of other components
remains conjectural. In 1975 Stites and Erikson demonstrated that
SP could suppress cellular immune responses, and proposed the la
vivo relevance of this phenomenon which is to prevent sens itisation of
females to repeated insemination. They also suggested that the
presence of immunosuppressive molecules may predispose the reproductive
tract to infection by organisms such as Neisseria gonnorrheae. In the
thirteen years following this paper a number of workers have
demonstrated seminal plasma mediated suppression on a wide range of
immune cell functions (reviewed by James and Hargreave 1984, Alexander
and Anderson 1987). Concern has also been expressed over the possible
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COMPONENT SEMINAL PLASMA CONCENTRATION REFERENCE
IONS FREE AM) BOUH) (mg/ml)
Sodium range 10.0 - 20.0 a
Potassium range 5.5-11.0 a
Calcium range 2.0 - 2.8 a
Magnesium range 0.3 -1.2 a
Chloride range 10.0 20.0 a
Zinc mean 1.4 a
Copper mean 0.15 a
Iron mean 0.008 a
PRQSTAGLAM) INS (ug/ml)
PGE . and _ range 2.0 - 272.0 b
19-OH-PGE f and - range 53.0 - 1094.0 b
PGF 1 * range 0.1 - 7.0 b
19-OH-PGF
^ and j range 3.0 - 62.0 b
POLYAMIKES (mg/ml)
Spermine mean 0.6 a
Spermidine approx. 0.06 a
Putresclne approx. 0.06 a
PROTEIN HORMONES (mlU/ml)
Lu+elnlslng Hormone mean 1.34 c
Follicle Stimulating Hormone mean 1.34 c
(ng/m I)
Prolactin mean 29.5 c
Growth Hormone mean 0.89 c
STEROID HORMONES (ng/ml whole semen)
Testosterone mean 0.19 d
Dlhydrotestosterone mean 0.95 d
Androstanedlol mean 0.47 d
Dehydroeplandrosterone mean , 0.95 d
Progesterone mean " 0.26 d
Oestrodlol mean 0.036 d
Oestrol mean 0.067 d
OTHER (mg/ml)
Proteinlike Material range 35.0 - 50.0 a
Fructose range 2.0 - 3.0 a
Citric Acid range 100.0 - 700.0 a
Lactic Acid range 20.0 - 50.0 a
Lactoferrln range 0.5-1.0 a
Free Amino Acid mean 12.6 e
Phospholipid mean 0.15 a
Pyruvic Acid mean 30.0 a
Ascorbic Acid mean 10.0 a
References: a. Mann 1964; b. Templeton s± al 1978; c. B1swas at a I.
PROTEOLYTIC AM) LIPOLYTIC ENZYMES SEMINAL PHOSPHATASES
Nucleosidase PhosphoryIase
TABLE 1. HUMAN SEMINAL PLASMA COMPONENTS
1978; d. Tea ,a± a±. 1976; e. Krampitz and Doepfmer 1962.
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contribution of seminal plasma In the aetiology and pathogenesis of a
wide range of genitourinary tract diseases.
The mechanism of action of seminal plasma and the primary
mediators of suppression, however, still remain to be Identified. The
aim of this work was threefold: firstly to establish a number of la
vitro systems to examine seminal plasma mediated Immunosuppression;
secondly to isolate and characterise some of the primary mediators
Involved In this suppression; and finally, to assess the immunological
properties of these mediators.
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1.2 THE MALE REPRODUCTIVE TRACT
The stepwise proliferation and transformation of the male germ
cell to a mature spermatozoan Is termed spermatogenesis. Many
Immunisation studies have demonstrated that sperm and germ cell
antigens can stimulate production of sperm antibody and/or experimental
autoimmune orchitis, but under normal conditions, immune responses are
not detected (Brown a± al. 1965, Alexander and Anderson 1987). In
this section, the anatomy (Figure 1) and the Immunological environment
of the male reproductive tract and the process of spermatogenesis is
reviewed.
1.2.1 The Peripheral Testis
The testis has two functional components; the seminiferous tubules
and the Interstitial cells. Within the testis the seminiferous tubules
appear as folded loops draining at both ends Into the rete testis.
They are composed of a basal membrane lined by a stratified epithelium
bounding the lumen. The two major cell types In the epithelium are a
fixed population of Sertoli cells .and a mobile population of germ
cells. Various developmental stages of germ cells are present
Including spermatogonia (types A and B), primary spermatocytes,
secondary spermatocytes, and spermatids. The three phases of
spermatogenesis are: (1) mitotic division of the primary spermatogonia;
(2) meiotlc cell division of these sperm precursors to produce haplold
spermatocytes; and (3) spermiogenesIs, during which the round
spermatocytes are metamorphosed Into flagellated spermatozoa. The



























FIGURE 1. A niAGRAMATIC OUTLINE OF THE MALE REPRODUCTIVE TRACT.
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The Sertoli cells act as a supporting matrix for the germ cells,
and form a continuous and complete lining within the tubular wall where
they extend from the basal lamina to the lumen of the tubules. The 40
to 50 tight junctions between each pair of cells (Friend and Gilula
1972) have classically been described as the morphological site of
the blood testis barrier, preventing passage of immunoglobulin, cells
and complement (Gilula et a 1. 1976). HLA-DR positive macrophages are
found around the seminiferous tubules and in close proximity to
the outer aspect of their walls (El Demiry et a 1. 1987). Whether
these macrophages are able to function as phagocytic or antigen-
presenting cells remains to be established. Lymphocytes are not
detected anywhere within the normal peripheral testis (El Demiry
jg± aL. 1987).
Interspersed between the seminiferous tubules is the interstitial
tissue. This contains Leydig cells, which synthesize and secrete
androgenic steroids, fibroblasts, mast cells, blood vessels, nerves,
and macrophages.
1 .2.2 The Re+e Testis
Testicular spermatozoa pass through the seminal tubules into the
rete testis, which is a network of canals lined by squamous epithelium.
Both T-cells and HLA-DR positive macrophages are found in normal rete
testis (El Demiry et a 1. 1987a). CD4 positive cells are mainly located
In the interstitium, whilst CD8 positive cells which are far more
numerous, are predominant in the epithelium.
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The presence of CD8 positive cells may be to limit an autoimmune
response to germ cells. Tight junctions In the rete are less extensive
than In the seminiferous tubules, and make It more permeable to antigen
and cells (Haas and Beer 1986). Further evidence for an active local
immune response In the rete comes from a murine model of experimental
autoimmune orchitis (Tung a± al. 1988). This disease can be
adoptively transferred to naive syngeneic recipients w4th donors
enriched T-cells, and the maximum pathology Is localised In the
straight tubules of the rete.
The rete testis Is thought to have a secretory and resorptlve
capacity, and the testicular plasma suspending the spermatozoa has a
low dry weight and protein content. The rete also acts as a valve,
permitting periodic release of sperm Into the efferent ducts and
movement of testicular semen towards the epididymis.
1.2.3 The Epididymis
The epididymis Is a convoluted duct system of 20 metres length,
and Is made up of a head (caput), body (corpus) and tall (cauda). The
epididymis has four functions: (a) It acts as a sperm reservoir; (b) It
produces epldldymal plasma; (c) It promotes maturation of sperm; (d) It
disposes of ageing and superfluous sperm.
When spermatozoa enter the epididymis they have no fertilizing
ability and no motility. Aqulsltlon of these Is largely due to
Inherent properties of the sperm, but also depends upon Interactions
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with the epithelium of the epldldymal duct and epldldymal plasma, such
as deposition of epldldymls-speclfIc glycoproteins on the surface of
the spermatozoa (Jones et a 1. 1980). The approximate transit time of
epldldymal sperm is twelve days. Their Increased fertilising ability
can be correlated to changes In morphology, chemical composition,
antigenicity and metabolism (Urry 1981). The distribution of Immune
cells Is similar to that In the rete testis (El Demlry and James 1988).
The epididymis has a high resorptlve power and the dilute
testicular semen Is turned Into more highly concentrated epidldymal
semen. A wide range of organic constituents are found In epldldymal
plasma including glyceryIphosphoryIcholIne which Is a secretory product
of the epididymis Itself (Dawson s± a 1. 1957), carnitine which Is
probably accumulated by the epididymis from the peripheral blood,
slalomucoprotelns, lipoproteins, and a number of lysosomal enzymes.
1.2.4 The Ductus Deferens
Upon leaving the cauda epididymis the spermatozoa enter the ductus
deferens, which transports sperm and Its suspending fluid to the
ejaculatory duct where It forms the excretory duct of the seminal
vesicles. The ductus deferens consists of a vasal part which Is
cylindrical and has a structure similar to the cauda epididymis, and a
smaller dilated area called the ampulla which Is similar In morphology
to the seminal vesicles. HLA-DR positive macrophages are located In
the lining epithelium of both parts of the ductus deferens, and CD8
positive cells are found In the vasal area (El Demlry and James 1988).
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In addition to sperm transport, the ductus deferens functions as a
reservoir of sperm. Ejaculated sperm are derived from the vas and the
epididymis in a 2/3 ratio.
1.2.5 The Prostate
The prostate is the largest male accessory gland, and is composed
of alveoli lined with tall columnar secretory epithelial cells. It
drains into the distal part of the prostatic urethra in close proximity
to the orifices of the ejaculatory ducts allowing addition of the
prostatic fluid to the other seminal components on ejaculation (McNeal
1981).
Within normal prostatic tissue, CD8 positive cells predominate and
these are located in the epithelial lining of the prostate (El Demiry
and James 1988). HLA-DR positive macrophages are also demonstrated in
the epithelium, and CD4 positive cells and B cells in the interstitium
(El Demiry and James 1988).
Prostatic secretions contribute 13 - 32$ of the volume of the
ejaculate (Brendler 1970). The high concentration of zinc found in
semen (14mg/100 ml) Is derived from prostate (MacKenzie et aj_, 1962),
and other markers of prostate secretion include acid phosphatase and
citric acid (Mann 1964).
1.2.6 The Seminal Vesicles
The seminal vesicles and ampulla open jointly through the
ejaculatory duct into the urethral canal. The vesicles consist of a
villous mucosa (epithelium and lamina propria), a layer of smooth
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muscle and an external sheath of connective tissue. Two types of
epithelial cells are present; secretory cells and basal cells.
Few lymphocytes are found in the seminal vesicles and these are
nearly all CD8 positive (El Demiry and James 1988). No B cells and no
macrophages are detected.
Secretions from the seminal vesicle form 46 - 80>6 of the ejaculate
volume (Brendler 1970). The seminal vesicles are the major site of
production of the prostaglandins (Eliasson 1959), lactoferrin, fructose
and the proteins which cause coagulation In semen (Jenkins et al.
1978).
1.2.7 Antigens on Spem
During the process of spermatogenesis, there are continual
additions and deletions of cell antigens, and It is estimated that
up to 50% of the antigens on mature spermatozoa were not present on
spermatogonia (Romrell and O'Rand 1978). The amount of sperm specific
antigens exponentially Increase from approximately 4$ to greater than
96$ by the late spermatid stage (Romrell and O'Rand 1978). Sperm
membranes not only possess sperm specific, but also HY and adsorbed
antigens (Schulman 1978). Testicular germ cells (Anderson et al. 1984)
and epididymal sperm do no express major histocompatibility antigens
(Anderson st al. 1982).
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1.2.8 The Cellular Component of Ejaculate
Leucocytes are found in the ejaculate of all men, but their
significance remains controversial (El Demiry et a 1. 1986, Wolff and
Anderson 1988a,b). A study in our laboratory found the mean leucocyte
count in fertile controls (44.9 ± 25.8/high power field) significantly
higher than in subfertile patients (14.6 ± 17.1/high power field),
with T-cells (predominantly CD8 positive) detectable in 20^ of the
patients but in none of the controls. There was no correlation of
white cell count with reduced semen parameters or positive microbial
culture (El Demiry et a 1. 1986). In contrast, Wolff and Anderson's
study (1988a) found higher numbers of leucocytes in Infertile patients,
with a similar distribution of immune eel I types in controls and
patients. A more recent report has also found that counts of more
than one million cells/ml of ejaculate was significantly linked with
reduced semen parameters (Wolff and Anderson 1988b).
1.2.9 Ejaculation
Little is known about the pre-ejacuIatory phase in man. Human
emission appears to be initiated by the urethral and Cowpers glands,
with the prostatic secretion and spermatozoa following, and the seminal
vesicle secretion delivered last. There is, however, an overlap
between pre-sperm, sperm-rich and post-sperm fractions.
1.2.10 Interactions Between Spermatozoa and Seminal Plasma
The secretions from the male accessory glands interact with each
other and with spermatozoa in a number of different ways. These
include: (1) Coagulation and liquefaction. On ejaculation, human semen
coagulates, and does not liquefy until approximately twenty minutes
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later. Scanning electron microscopy reveals a dense network of fibres,
separated by narrow spaces which do not allow free movement of
spermatozoa. As liquefaction proceeds, amorphous material consisting
of small globules appear on the fibre surface, until the fibres
completely disappear (Zaneveld 1974). (2) Coating of spermatozoa. A
number of seminal plasma components coat the surface of sperm. These
Include the ABO blood group antigens In the prostatic secretion of
secreter males, a lactoferrln like substance called Well's sperm
coating antigen, and sperm agglutinating antibodies, which are
discussed later. (3) Ionic and metabolic exchanges. Zinc Is avidly
taken up by spermatozoa (LIndholmer and Ellasson 1974), and the
Intracellular level of coenzymes such as ATP, NAD and cAMP Is
controlled by fructose, pyruvate and lactate In the seminal plasma.
Carnitine from the epididymis acetylates In spermatozoa to
acety(carnitine and facilitates lipid oxidation.
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1.3 THE FEMALE REPRODUCTIVE TRACT
Spermatozoa are Immunologically foreign to women, but repeated
Insemination does not usually Induce an Immune response. This apparent
Inability to recognise sperm antigens Is not explained by the
prlvlllged Immune status of the female tract. The vaginal route Is
adequate for Immunisation against a variety of antigens (Straus 1961,
Yang and Schumacher 1979) and hlstoIncompatible grafts are uniformly
rejected (Beer and Bill Ingham 1975). In addition, antlsperm antibody
can be detected In a small number of women and may correlate to
Impairment of their fertility (HJort 1983).
The distribution of leucocytes In the female tract has rarely been
studied. An Initial project undertaken In our laboratory
demonstrated the presence of T-cells In the endocervlcal, endometrial
and ovlductal eptthella above the basal lamina, and between the
epithelial cells, and In subepithelial connective tissue (El Demlry
1987b). The majority of these cells were CD8 positive. CD4 positive
cells were few In number. Macrophages were found In the subepithelial
connective tissue and these were demonstrated as HLA-DR positive.
In this study B cells were rare, and only detected In the
subepithelial connective tissue. In contrast, a number of studies have
shown the presence of IgA and IgG containing plasma cells In the
endocervlx (Hulka and Omran 1969, LIppes at al. 1970). IgG containing
plasma cells are found Infrequently In uterus and vagina (Ogra et al.
1981).
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Female reproductive tract secretions contain small but significant
levels of immunoglobulin. IgA, IgM, and IgG have been detected In
uterine and endometrial secretions (Moghissi 1970), cervical mucus
(Moghissi 1970) and IgA and IgG In vaginal secretions (Moghissi 1970).
Lactoferrin has also been located In uterine secretions (Lippes et a I.
1970).
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1 .4 THE IMMUNOLOGICAL EFFECTS OF SEMINAL PLASMA IN VITRO
Literature surveys reveal that seminal plasma Is reported to
modulate the In vitro function of T and B lymphocytes, natural killer
(NK) cells, polymorphonuclear neutrophils and mononuclear phagocytes
(reviewed by James and Hargreave 1984, Alexander and Anderson 1987).
Suppression has been demonstrated with seminal plasma from man (Stltes
and Erlckson 1974, Marcus et al. 1978f Majumdar ,s± al^. 1982), mouse
(Anderson and Tarter 1982), rabbit (Mukherjee et al. 1983)f and
bull (Prakash et al. 1976), and the suppression Is not species
specific (Prakash et al. 1976, Lord et a 1. 1977 and James et a I.
1983). Effects with human seminal plasma can be demonstrated In normal
and.vasectomlsed men, and the inhibition Is independent of antlsperm
antibodies (James and Szymanlec 1985).
1.4.1 Lymphocytes
Seminal plasma Is demonstrated to suppress lymphoprolIferative
responses to the mitogens concanavalln A (Prakash et a 1. 1976, Lord
et a 1. 1977, Anderson and Tarter 1982), phytohaemaggIutinIn (Stltes
and Erlckson 1974, Anderson and Tarter 1982) and pokeweed mitogen (Lord
et al. 1977), the antigens Candida albicans and tetanus toxoid (Lord
et a 1. 1977). allogeneic sperm (Mukherjee s± SlLl 1983) and allogeneic
cells (Prakash et a 1. 1976, Lord et a 1. 1979). Inhibitory effects are
not reported to be due to the loss of eel I viability (Lord et al. 1977
Majumdar et a 1. 1982, James et a 1. 1983). Preactivated lymphocytes
are less susceptible to suppression (Majumdar et al. 1982).
15
The mechanism of action of suppression of cytotoxic T-celI
activity by seminal plasma is as yet unclear. Lord et a I. (1977)
report that SP inhibits the induction, but not the expression of cell
mediated cytotoxicity. However, Glater and Anderson (1988) found that
SP prevented destruction of cytomegalovirus (CMV) infected target cells
by activated cytotoxic T-celIs. This was through preventing binding of
the T-celIs to targets and was only seeen when the effector cells were
preincubated with seminal plasma. Turner and associates (1987) also
report that SP inhibits the response of cytotoxic cells to Epstein Barr
Virus (EBV) Infection, permitting polyclonal B cell proliferation.
Plaque forming cell assays indicate that the in vitro humoral
response to T-celI dependent (sheep red blood cells) and independent
(DNP-F, TNP-BA) antigens is reduced by seminal plasma (Lord £± a I.
1977, Thomas and Erickson 1984).
Spermatozoa themselves, when well washed of seminal plasma, are
not reported to suppress lymphocyte function. Human spermatozoa show a
variable, sometimes stimulatory effect in the human MLR (Stites and
Erickson 1975). Autologous murine spermatozoa give a statistically
insignificant slight inhibitory effect in the MLR, whilst no effect at
all could be demonstrated with soluble sperm antigen (Stites and
Erickson 1975). Epididymal spermatozoa did not demonstrate a
suppressive effect on the in vitro humoral response to antigen (Thomas
and Erickson 1980).
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1.4.2 Natural Killer Cells
A number of laboratories have Independently concluded that seminal
plasma has a profound effect on the NK eel I mediated killing of the
K562 human erythroleukemic cell line (James and Szymanlec 1985, Tarter
S± 2± 1986, Marcus et a 1. 1987 Vallely et al. 1988). The Inhibition
of activity Is recorded at all effector:target ratios used (Tarter a±
al. 1986, Marcus £± a 1. 1987) and Is not due to loss of cell
viability (Tarter et al. 1986). PreactlvatIon of the NK cells
renders them far less susceptible to the seminal plasma (S. Szymanlec,
personal communication). The suppressive moiety Is heat stable
(James and Szymanlec 1985, Marcus et al. 1987), and cannot be absorbed
out with the K562 cells (James and Szymanlec 1985).
1.4.3 Mononuclear Phagocyte Systea
Two studies were performed on monocytes and macrophages. James
and coworkers (1983) report that seminal plasma Interferes with the
attachment, spreading and phagocytic activity of Corynebacterlum parvum
elicited murine peritoneal macrophages and the release of reactive
oxygen species from zymosan triggered human peripheral blood monocytes.
Chvapll and coworkers (1977) used human prostatic fluid and extracts of
dog prostatic fluid to demonstrate suppression of rat peritoneal
macrophage oxygen consumption and motility.
17
1.4.4 PoIymorphonucI ear Neutroph11s
Human seminal plasma inhibits release of reactive oxygen species
from zymosan triggered polymorphs (James al- 1983) and dog
prostatic fluid Inhibits oxygen consumption, hexose-monophosphate-shunt
activity and phagocytosis in activated polymorphs but not resting cells
(Stankova et al. 1976). Inhibition of antibody complement mediated
killing and opsonisation of Neisseria gonorrhoea and other gram
negative organisms by polymorphs have also been observed, but
attributed to an anticomplementary activity of seminal plasma (Brooks
A± a_L_ 1981).
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1.5 THE IMMUNOLOGICAL EFFECTS OF SEMINAL PLASMA IN VIVO
A limited number of studies have reported the In vivo effects of
seminal plasma In animals. Anderson and Tarter (1972) used murine
seminal plasma to abrogate both primary and secondary humoral
responses In mice Immunised with epidldymal sperm and other antigens.
Preincubation of epidldymal sperm with seminal plasma prior to
Immunisation reduced their tmmunogenIclty, as did simultaneous
Injection of seminal plasma and sperm at separate sites. Hess and
Bernstein (1985) have shown that In certain circumstances seminal
plasma may be Immunomodulatory la vIvo and not merely suppressive: the
In vivo responses to PHA or splenocytes from normal mice were abrogated
In the presence of seminal plasma, but In mice Immunised with seminal
plasma, In vitro responses were enhanced but variable. Administration
of seminal plasma rectally Into rabbits Is reported to depress Immune
responses (Richards a± a± 1984). Unpublished observations from our own
laboratory suggest that seminal plasma may enhance the growth of
transplanted methyIcholanthrene Induced tumours In syngeneic mice (K.
James, persona I•communIcatIon).
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1.6 POSSIBLE IM*JNOREGULATORY COfTONENTS IN SEMINAL PLASMA
Many of the components of seminal plasma have well-established la
vitro and In vivo ImmunoreguIatory effects, and It Is highly probable
that a number of them could contribute to the reported suppressive
activity of seminal plasma. In Table 2, some of the molecules possible
responsible for this suppression are listed, along with evidence for
their tnvolvment. The prostaglandins, Ionic zinc and the polyamlnes
are discussed In detail below as these components were examined In the
course of this thesis.
1.6.1 Prostaglandins
Semen contains uniquely high concentrations of prostaglandins
which derive from the seminal vesicles. Early work by von Euler (1936)
had proposed the prostate as the major source, but later studies showed
that prostaglandin levels correlated with fructose levels In split
ejaculates (Eliasson 1959) and that seminal vesicles produce
prostaglandins Jn. vItro (Hamberg 1976).
Prostaglandins are 20 carbon containing fatty acids consisting of
a cyclopentane ring to which Is attached two chains, containing 7 and 8
carbons respectively, and are derivatives of the unsaturated fatty acid
llnolelc acid. DIhomo-tf-lInolelc acid and arachldonlc acid are
Incorporated In the phospholipids of cell membranes and become the
precursors of the 1 and 2 series respectively. The four major
prostaglandins In semen are PGE1^ pGE2f 19-oh-PGEj and 19-0H-PGE2.
The 19-OH-E prostaglandins are found In concentrations up to 7.0 x 10~4
M, and the E prostaglandins up to 2 x 10~4M (Figure 2) (Bendvold ,s± a I.
COMPONENT
DIRECT EVIDENCE FOR INVOLVEMENT IN SEMINAL PLASMA MEDIATFD [MMUNOSUPPRESSI ON
TECHNIQUE FOR CHARACTERISATION SYSTEM SUPPRESSED REFERENCE
FROM SP OR PROSTATIC FLUID
PROSTAGLANDINS Lipid extraction of SP and HPLC.
Suppressive activity associated with the
fractions containing 19-OH-PGE^ and 1g-OH-PGE^.
IK eel I Tarter at al. (1986)
Ion-exchange chromatography
The fraction wIth peak suppressive activity
was rich In PGE2
NK eel I Val lely at al* (1988)
ZINC/ZINC PEPTIDE
COWLEXES
Prostatic fluid fractionated by Sephadex G100
chromatography. Fractions of low MW (< 5 KD)
and high zinc content were suppressive, but





Chvapll at AL (1977)
Affinity chromatography fractions with high







POLYAMINES Unable to Isolate from SP. Suppression
In bovine serum supplemented cultures
partially overcome by pretreatment
of the serum with hydroxy 1 amine,
suggesting formation of a suppressive
molecule by Interaction of bovine serum
polyamlne oxidase with seminal polyamlnes.
IK cell activity suppressed
In cultures supplemented
with bovine serum, but not
In cultures supplemented
with human serum, or In
serum free medium.
Vallely et al. (1987)




Seminal plasma elutlon profile Identical to
PAPP-A. Removal of PAPP-A from seminal
plasma removed suppressive activity.
Lymphocyte transformation. BIschof at at-. (1983)
94-KD Fc-RECEPTOR Seminal fluid fractionated by gel exclusion
chromatography. Fraction Inhibitory to
aggregrated IgG binding Isolated by affinity
chromatography on Fc coupled to CNBr-
actlvated Sepharose 48.
Binding of aggregated human
IgG to bull spermatozoa.
Wltkln at aL* (1983)
UTEROGL06ULIN AND
TRANSGLUTAMINASE
None. Treatment of prostatic fluid with
ant 1 sera against uteroglubulIn or trans¬
glutaminase, or an Inhibitor or trans-
glutamlne (neopentyl chloroethy nitrosourea)
reduced Its suppressive effect.
Lymphocyte transformation
(to epldidymal sperm).
Mukherjee at al- (1983)
OPIATES ^-Endorphin Immunoreactlve peptides
extracted with octadecys11ane C8 reverse
phase beads and -endorphin Immunoreactlvlty
assayed by RIA. Suppression overcome by
naloxone addition.
T-Rosette formation. Fabbrl at al■ (1985)
3KD MOLECULE 3KD molecule Isolated from SP by extensive
dialysis, extraction and chromatographic
procedures.
Lymphocyte transformation. PI tout and Jordaan (1976)
PfcCTEIN MW < 20 KD Suppressive activity dlalysed from whole
seminal plasma and from the two major peaks
of a Sephadex G25 separation of SP.
Inhibition of antibody
comp1ement-med1ated k 1111ng
and opsonlsatlon of ti.
gonorrhoeae and other gram
negative organisms.
Brooks at aL* (1981)
PROTEIN MW > 100 KD Sephadex G-100 chromatography of SP fraction
of 1000KD contained suppressive activity.
Lymphocyte transformation. Prakash at aL* (1976)
Sephadex G-25 chromatography of SP void volume
contained dominant Immunosuppressive activity.
Lymphocyte transformation. Lord a± aL* (1977)
TABLE 7. SEMINAL PI ASMA COWONEMTS POSSIBIY INVOLVED IN IMMUNOSUPPRESSION.
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400
H Templeton et a[. 1978
19-OHPGE PGE 19-OHPGF PGF
FIG 2: PROSTAGLANDIN LEVELS FOUND IN SEMEN
IN TWO COMPLETE STUDIES.
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1970, Templeton a± iL. 1978). Smaller amounts of PGF^t PGF2
19-OH-PGF^ and 19-0H-PGF2 are also present. Literature prior to 1974
cites a total of 13 prostaglandins to be found In semen, Including PGA,
19-0H-PGA, PG8 and 19-0H-PG8, but It Is now clear that these are
artifacts of storage (MiddledItch 1975).
A substantial body of evidence Is available recognising PGE as a
major modulator of Immunological and Inflammatory processes. The
action of PGE In controlling cell function Is by a paracrine mechanism
raising Intracellular cAMP concentrations through receptors coupled to
adenyl cyclase via G proteins (Makoul s± al. 1985). Reviewing the
effect of prostaglandins on lymphocytes, Goodwin and Ceuppens In 1974
concluded that PGE Is a feedback Inhibitor of lymphocyte proliferation,
lymphoklne production and T-cell cytotoxicity. More recent studies
have reported that PGE exerts Its antiproliferative effects through
Inhibition of IL—2 production (Tllden al. 1982, Walker at al.
1983, Choualb at al. 1985, Mary at al. 1987, Vercammen and Ceuppens
1987), IL-2 receptor Induction (Vercammen and Ceuppens 1984) and
transferrin receptor expression (Choualb et a 1. 1985). Prostaglandin
E also suppresses the NK cell mediated lysis of susceptible target
cells (Droller et al. 1980, Kendall and Targan 1980).
Macrophages syntheslse and release prostaglandin E In response to
Inflammatory and Immunological stimuli (Humes et a 1. 1977). PGE can
suppress the production of interleukln 1 and la expression whereas
Indomethacln augments these functions, suggesting that PGE acts as an
autocrine regulatory molecule of macrophage Immune function (Synder s±
al. 1982, Kunkel et a 1. 1986).
The immunological properties of 19-OH-PGE has so far only been
Implicated In one study. Tarter at al. (1986) report that an acid
lipid fraction rich In 19-OH-PGE suppresses the cytotoxic activity of
NK eel Is.
The role of prostaglandins In semen Is still open to conjecture,
but It has been postulated that they may participate In the ejaculatory
process, Influence sperm motility, or aid sperm transport In the female-
tract.
Movement of sperm In the upper reproductive tract In ejaculation
would Involve PG synthesis In the vas and epididymis, for which there
Is no evidence (Kelly 1988). Although prostaglandins affect neural
transmission, the levels required are many orders of magnitude below
those found In semen, and It Is unlikely to be the Intended purpose
(Kelly 1988).
The motility of a spermatozoan Is Important In Its fertilising
capacity as certain parts of the female tract, namely the cervix and
the utero-tubal Junction, form a natural barrier to sperm penetration.
The various prostaglandins have small but different reported effects on
sperm motility. Gottlieb et a I. (1988) found that addition of PGE^,
PGE2 and PGF had no effect on sperm motility, 19-OH-E Increased
motility and PGF decreased motility. Only PGF results were
significant. Conversely, Schlegel et a I. (1981) found that PGF£ in
ejaculate negatively correlated with sperm motility and was always
higher In men with disturbed fertility than In the controls.
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Sperm transport in the female tract implies a passive movement of
sperm due to contractile mechanisms in the female musculature.
Seminal prostaglandins are active in relaxing the human uterus in vitro
(Eliasson 1959), but in experiments where semen was deposited intra-
vaginally, results were equivocal (Eliasson and Posse 1960). Kelly
(1988) also notes that in vivo no vascular connection between vaginal
venous drainage and uterus is known, therefore prostaglandins would
have to be absorbed, and sufficient molecules escape degradation in
the lungs, to affect other tissues or organs.
1.6.2 Zinc
The zinc in semen derives mainly from the prostatic secretion
(Mackenzie st. a 1. 1962) and there is a wide physiological range in
concentration. Analysis of nearly 1500 specimens calculated a mean
seminal fluid concentration of 13.3 mg/100 ml, but amounts varied from
0.1 to 62.1 mg Zn/100 ml (Eliasson and Lindholmer 1971). In human
prostatic secretions and seminal plasma, zinc is loosely complexed with
proteins, mostly of a glycoprotein type (Herrmann 1975). The zinc is
removed by dialysis, but despite the weakness of the linkages, its
binding to the cytosol is strong enough to withstand ion exchange
chromatography and electrophoresis (Heathcote and Washington 1974).
A number of In vitro studies have been made on zinc and immune
cell function. Zinc is mitogenic for human lymphocytes (Berger and
Skinner 1974), and requires binding of a zinc-transferrin complex
(Cunningham-RundIes and Cunningham-RundIes 1988). However, similar
concentrations of zinc (0.1mM) suppress the PHA induced proliferation
of lymphocytes (Berger and Skinner 1974), the NK cell mediated lysis of
K562 cells (Ferry and Donner 1984) and reduce the oxygen consumption
and phagocytosis of monocytes (Chvapll et a 1. 1977).
In the reproductive tissues, zinc appears to be essential for
normal testicular function. During spermatogenesis, zinc Is first
Incorporated Into the male gamete In the late stages of the process,
with the keratanold protein of the sperm tall binding the Ion. It Is
suggested that zinc plays a role In sperm maturation by protecting
thiol groups In this protein from excessive oxidation (BaccettI
et a 1. 1973). Seminal plasma zinc may continue this stabilising
function, as studies demonstrate that zinc concentrations In
spermatozoa can be raised by Incubattng them In a zinc sulphate enriched
medium (Ellasson et a 1. 1977, LIndholmer and Ellasson 1974).
1.6.3 Polyamlnes
Human seminal plasma Is a rich source of polyamlnes, with a mean
concentration of 60mg/100 ml of spermine detectable and around ten
times less spermidine and putresclne (Mann and Lutwack-Mann 1984). If
semen Is left to stand, the spermine Interacts with liberated
phosphate from the dephosphoryI at Ion of phosphorycholIne, leading to
the formation of characteristic crystals. The polyamlnes are organic
bases, and are thought to derive from the prostate (Mann and' Lufwack-
Mann 1984). Studies In the rat reveal the key substance In the
synthesis of spermine Is putresclne, a metabolite of arglntne.
Arglntne Is converted In the prostate to putresclne, via the
decarboxylation of ornithine by ornithine decarboxylase. Putresclne
Interacts via spermidine synthase with decarboxyIated S-adenosyl-
methtontne, yielding spermidine, and spermine Is formed from spermidine
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by spermidine synthetase (W111 lams-Ashman et a 1. 1976f WI11 lams-Ashman
and Cane 11akIs 1979).
Information on the the Immunological effects of polyamlnes Is
scarce, but there Is evidence that they stimulate RNA metabolism In
lymphocytes and other cells, probably at the level of RNA synthesis.
Mltogenlc stimulation of peripheral blood lymphocytes results In
Induction of ornithine decarboxylase and S-adenosyI-methionine
decarboxylase (Kay and Lindsay. 1973) and multi-fold Increases In
spermidine, spermine and putresclne In lymph node lymphocytes
(Fllllngame and Morris 1973). The Immunological consequences of adding
polyamlnes Into lymphocyte cultures supplemented with bovine serum,
which contains a polyamlne oxidase, are reported In a number of studies
(Tabor et a 1. 1964, Byrd e± a 1. 1977 r Lablb and TomasI 1981).
Synthetic polyamlnes suppress murine lymphocyte responses to mitogen
and allogenic cells In fetal calf serum supplemented cultures, but not
In human serum supplemented cultures (Byrd £± al. 1977). The
suppression Is not cytotoxic and Is fully reversible. Conversely,
bovine serum and polyaralne Interactions have resulted In loss of cell
viability (Tabor et al. 1964, Lablb and TomasI 1981), and It Is
suggested that spermine and spermidine are converted Into toxic
amlnoaldehydes by polyamlne oxidase (Tabor et al. 1964), and then Into
acrolein (Alarcon 1970). Allen and Roberts (1986 and 1987) and
Vallely et al. (1988) have both correlated seminal plasma mediated
suppression with cytotoxicity In bovine serum supplemented cultures,
and suggest much of the reported work on seminal plasma Is In fact
artefactuaI.
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The exact role of polyamines in ejaculate is still debatable,
although a number of suggestions have been forwarded. Spermine and
spermidine are known to promote cellular growth by stimulating
DNA-primed RNA polymerase. This may be important in the accessory
glands themselves, but is unlikely to be operative in spermatozoa since
they have weak RNA synthesizing activity. The polyamines can also
covalently attach themselves to certain proteins under the Influence
of transglutaminases, and the post-ejaculatory clotting of rodent semen
probably depends on this reaction with vesicular secretion protein
(Williams-Ashman and Cane 11akIs 1979). Spermine and spermidine have
also been implicated in sperm maturation (Bamberg £± al. 1975),
protection from lipid peroxidation conferred upon cell microsomes
(Kitada et a 1. 1979) and inhibition of the conversion of proacrosin to
acrosin (Parrish et al. 1979).
1.6.4 Others
Many components have been implicated in the immunosuppression
mediated by seminal plasma (Table 2). These include a number of other
low molecular weight Inhibitors besides zinc and the prostaglandins and
polyamines. In the rabbit, the antigenicity of spermatozoa is reduced
by the cross linking of uteroglobuI in with cell surface proteins in
the presence of transglutaminase (Mukherjee s± a_L. 1983). Endorphin
immunoreactive peptides extracted from semen (Fabbri et a 1. 1985), a
small (3kD) molecule (PItout and Jordaan 1976) and a low molecular
weight protein (20kD) extracted by G-25 chromatography (Brooks a I.
1981) have all been reported to suppress lymphocyte responsiveness.
28
Prakash £± a I. (1970) and Lord si a I. (1977) have both isolated
a protein of >100 kD from Sephadex G100 and G150 chromatography of
seminal plasma which inhibited lymphocyte transformation. A large (94
kD) Fc-receptor binding protein was isolated from seminal fluid by gel
exclusion chromatography, and as this inhibited binding of IgG to
spermatozoa (Witkin et a 1. 1983), the authors postulate this would
protect the sperm from immunological consequences of surface bound
antibody in vivo.
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1.7 SEMINAL PLASMA AM) INFERTILITY
l+ has been estimated that up to fifteen percent of all marriages
are Involuntarily childless (Swerdloff et al. 1985), and that the male
factor Is present In or contributes to, 50$ of these cases (Ross 1983).
There are many causes of Infertility, Including physical, hormonal
and Immunological pathologies, but It Is Immune Infertility which
Is least well understood (Prakash 1981).
Ant I sperm antibodies can be measured In the blood, semen and the
secretions of the female tract (Rumke and Hellinger 1959, Franklin and
Dukes 1964). The origin of these antibodies Is unclear but much of the
Immunoglobulin Is found In the first portion of the split ejaculate and
Rumke (1976) has correlated serum and semen tltres of IgG, suggesting
that this class of Immunoglobulin transudates from blood Into the
prostate. IgA concentration varies Independently from serum levels,
Indicating a local production by plasma cells In the genital tract
(Rumke 1974).
Approximately 9-10$ of men In Infertile marriages are reported to
have significant serum levels of antlsperm antibodies (Hendry et al.
1977, Hargreave 1982) and a number of studies have shown a
correlation between Increasing antlsperm antibody tltre (Rumke et al.
1974, Mathur et al. 1981, Mandelhaum et al. 1984) and antibody bound
sperm (Ayvallotls at al. 1985) with decreasing fertility. It Is
postulated that antlsperm antibodies could Interfere with fertility In
a number of different ways. Antibodies may Immobilise sperm In cervical
mucus preventing cervical penetration (Kremer and Jager 1980);
stimulate complement mediated cell lysis (Bronson et a 1. 1982);
enhance phagocytosis by macrophages (London et al. 1985); Interfere
with capacltatlon or acrosome reactions (Bronson et a 1. 1983); or
Induce a defective Interaction with the ovum (Mandelhaum et al. 1987).
Bronson et al. (1982) demonstrate that antibodies directed against
sperm heads affect all of these functions, whereas those directed
against tails only weakly affect mucus Interactions.
The reason ant I sperm antibodies are produced In a small number of
men and women remains 'unclear. In the male a breach of the blood
testis barrier by Infection or chemical or physical trauma may result
In their production, with 40 - 60% of vasectomlsed men developing
detectable antibody levels (Alexander and Anderson 1979). However,
antibodies can also occur without histological evidence of damage
(Ritchie et al. 1984). In females, It Is assumed that sensltlsatlon
occurs because of an abnormal Immune response by the female, or
a deficiency In the suppressive activity of their partners semen.
Cell mediated Immune responses against spermatozoa In the male and
female have not been Investigated.
Seminal plasma samples have also been analysed In specific groups
of patients and controls In an attempt to correlate abnormally high or
low concentrations of particular components with Infertility.
Several papers have Implicated low levels of prostaglandins with
Infertility. Bygdeman and associates (1970) calculated the mean PGE
concentration In normal fertile men as 34.4 ug/ml, but only 18.1 ug/ml
In patients with unexplained Infertility. None of the fertile group
samples had PGE concentrations of less than 11 jug/ml, but 41$ of
the patient samples fell below this value. Brummer and Gillespie (1974)
obtained results which were not in total agreement with this study.
They found no significant difference in the mean PGE levels of men
awaiting vasectomy, men with unexplained infertility, and potentially
infertile men with low sperm counts or motility. There was, however,
a significance difference in the scatter of the first two groups. As
this was due to an absence of high values in the group with unexplained
infertility and a number of the fertile group had low levels of PGE,
the authors single conclusion was that high levels of prostaglandin E
could be associated with Increased infertility.
Studies on zinc concentration and total zinc in the seminal plasma
of infertile men have shown no differences in men with normal
spermodiagrams, abnormal spermodiagram or those with varicocele
(Sarada and Yoshida 1985). However, the percentage of men with
decreased motility and normal sperm concentration was significant
in the group with lower zinc concentration or decreased total amount of
z inc.
A very recent study by Shohat s± a I. (1988) has correlated
polyamine levels, antisperm antibodies and fertility. Infertile
couples of at least 3 years duration and with antisperm antibodies in
the sera had levels of spermine and spermidine 50$ lower than controls,
and a reduced ability of seminal plasma samples to induce
immunosuppression.
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1.8 SEMINAL PLASMA COMPONENTS AND GENITOURINARY TRACT DISEASE
Seminal plasma may play a vital physiological role in preventing
sensitisation of females to spermatozoa during coitus, but a number of
workers have suggested that this very role may implicate It as a factor
in the aetiology or pathogenesis of a number of genitourinary tract
diseases such as bacterial and viral infection and neoplastic disease
(James and Hargreave 1984, Alexander and Anderson 1987). Many
microorganisms are transmitted by sexual intercourse including
Neisseria gonorrhoea, chlamydia, hepatitis B virus (Heathcote et a I.
1974), human immunodeficiency virus (.HIV) (Ho £± al. 1984), herpes
simplex virus (HSV) (Centifanto et a 1. 1972), CMV (Lang and Krummer
1972), Epstein Barr virus(EBv) (Sixbey et a 1. 1986) and the papilloma
virus (Meisels and Fort in 1976). In vitro studies have revealed that
seminal plasma inhibits the complement dependent antibody mediated
lysis of Neisseria gonorrhoea and other gram negative rods (Brooks si
a 1. 1981), the phagocytic activity of macrophages (Chvapil et a I.
1977, James et a 1. 1983), the destruction of CMV infected target cells
by cytotoxic T-cells (Glater and Anderson 1988) and the response of
T-cells to EBV infection (Turner et a 1. 1977).
Prostatic and cervical cancer are two of the most prevalent
neoplasms in men and women respectively (McGregor and Teper 1978,
Bouffioux 1983). Very little work has been performed on seminal plasma
and tumour growth, but data from our laboratory has suggested that
seminal plasma enhanced growth of transplanted methyIcholanthrene
induced tumours in syngeneic mice (James and Hargreave 1984).
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1.9 AIMS OF THIS STUDY
1) to establIsh in vitro models of T-celI, NK eel I and macrophage
function, confirm the Immunosuppressive properties of whole seminal
plasma and study Its mechanism of action.
2) to characterise components from semen which are responsible for
suppression of Immune eel I function.





2.1 BASIC MATERIALS AM) EQUIPMENT
2.1.1 Media
Unless otherwise stated, cell cultures were maintained In complete
RPMI-1640 (cRPMI). RPMI-1640 medium (Gibco) was supplemented with 2mM
L-glutamlne (Gibco), 100 lU/ml penicillin (Gibco), 100 ug/ml
streptomycin (Gibco), 5 x 10"® M mercaptoethanol (BDH) and 1058 pooled
human AB positive serum (Sigma). In some experiments AB serum was
replaced by 1058 foetal calf serum (Flow) (cRPMI-FCS) or 1058 newborn calf
serum (Flow) (cRPMI-NBCS). In experiments requiring serum-free
culture, HB103 serum free medium for human mononuclear cells (NEN
products) was used.
2.1.2 Blood Samples
Blood samples were obtained with consent from laboratory staff or
from donors to the Blood Transfusion Service, Edinburgh. Blood was
collected Into 10 ml sterile blood collection tubes containing 0.1 ml
of a 1358 solution of EDTA (Monojet). Peripheral blood mononuclear
cells (PBMC) were Isolated by gradient centrIfugatIon on lymphocyte
separation medium (Flow). Cells were washed x 3 with Hanks Balanced
Salt Solution (HBSS) (Gibco) and resuspended to the appropriate
concentration In cRPMI.
2.1.3 Seminal Plasma (SP)
Seminal plasma was obtained from routine laboratory specimens of
donors attending the Infertility clinic run by this department. All
were negative for antibody to sperm as tested by the tray agglutination
3®
procedure (Friberg 1974). Spermatozoa were removed by centrifugatIon
at 1000 g for 10 minutes and pools of approximately 20 samples were
made. 1 ml alIquots were stored at -20°C until used. Most batches
were tested for hepatitis B surface antigen and antibodies to HIV
(courtesy of the Virology Department, University of Edinburgh).
2.1.4 Mitogens and Antigens
The mitogen used throughout the study was phytohaemaggIutlnIn
(PHA) (purified grade, Sigma), dissolved in phosphate buffered saline
(PBS, pH 7.2) to a stock concentration of 5 mg/ml, and stored in
a IIquots at -20°C until use. Lipopolysaccharlde (£. col I serotype
055:BS, Sigma) was dissolved In phosphate buffered saline to a stock
concentration of 10 mg/ml and stored in aliquots at -20°C until use.
Tetanus toxoid antigen was prepared from tetanus vaccine BP (14LF/0.5ml
in simple solution with 0.01 % thIomersaI)(Wei I come). 0.5ml of vaccine
was dialysed for 48 hours against 2 litres of PBS, filter sterilised,
allquoted and stored at 4°C until use.
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2.1.5 Monoclonal Antibodies (mcAbs)
Monoclonal antibodies used for studying leucocyte surface- markers
are given in Table 3.
Leu 2,3 and M3 were supplied as 500 jjg of purified immunoglobulin
in phosphate buffered saline containing 0.2% gelatin and 0.1% sodium
azide. The HLA-DR monoclonal antibody was in the form of tissue culture
supernatant containing 0.1% azide. Transferrin receptor and interleukin
2 receptor (IL-2R) monoclonal antibodies were supplied as tissue culture
supernate with FCS and 15 uM sodium azide. All McAbs were titrated out














CD71 Transferrin receptor Ber-T9 Dakopatts
IL-2R CD25 IL-2 Receptor ACT-1 Dakopatts
HLA-DR Non-polymorphIc
class II antigens
DA6.231 Gift of K.Guy
Leu M3 Monocyte-macrophages M0-P9 Becton
DickInson
TAB! F 3. MONOCL QNAL ANTI BOD IES
2.1.6 Grcw+h Factors, Prostaglandins and Spermidine
Human recombinant in+erleukln 1 (rlL-1) was obtained from Genzyme
In a stock concentration of 100 Units/ml. AIiquots were stored at
-20°C for a maximum of one month before use. Human recombinant IL-2
(rlL-2) was obtained from Boehringer-Mannheim at 200 U/ml and stored in
aliquots at -20°C. Prostaglandin (Tissue culture grade,
Sigma) was dissolved in ethanol (5 mg In 1 ml), diluted with RPMI to
-4
1 x 10 M, aliquoted and stored at -20°C. 19-OH-prostaglandin
(19-OH-PGE^ and 19-OH-prostaglandin (19-OH-PGF^) (Cayman Chemicals)
-4
were made Into stock solutions of 3.33 x 10 M and stored In a Iiquots
at -20°C. Spermidine (free base, tissue culture grade) (Sigma) was
diluted in distilled water to 10mg/ml and stored at 4°C until use.
2.1.7 FIuorescent Microscope
A Carl Zeiss Jena fluorescence research microscope was used.
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2.1.8 Incubator
Unless otherwise stated all incubation procedures were carried out
in a Heraeus incubator providing a constant 37°C temperature and 5% CO^
level.
2.1.9 Cell Harvester
A Skatron semi-automatic cell harvester with a filterdisc transfer
system was used.
2.1.10 Counter
{& Emissions were measured using an LKB scintillometer, and
emissions using an LKB 1260 multigamma counter.
2.1.11 Flow Cytometer
The flow cytometer used in these studies was the Coulter Epics C
Clinical Flow Cytometer (EPICS) (Figure 3). Flow cytometry Is a high
precision technique which allows rapid phenotypic analysis and sorting
of cells based on their physical and fluorescence associated
measurements. A single cell suspension is a prerequisite of the
technique. Cells are stained using a direct or indirect fluorescent
technique and the preparation injected into the flow cell of the
cytometer (1) where they are hydrodynamically focused (2) into single
file for passage through the interrogation point. Excitation takes
place either in an enclosed quartz flow cell or in air (3). Cells
physically interact with the exciting beam of light, scattering it in
all directions. Light scattered in the forward direction Is related to
size of the cell and that at 90° to the degree of refraction of its




FIGURE 3. A SCHEMATIC REPRESENTATION OF FLOW CYTOMETRY.
The crossed circles represent fluorescence positive cells and the
open circles fluorescent negative cells. Abbreviations used: FALS -
forward angle light scatter; F1 and F2 - Fluorescence
photomuItlpller tube detectors; 90° LS - 90° light scatter detector;
D - dichrolc mirror; F - filter; pd - potential difference; ADC -
analogue to digital converter.
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measurements are also possible if an appropriate sizing device or
polarisation filters are fitted. Excitation of the fIuorochrome(s)
occurs at the interrogation point (3) with the emission of light of a
longer wavelength. This is also collected at 90°; selected wavelengths
are directed by dichroic mirrors to photomuitipIier detectors(5) and
unwanted fluorescence and scattered laser light are blocked by optical
filters. Analogue electric signals are generated for each particle (6)
and converted to digital signals (7) for processing by computer




2.2.1 The Lymphoproliterative Response to Mitogen and Antigen
Washed PBMC were suspended in cRPMI at a concentration of 1 x
10^/ml. 100 ul al iquots were cultured in triplicate with 20 >u I
mitogen and 20 ul diluted test material in 96 well round bottomed
plates (Sterilin). Cultures were pulsed with tritiated thymidine
(Amersham) (0.75juCi/weI I) after 72 hours (mitogen) or 6 days (antigen)
and harvested 18 hours later with the Skatron semi-automatic cell
harvester onto filter mats (Skatron). When mats were dry, each disc
was placed in a closed vial with 3 ml of scintillant and counted for
60 seconds in the /^-scintillometer.
Time course studies: test material was added at stated times before and
after mitogen addition.
Preincubation studies: PBMC were incubated in cRPMI with test material
in conical bottomed centrifuge tubes (Sterilin) for four hours. Cells
were washed x 3 with HBSS before plating out with mitogen as described,
.recombinant IL-2 supplemented studies: rlL-2 was added to cultures with
mitogen and test material.
2.2.2 Viability Studies
These were based on a method by Parks s± aJ. (1979) using ethidium
bromide (EB) and acridine orange (AO). A 100 x stock solution was made
with 50 mg of EB and 15 mg AO dissolved in 1 ml of 95? ethanol and
diluted 1/100 with PBS, and frozen. 1 ml of stock was diluted 1/100 in
PBS when required and stored in an amber bottle at 4°C for up to one
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month. Cells were adjusted to 1 x 10^/ml in RPMI, 20 ul mixed with
20 ul of AO/EB, and 200 cells per sample counted under the fluorescent
microscope. Acridine orange enters living cells giving the nuclei a
green fluorescence, and ethidium bromide is excluded by intact cell
membranes, but stains the nuclei of dead cells orange fluorescent.
2.2.3 Analysis of Cell Surface Markers and Activation Antigens
Washed PBMC were suspended at-a concentration of 1 x 10^/mi and
duplicate 1 ml aliquots were cultured with 20 ul mitogen and 20 ul test
material in conical bottomed centrifuge tubes for 60 hours. Cultures
were washed x 3 with HBSS and stained as follows using an indirect
ImmunofIuorescent technique. After the third wash, each pellet of
cells was suspended in its residual medium and 20 ul of staining medium
(RPMI + 0.1$ azide + 2% bovine serum albumin). 1-10 jj I of monoclonal
antibody was added to one tube of each duplicate and 10 ul of PBS to
the other. Tubes were incubated for 30 minutes on ice, 5 ml
of HBSS added, and centrifuged at 1000 g for 7 minutes. Pellets were
resuspended and a 1/20 dilution of sheep anti-mouse (Fab^-FITC
antibody (Sigma) added in 15 ul' staining medium. After 30 minutes
cells were washed twice in HBSS and the pellets resuspended and fixed
in 1 ml of 1$ formaldehyde in PBS. Samples were generally stored for
24-96 hours before analysis. This does not affect any parameters being
measured (Eric Miller, personal communication). Cells were analysed
using the Coulter Epics C CI inical Flow Cytometer. Samples stained for
second antibody only were used to define negative populations (setting
an acceptable background fluorescence) and to ensure non-specific
binding was not occurring in the different test situations. Samples
were gated for lymphocytes using forward angle light scatter, and a
minimum of 20,000 cells per sample were counted.
2.3 NATURAL KILLER CELLS
2.3.1 Natural Killer Cell Mediated Cytotoxicity Assay
PBMC were washed, resuspended to 4 x 106 cells/ml in cRPMI, and 5
ml aliquots were incubated in 25 cm^ flasks (Corning) for 20 minutes at
37°C to remove adherent cells. Non adherent cells were poured off,
spun at 1000 g for 5 minutes and resuspended to 2.5 x 106 cells/ml in
cRPMI.
Target eel I s: The K562 human erythroleukemic line was continuously
maintained in suspension culture in cRPMI + ]0% FCS. Twenty four hours
before an assay 5 ml of a well grown culture was added to 15 ml of
fresh medium. On the day of the assay 10 mis of culture (approximately
2 x 10^ cells) was removed to a conical bottomed centrifuge tube and
washed x 3 with RPMI. The pellet of cells was resuspended In residual
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medium, labelled with 100 jjCi Cr (Amersham), 1 ml of RPMI added and
then incubated in a 37°C water bath for 1 hour. Cells were washed and
resuspended in 10 ml of RPMI for 30 minutes at room temperature
to allow the release of isotope from dying cells. After a final wash,
5
cells were suspended in cRPMI at 2 x 10 /ml.
Chromium re I ease assay: This was performed by adding 50 xi I of
target cells to 100 ju I of lymphocytes and 15 ul of diluted test
material. The effector to target cell ratio was 25 to 1 (unless
otherwise stated) and assays were performed in triplicate. Background
release was monitored using target cells and medium only, and total
release was calculated from target cells lysed with (v/v) Nonidet
(BDH). Plates were incubated for 4 hours, centrifuged to pellet the
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cells and 100 jul superna+e removed for counting in the gamma
scintillometer. Percentage release was calculated using the formula:




2.4.1 Separation of Monocytes
This was based on a method by Freundlich and Avdalovic (1983). 25
cm"5 flasks were precoated with a 2% gelatin solution and allowed to dry
thoroughly. Flasks were stored in a dry incubator for up to one month
before use. Donor blood was separated by the usual method, but plasma
was retained and spun at 1500 g for 15 minutes. 5 ml of autologous
plasma was pipetted into each gelatin coated flask, swirled around and
Incubated for 60 minutes. Plasma was poured off, the flasks gently
rinsed, and PMBC at 3 x 10^/ml in cRPMI-20? horse serum were added.
Flasks were incubated for 40 minutes. NA cells were poured off and
flasks rinsed with RPMI. 10 ml of a 1:1 solution of 10mM EDTA in PBS
and cRPMI-20? horse serum were added to the flask, which was then
tapped gently for 10 minutes. Adherent cells were poured off, spun
down, and resuspended in the residual medium. The average viability of
cells after this procedure was 99.0%. The average differential count
from this separation procedure was 94.0% monocytes and 6.0? large
lymphocytes (see below for method).
2.4.2 Testing the Purity of Monocytes
A drop of the monocyte preparation and a drop of FCS were mixed
together, and cytospin preparations were made. Slides were fixed for 1
hour in acetone. Monocyte purity was examined using an indirect
immunoperoxidase technique with the Leu M3 monoclonal antibody
(Becton-Dickinson). Briefly, slides were rinsed in tris buffered
saline(TBs) buffer (100 ml 0.2 M Tris, 165 ml 0.1M HCI, + 17 g NaCI made
up to 2 Iitres and the pH adjusted to 7.6) for 5 minutes, followed by
an incuba+ion in 25? normal rabbit serum (NRS) in TBS for 10 minutes.
A 1/100 dilution of Leu M3 in TBS + 2? NRS was then applied for 30
minutes. Slides were rinsed with TBS, and rabbitA/mouse peroxidase
conjugate (1/30 dilution) in TBS+2? NRS was added for 30 minutes.
Slides were washed twice with TBS. The final colour reaction was
achieved by incubating preparations for 5-8 minutes in 0.01? H2^2 anc'
0.05? DAB freshly prepared in TBS. Slides were dehydrated in graded
alcohol, cleared in ethylene and mounted in DPX.
2.4.3 Production of Interleukin 1
The method for producing and assaying IL—1 was adapted from a
method by Gearing et a I. (1985).
Monocytes were resuspended in HB103 serum free medium to a
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concentration of 2 x 10 /ml. Aliquots of 1 ml were dispensed into
conical bottom centrifuge tubes and 15 ul of diluted SP or medium alone
were added. After one hours incubation, cells were washed x 3 with
HBSS and resuspended to 2 x 10 cells/ml. Each of the treated samples
was dispensed into triplicate 200 ul a Iiquots in 96 well round bottom
plates, and 0, 1, or 10 jug of LPS / ml added. After 20 hours
incubation, cells were spun down gently and supernatants pipetted off.
Supernatants were passed through a 0.2 urn disposable filter unit
(Gelman Sciences), and stored at -70°C until use.
2.4.4 Assay of Interleukin 1
This was by the comitogenic mouse thymocyte assay. Endotoxin
resistant C3H/He mice were used between 4-6 weeks of age. Animals were
killed, the thymus removed, and a single thymocyte suspension made by
teasing the organ apart with two syringe needles. Cells were washed x
3 in HBSS and adjusted to 5 x 10® /ml in cRPMI-FCS (approximately 10®
cells were obtained per animal). PHA was added at 1 jug/ml.
Quadruplets of 175 ju I of thymocytes were dispensed into 96 well round
bottom plates. 25 ul of supernates were added in doubling dilutions
from 1:2 to 1:64 (final dilutions in culture were therefore 1:16 to
1:512). A recombinant IL—1 standard curve was also prepared using
doubling dilutions from 0.375-6 Units/ml. Plates were Incubated for 48
hours before pulsing with tritiated thymidine (0.75 yCi/well). Cells
were harvested 18 hours later onto filter discs, and counted as
described earlier.
2.5 PRESENTATION OF RESULTS
Triplicate cultures were made In all lymphocyte and NK cell
studies, and quadruplet cultures in the thymocyte proliferation assay.
Very occasional single rogue counts were not included in the final
data. All results are presented as the mean and standard deviation
(standard deviations are given as horizontal bars above and below the
mean in all graphs). Standard deviations in mitogen and antigen
stimulated lymphocyte cultures, the thymocyte proliferation assay, and
NK cell assays were less than 20$, and in baseline lymphocyte
cultures, were less than 25$. Where indicated, results were




2.6.1 Large Volume Dialysis
8/32 dialysis tubing was soaked In several changes of PBS, and 2
ml of seminal plasma was securely tied In a length of the tubing and
dlalysed overnight at 4°C In 4 litres of PBS. DIalysed seminal plasma
(HSPjvd) was stored at -20°C until use.
2.6.2 Small Volume Dialysis
8/32 dialysis tubing was soaked In several changes of PBS, and 1
ml of seminal plasma I was securely tied In a length of tubing and
dlalysed overnight at 4°C In 20 ml of PBS. Dialysis tubing containing
buffer only was also dlalysed to act as a control for culture
experiments (B). Dlalysed seminal plasma (HSPsvcj> and the dlalysate
were stored at -20°C until use.
2.6.3 Fractionation of Seminal Plasma by Sephadex G200 Gel Filtration
Sephadex G200 (Pharmacia) was swollen by adding 10 g to 730 ml
of PBS and leaving overnight. Excess liquid was removed, and the
gel pipetted Into a 30 x 3 cm column. Once the column was packed, PBS
was pumped through St approximately 20 ml/hour using a peristaltic
pump. Seminal plasma (0.5 ml centrlfuged at 50 000 g for ohe hour)
diluted In 0.5 ml PBS was applied to the column. An automated
fraction collector was attached to the column and 1.5 ml fractions
were collected. UV absorbing material was monitored at 280 nm, and
the fractions from the three resulting peaks pooled, filtered and
stored at -20°C.
2.6.4 Reverse Phase Chromatography
This procedure was carried out by Dr. R.W. Kelly of the MRC
Reproductive Biology Unit, Edinburgh. A 20 ml pool of a seminal plasma
was centrlfuged at 50 000 g for 15 minutes, and the preclpate
discarded. The sample was then separated by reverse phase
chromatography on a 15 x 300 mm c18 30uM silica column (Waters, Harrow)
with a linear gradient of acetonttrlle In water from 0 to 80?. Sixty
4 ml fractions were collected over a 4 hour period. A 0.7 ml aliquot of
each fraction was removed to determine UV absorbance and 0.1 ml was
diluted to 1.1 ml with a methyl ox Imating solution and assayed by
radioimmunoassay for PGE (see below). The remainder of the fractions
were freeze-drled and reconstituted with RPMI-1640 (GIbco). AlIquots
were frozen at -20°C until use.
2.6.5 Dellptdatlon of Seminal Plasma by Absorption Chromatography
This procedure was carried out by Dr. R.W. Kelly. A 20 ml pool
of seminal plasma was centrlfuged at 50 000 g for 15 minutes, and the
precipitate discarded. 2 ml of the sample was dellpldated by passage
through a C18 reverse phase cartridge (Seppack-Waters) which had been
primed with methanol. A small sample of the eluate was measured for
PGE and 19-0H-PGE (see below), and the remainder of the sample frozen
In alIquots at -20°C until use.
2.6.6 Anion Exchange Chromatography
The procedure was carried out by Dr. R.W. Kelly. A 20 ml pool
of seminal plasma was centrlfuged at 50 000 g for 15 minutes, and the
preclpate discarded. 2.5 ml of the sample was loaded onto a PD10
Sephadex G25 column (Pharmacia) which had previously been washed with
20 ml water. The excluded protein was collected in 3.5 ml water and
2.0 ml of this eluate together with 2.5 uCi of a PGE2 tracer (Amersham)
was injected into a 7.5 x 75 mm DEAE 5PW HPLC column (Waters). The
column was equilibrated with 20 mM ammonium formate (pH 7.6) (buffer A)
and eluted at 3 ml/min with a gradient to 100$ of buffer B (1.0 M
ammonium formate). Protein distribution was determined by UV
absorption at 280 nM and 2 min fractions were collected. Distribution
of labelled PGE was assessed by scintillation counting. The PGE
content of each fraction was determined by mixing 200 ul aliquots of
each fraction with methyI oximating solution and measuring after
suitable dilution in the PGE2 radioimmunoassay (see below). The
remainder of each fraction was freeze-dried and reconstituted with
RPMI-1640 (GIbco). AIiquots were frozen at -20°C until use.
2.6.7 Radioimmunoassay of PGE and 19-OH-PGE
This was carried out by Dr. R.W. Kelly and Ms. P. Holland.
Radioimmunoassays were carried out on prostaglandins protected as
methyl oximes, and has been described in detail elsewhere (Kelly et a I.
1984). Antisera was raised against the methyI oximated prostaglandin,
and methyI oximated standards were used to create the standard curves.
For the 19-OH-PGE assay the prostaglandin used to raise the antiserum
was extracted from human semen and the antiserum cross reacted equally
with 19-OH-PGE.j and I9-OH-PGE2. The cross reactivity against PGE2 and
PGE.J was less than 1$ although there was appreciable (5$) cross
reactivity with 19-OH-PGF. The latter was not considered a problem
given the lower amounts of 19-OH-PGF found in semen (Templeton et a I.
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1978). In the PGE£ assay the cross reactivity against PGE^ was 26%
and against 19-OH-PGE^ ]%. The tracers used were a labelled
peptide coupled through proline to PGE 2 methyloxine for the assay
and a similar conjugate with tyrosine methyl ester for the 19-OH-PGE
methyl oxine assay. Separation of bound and free tracer was achieved





3.1 MECHANISMS OF ACTION OF WHOLE SEMINAL PLASMA ON IMMUNE CELL
FUNCTION
3.1.1 The LymphoprolIterative Response to Mitogen
Lymphocyte proliferation may be Induced by plant lectins such as
phytohaemagglutlnin (PHA), and can be measured by assessing
Incorporation of a radlolabelled precursor of DNA (usually trltlated
thymidine) Into dividing cells. Unless stated otherwise, DNA synthesis
was assessed In PBMC cultures 90 hours after Initiation of culture,
with addition of trltlated thymidine 18 to 20 hours before harvesting.
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A comparison q± fresh jand. frozen seminal .plasma pools, and. Q±
different frozen seminal plasma pools.
Practicality dictated that seminal plasma samples routinely
tested were stored at -20°C for a number of months during use. It
was therefore necessary to establish that these frozen samples
behaved in a similar way to fresh semen samples. A 90 hour
lymphocyte proliferation to PHA was performed with the addition of
either a frozen SP pool (n = 30 donors) which had been stored for
approximately 2 months at -20°C and frozen-thawed twice, or a fresh
SP pool (n = 20 donors) which was used within 6 hours of collection.
Cultures were stimulated with 0, 1.25, 5 or 10 ng/ml PHA in the
presence of 1, 1 or 2$ SP (v/v).
The results demonstrate that SP has little effect on basal
proliferation (± 15^) and the suppressive effect decreases with
higher concentrations of PHA. This is discussed in detail from page
55. Statistical analysis of the results with fresh and with frozen
SP was made using a paired t-test. Eight pairs were constructed
using the proliferation results obtained with the four mitogen
concentrations and 1 and 2% SP. No significant difference was found
between the pools ( p > 0.5).
It was also necessary to demonstrate that the four frozen SP
pools used in this study all had a similar pattern of activity. The
pools could not be tested in a single assay as they were used
sequentially over 18 months, but Figure 4 illustrates the results
for four proliferation assays to 5 and 10 jug/ml PHA using the same
PBMC donor and 2% SP (v/v). As the standard deviation bars overlap,
we can conclude there is no difference in the activity of the pools
except that due to samp Iing error.



































Tahla4.ACOMPARISONFTHEEFFECTOFFRFSHANDFR07 NS MIN IPIAS AOTHELYMPHOPRQI.IFERA IVRESP NSTPH .
FIG 4 ; A COMPARISON OF THE EFFECT OF FOUR DIFFERENT FROZEN
SEMINAL PLASMA POOLS ON THE LYMPHOPROL1FERAT1VE RESPONSE TO PHA.
In four separate experiments.PBMC from the same donor were cultured
for 90 h ours with 5>ug/ml PHA (4A.) or 10jug/ml PHA (4B.) and medium
alone or 2% SP (v/v) from one of the four pools. Results are expressed
as the % suppression of the control culture in the absence of SP". Control
responses in cpm + sd were: 42415±6255; 23311 4 491; 23158 43275;
& 30936 i 5537 at 5pg/ml and 44680 ± 558; 66691 15987; 38597 ±
5220 &38407 ± 2373 at 10ug/ml.
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A comparison oi PBMC donors.
In addition to ensuring that different SP pools behaved
similarily, It was Important to establish that the proliferative
responses of different PBMC donors were suppressed in a similar way.
Figure 5 illustrates the results obtained in four 90 hour
proliferation assays with four different donors to 1.25, 5 and 15
ug/ml PHA in the presence of 2% SP (v/v). Although control donor
responses to PHA varied considerably (data not given here, but see
throughout results section), SP suppressed proliferation in each
donor by a similar value. Standard deviation bars overlap at each
mitogen concentration, and we can conclude there is no difference in
the effect of SP on different PBMC donors, except that due to
sampling error.
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FIG 5 : A COMPARISON OF THE EFFECT OF SEMINAL PUVSMA ON FOUR
PBMC DONORS.
PBMC from four donors were cultured for 90 hours with 1.25 (5A.)P
5.0 (5B.) or 15.0 (5C.) .ug/ml PHA and 2% SP (v/v). Results are
expressed as the % suppression of the control culture in the absence
of SP. The controlvalues for donors A, B, C and D respectively were
(cpm * s.d.): 6019 ± 910, 7893 ± 844, 9854 s. 624 & 16538 i-1423
at 1.25 ug/ml PHA; 36017 ± 920, 19833 1264, 49712 ±1793 &
51194 ± 1035 at 5.0 ug/ml and 5024 1 488, 34724 ±- 3873,
70379 i 249 & 98724 ± 9944 at 15.0 ug/ml.
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D£££ response curves ami viabiIity q± i£ treated eel Is.
The 90 hour proliferative response to a range of PHA
concentrations (1.25 - 40 ug/ml) in the presence of 1 or 2% (v/v)
seminal plasma in culture is illustrated in Figure 6. Suppression
mediated by 1 and 2% SP is maximal at the lowest PHA concentration
used in this experiment, and decreases with increasing mitogen dose.
At a post optimal PHA concentration, suppression by ]% SP is
completely abrogated.
In Figure 7 a seminal plasma dose response curve to three
suboptimal concentrations of PHA is shown. Suppression is again
maximal at the lowest mitogen dose, and SP is effective from 0.25-4^
(v/v) in culture. Viability studies were made on PBMC exposed to
These concentrations of SP for 90 hours with no mitogen present
(Table 5). Using ethidium bromide which stains non-viable cells
orange, and acridine orange which is a vital stain, only a very
small loss of viability was demonstrated. This was < 4% with SP
used between 0.5 - 2%, and 9% when SP was used at a final
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FIG 6 ; THE EFFECT QF SEMINAL PLASMA QN THE LYMPHQPRQLIFERATIVE
RESPONSE TO INCREASING CONCENTRATIONSOF PHA.
PBMC were cultured for 90 hours with 1.25 - 40.0ug/ml
PHA and medium alone(»),1% SP(v/v)(«) or 2% SP(v/v)(A).
The figures in brackets are the % suppression of the control
response without SP.
56
% SP IN CULTURE
FIG 7 :THE DOSE-RESPONSE EFFECT OF SEMINAL PLASMA ON
PHA INDUCED LYMPHOPROUFERATION.
PBMC were cultured for 90 hours with 1.25 (•), 5.0 (■) or
10.0 (A) ug/ml PHA and medium alone or 0.25-4% SP(v/v).
Results are expressed as the % suppression of the control
response without SP. (Control responses in cpm 1 sd were:
47871 251 at 1.25 ug/ml PHA; 37951 12552 at 5ug/ml PHA;
and 419241184 at 10 ^jg/ml PHA.
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TABLE 5. THE VIABILITY OF CELLS AFTER
90 HOURS IN CULTURE WITH SEMINAL PLASMA.
Viability was assessed using ethidlum bromide
and acrtdtne orange and 200 cells were counted
per sample.
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Reverslb I IIty Q± suppression.
A preincubation study was next Initiated to discover If
pretreatment with seminal plasma could suppress subsequent responses to
mitogen. PBMC were Incubated with or without 1 % SP (v/v) for four
hours at 37°C, washed three times and then cultured with PHA for 90
hours (Table 6). At all concentrations of PHA, proliferative values of
SP pretreated cells were equal to those of the SP untreated cells,
suggesting complete reversibility of suppression.
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PHA >ug/m 1 CONTROL CELLS 1* SP PRETREATED
CELLS
0 437 ± 57 487 ± 44
1.25 6088 ± 871 6888 ± 2090
5.0 28023 ± 2158 29867 ± 233
10.0 24772 ± 1206 24308 ± 1520
TABLE 6. THF EFFECT OF PRETREATING LEUCOCYTES WITH SEMINAL PLASMA.
PBMC were pre+reated wi+h medium alone or \$ SP (v/v) at 37 °C for
4 hours before culture with PHA for 90 hours.
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Time course studies.
A time course assay was established to examine at which time
points In the process of activation and differentiation SP could
mediate its effects. SP (v/v) was added to cultures at 4 and 24
hours prior to, at the same time, or 4, 24 or 72 hours after PHA.
Two suboptimal concentrations of PHA were used, and cultures
harvested after 90 hours (Figure 8). Suppression of proliferation
was maximal when SP and mitogen were added together or when SP was
added 4 hours before mitogen. Addition of SP 24 hours before or
4 hours after PHA resulted in a small(<20$) decrease In suppression.
If SP addition was delayed until 24 or 72 hours after initiation of












































FIG 8: THE EFFECT OF TIME OF ADDITION OF SEMINAL PLASMA ON
THE LYMPHOPROLIFERAT1VE RESPONSE TO PHA.
PBMC were cultured for 90 hours with 0.6(8A.) or 5.0 (8B.) ug/ml
PHA. 1% SP(v/v)£2 . or RPMI□ were added at the same time,
24 and 4 hours before, or 4,24 or 72 hours after mitogen.
Figures given are the % suppression of the control response without SP.
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Expression q± the. IL-2 receptor.
Induction of T-cell proliferation first requires that the
T-cells are activated to express receptors for interleukin 2 and
subsequently that they respond to IL-2 by pro IiferatIon and that
they produce this growth factor (CantrelI and Smith 1984). A
study was therefore initiated to look at the correlation between
receptor induction and proliferation in PHA stimulated cultures
under the influence of SP. IL-2 receptor expression was measured
using a monoclonal antibody to the receptor in an indirect
immunofluorescence staining technique, with subsequent analysis of
cells using a flow cytometer. Initial experiments with control
cultures showed that when PHA induced IL-2 receptor expression was
measured over a few day period, maximum expression occurred
between 48 and 72 hours (data not given), therefore, all subsequent
experiments measured receptor expression at 60 hours.
Table 7A illustrates the result of culturing PBMC from 2 donors
with 0.25 or 10 yg/ml PHA and 2% seminal plasma (v/v). Parallel
cultures were set up to measure receptor expression and
proliferation (these cultures were pulsed at 48 hours and harvested
at 60 hours). The number of freshly prepared PBMC expressing
receptors for IL-2 and the CD4 and CD8 antigens was analysed to
verify that donors values fell within the normal range. In 60 hour
cultures with no added mitogen, the number of cells expressing IL-2
receptors in both donors was similar to the number of freshly









































































TABLE7A.THEFFECTOFS MINAL.PLASMQ11-2REC PTOREXPRESSIONANDLYM H PROLIFERATI N. PBMCfrom2donorswereculturedfo60h urswith0,2.5o10ug.mlPHAandmediualo eor2*SP(v/v)DonorAfresh PBMCvalueswer:IL-2R=1.7*,CD430 1$,8=1 .4*.DonorBIL-2R=1.8*,D417 *,C=1 .5*.
decreased the number of cells expressing the IL—2 receptor in
stimulated cultures, and suppression was more effective at the
lower PHA concentration. In all the experimental conditions,
receptor expression paralleled the values for proliferation.
Similar results were achieved with donor B, except for the
disproportionately large decrease in proliferation at the lower PHA
concentration used. The proliferation results obtained in these
studies also confirm that the pattern of suppression by seminal
plasma is the same after 60 hours of culture as 90 hours of culture.
It was not possible to present any statistical analysis of the
receptor studies. Duplicate cultures were always made, but one was
stained for second antibody only to provide a control for each
treatment. Table 7B, however, illustrates the effect of 2% SP (v/v)
on IL—2 receptor expression in five separate experiments using six
PBMC donors stimulated with 2.5 and 10 ug/ml PHA. Suppressive
effects were remarkably consistent with standard deviations of less
than 5%, and indicate that the single results obtained in these
studies are reliable, and that suppressive effects of seminal plasma
are similar in all donors.
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% SUPPRESSION OF CONTROL IL-2 RECEPTOR
EXPRESSION BY 21 SP (v/v)




























Table 7B THE EFFECT OF SEMINAL PLASMA ON IL-2 RECEPTOR EXPRESSION
IN SIX PBMC DONORS.
In five experiments, PBMC from six donors were cultured for 60
hours with 2.5 or 10 .ug/ml PHA and medium alone or 2% SP (v/v).
Results are expressed as the percentage suppression of IL-2 receptor
expression of the control values (at 2.5 jug/ml PHA these values were
25.5, 46.3, 25.3, 44.4 and 37.5 % cells positive for IL-2R in donors
A, B, C, D, F, respectively, and at 10 ug/ml PHA 61.3, 52.6, 59.1,
21.5 and 49.9 % cells positive for IL-2R in donors A, B, D, E, and
F, respectively).
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Addition q± i-Roomh i nant 1 L-2
in lymphocyte cultures where endogenous IL-2 production is
deficient, addition of an exogenous source has been shown to overcome
this, resulting In an Increased proliferation similar to controls
(Palladlno and Welte 1984, Farmer et a 1. 1986)
In this assay, a recombinant IL-2 preparation (2 or 5 U/ml) was
added at the Initiation of culture with 0, 1 or 2% SP (v/v) and 0, 0.6,
5.0 or 10.0 jug/ml PHA (Table 8). Results are expressed as a ratio of
the control counts divided by the counts observed In the presence
of SP, hence a value of 1.0 would Indicate that the suppressive effects
of SP had been overcome.
In control cultures, 2 U/ml rlL-2 Increased the basal
proliferative response and the response to 0.6 >ug/ml PHA over twofold.
Slightly greater values were obtained with 10 U/ml rlL-2. At the two
higher concentrations of mitogen, very small effects of rlL-2 were
observed (< 1058 stimulation). In the presence of \% SP a
proportionately greater stimulation of proliferation was observed at
all mitogen concentrations with rlL-2 addition, and with 10 U/ml
virtually no suppression occurred. Similar but smaller proportionate
Increases were observed with 258 SP and rlL-2, and suppressive effects













































































TABLE8.HEFFECTOFRECOMBINANTIL-2SE ALPLASMAINDUCEDSUPPRFSSIONYM HOPROII FR N. PBMCwerecultur dfo90h rswithPHA( ,0.6,5 0or1 .0g/ml),r2$SPandoU/ lrecombinantIL-2.Standarddeviationsaretgiven,buwerelllestha15$(m togentimulations)r20$(b s l eva ue .
3.1.2 The LymphoprolIterative Response to Antigen
PBMC from a known responder were cultured for seven days with
tetanus toxoid, with or without 1J6 SP (Table 9). SP suppressed the
proliterative response to tetanus toxoid at all concentrations of
antigen tested, and a small decrease In suppression was noted with
increasing antigen dose. Similar results were obtained from one
other known responder.
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FINAL CONCENTRATION CPM + SD % SUPPRESSION OF
OF TT IN CULTURE CONTROL \% SP (v/v) CONTROL RESPONSE
Lf/ml IN CULTURE
0 592 + 62 660 + 91 0
0.08 2473 + 255 800 + 150 67.7
1 .3 4942 + 919 2154 + 302 56.5
4.0 4032 + 677 2286 + 565 43.3
TABLE 9. THE SEVEN DAY LYMPHOPROLIFFRATIVF RESPONSE TO TETANUS TOXOID.
AND THE EFFECTS OF SEMINAL PI ASMA.
PBMC were cultured for 7 days with tetanus toxoid and with medium alone
or \% SP (v/v).
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3.1.3 MC Cell Mediated Cytotoxicity
NK cells are able to lyse certain tumour cell lines and virally
Infected non-malignant cells without prior immunisatlon and without MHC
restriction. As yet, no unique antigen has been Identified on these
cells, but the predominant phenotype is CD3 negative, CD4 negative,
CD16 (IgG Fc receptor) positive and H-NK positive (Lanier and Phillips
1988). In vitro NK cell activity was assessed by measuring
cytotoxic activity In a four hour ^chromium release assay (James and
Szymanlec 1985). The target cell used was the K562, an MHC deficient
tumour cell line derived from a patient with chronic myelogenous
leukemia in blast crisis (Lozzlo and Lozzlo 1975).
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Dose response curves.
Various concentrations of seminal plasma were incubated with
adherent cell depleted PBMC and target cells for 4 hours at 37°C.
Effector:target ratios used were 50:1 and 20:1 (Figure 9). NK cell
mediated cytotoxicity as measured by chromium release from target
cells decreased with increasing concentrations of seminal plasma. A
similar, pattern of response was seen at both effector:target ratios.
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% SP (v/v) IN CULTURE
FIG 9 : THE EFFECT OF SEMINAL PLASMA ON NK CELL
MEDIATED CYTOTOXICITY.
Adherent cell depleted PBMC were incubated for 4 hours
with Cr labelled K562 cells and various concentrations
of seminal plasma. Effector : target ratios used were
50:1 ( • ) and 20:1 (■).(Total release = 2186 cpm)
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Preincubation ol Ml eel Is.
NK cells were preincubated overnight at 37°C before use, as a
previous study In our laboratory had suggested that these cells were
less susceptible to suppression (S. Szymanlec, personal communication).
In a comparative study with fresh cells (Table 10) It Is clear
that seminal plasma had very little effect on the preincubated cells,
































TABLE 10. A COMPARISON OF THE SUPPRFSSIVE EFFECT OF SEMINAL PLASMA ON
FRESH AND PRE INCUBATED NK CELLS.
Fresh (A) or overnight Incubated (B) adherent cell depleted PBMC were
Incubated for 4 hours with Cr labelled K562 cells (Effector target
ratio was 25:1 and total release 1600 cpm).
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3.1.4 IL—1 Production by Monocytes
IL—1 is normally produced by activated mononuclear phagocytes,
common la vitro stimuli used include LPS, PMA, whole StaphyIococcus
a I bus, PHA and Con A. Supernatants are collected between 18 and 48
hours of culture and their IL—1 content is detected by measuring
their effect on the proliferation of mouse thymocytes (Gearing £± a±
1985). Stimulation of proliferation is due to IL—2 released by IL-1
stimulated T-cells (Oppenheim and Ger.y 1982), and the presence
of small concentrations of mitogen boosts responses (this Is
called the costimulator assay - Paetkau £± a 1. 1976).
In this study, monocytes were isolated from PBMC, pre incubated
with or without SP(v/v) for 1 hour, washed and then cultured with
or without LPS for 20 hours. This was performed in serum-free medium
to reduce background responses. Supernatants were collected and
tested in the costimulator assay along with a standard preparation
of recombinant IL-1. The full term effect of SP on IL-1 production
was not studied as PGE adversely affects the assay (Kristensen et a I.
1982).
The 48 hour proliferative response of .mouse thymocytes to the
supernatants is Illustrated in Figure 10. Supernatants from LPS
stimulated control monocytes induced thymocyte proliferation in a
dose-dependent manner. Similar but greater proliferative effects
were induced by SP pretreated LPS stimulated monocytes. This
difference was highly significant when results were analysed using a
paired t-test (p < 0.02). Supernatants from unstimulated control
and SP pretreated monocytes also induced a proliferative response,
but this was very small. Recombinant IL-1 at concentrations
between 0.5 to 8.0 U/ml induced a similar measure of proliferative
response as the supernatants (Figure 11).
DILUTION OF SUPERNATANTS.
Fig 1Q ;THE PROLIFERATIVE RESPONSE QF MURINE THYMOCYTES
TO SUPERNATANTS FROM LPS STIMULATED MONOCYTES.
Murine thymocytes were cultured for 48 hours with 1 Ajg/ml
PHA and doubling dilutions of supernates from 20 hour cultures
of monocytes only( A ), monocytes + 10 ug/ml LPS( ■ ), SP
pretreated monocytes only ( + ) or SP treated monocytes




FIG 11 :THE PROLIFERATIVE RESPONSE OF MURINE
THYMOCYTES TO RECOMBINANT IL-1
Murine thymocytes were cultured for 48 hours
with 1 ug/ml PHA and RPMI only, or doubling
dilutions of rlL-1 from 0.5-8.0 Units/ml
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3.2 CHARACTERISATION STUDIES
After establishing the major Immunological properties of whole
seminal plasma, the next phase of the study was to characterise the
molecules responsible for the observed suppression. A particular
emphasis was made on the prostaglandins of the E series. This was
because of their uniquely high concentration in semen, and because
initial studies in our laboratory suggested that seminal plasma
suppression was mediated by low molecular weight components.
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3.2.1 Dialysis of Seminal Plasma
Dialysis studies were first performed to establish the molecular
weight of possible suppressive components. Seminal plasma was
dialysed for 48 hours in dialysis tubing (molecular weight cut off
12 to 14 kD) against 20 volumes of PBS (small volume dialysis) or
2000 volumes of PBS (large volume dialysis). The dialysate from
the small volume dialysis was also retained. Whole SP and the three
preparations were tested in the lymphoproliferative assay with a sub
optimal concentration of PHA, and were analysed for PGE content
(Table 11).
The lymphoproliferation results suggest that the greater
proportion of suppressive activity is dialysable, but that a
significant amount of activity is retained in the SP even after
large volume dialysis. Radioimmunoassay for PGE revealed that 94?
of the seminal prostaglandins are dialysed out, immediately
suggesting that a large molecular weight inhibitor was responsible
for the retained inhibition. However, it must be noted that the
retained PGE (0.14 ug/mj or 4 x 10 7 M) is an immunologically active
concentration).
The whole seminal plasma pools used throughout the study had
prostaglandin E levels between 2 to 10 jjg/ml.
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+ 2% SP (v/v) QR EQUIVALENT
PREPARATION PGE CPM ± SD % SUPPRESSION OF
jjg/ml CONTROL RESPONSE
CONTROL (0 SP) - 36017 + 910
SP 4.34 4605 + 449 87.3
SP-SVD 0.28 12646 + 1599 64.9
DIALYSATE 0.18 6931 + 1461 80.8
SP-LVD 0.14 18679 + 3731 48.1
TARI F 11. THF DISTRIBUTION OF PROSTAfil AND IN F AND SUPPRFSSIVF ACTIVITY
IN DIALYSED PREPARATIONS OF SEMINAL PLASMA.
Seminal plasma was dlalysed for 48 hours at 4°C against 20 volumes of
PBS (SP-SVD) or 2000 volumes of PBS (SP-LVD); the dialysate of the
small volume dialysis was also retained. Whole SP and dialysed SP
preparations at 2% (v/v) and the dialysate at the equivalent of 2% SP
(v/v), were tested in the 90 hour pro I i ferat i ve assay to 5.0 jjg/ml PHA.
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3.2.2 Sephadex G200 Gel Filtration
Seminal plasma was fractionated by gel filtration on a G200
column. Fractions were assayed for protein, and three major peaks
identified (Figure 12). The fractions from each peak were pooled,
analysed for PGE content and tested in the lymphoproliferation assay
at an equivalent concentration to 2% SP (Table 12). PGE was only
detected in fraction three, as was suppressive activity. Suppression
was not achieved at the very highest concentration of PHA. In this
study it was unclear if the prostaglandin which eluted in the third
peak was bound to a low molecular weight protein, or was free.
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1620483245678926 FRACTIONNUMBER FIG12:THEDISTRIBUTIONOFPROTE NINRAC IONSB AINEDFR M SEPHA;DEXG200EPARATIONOFMIN LPLASMA
TESTPGECPM+SDUOFONTROLRES ONGIV NIB ACK T ) ng/mi0ju lPHA1.25jug/ml5 0ug/mlPHA15.w / l CONTROL509±4877663 5361328325 301799 Fr1'4.354±3994802(122. )3 047 901 3)5 8 7246292.3) Fr214.3674±4270011 9(9 . )394754420( .4601 818(1 3 3) Fr3222.0562±961439(67.7)11 3007134.1)62994(108. ) TABLE12.HEEFFECTQFSEP AD XG2QQFRACTIONSNLYMPHQPRQLIFERATIQN. Fractionsobtainedfr mSeph dexG200separationfmi alpl s aw reu eanequivale tof2%SP(v/ )Inth90h lymphoprolIterativeassaytva iousconcentrationfPHA.
3.2.3 Reverse Phase HPLC of Seminal Plasma
Further characterisation of seminal plasma was made by
separating a pooled sample by C18 reverse phase chromatography.
Fractions were analysed for PGE, 19-OH-PGE, and PGF (Figure 13).
PGE was detected in two peaks between fractions 26 and 34 and 38 to
46. A single peak of 19-OH-PGE overlapped the PGE peak between
fractions 28 to 34. A very small amount of PGF was distributed
between fractions 38 to 45.
Fractions were tested in the NK cell assay (Figure 14 B). Two
peaks of suppressive activity were demonstrated between fractions
24 to 35 and fractions 39 to 47. These coincided exactly with the
peaks of PGE and 19-OH-PGE.
Fractions were also run in the lymphoproliferation assay using
a suboptimal concentration of PHA (Figure 14 C). Components
Inhibiting proliferation were distributed In two peaks between
fractions 24 to 36 and 37 to 52. Again this distribution correlated
well with the prostaglandin content of the fractions, except
suppressive activity was detected until fraction 52 whilst PGE
activity dropped off at fraction 46. This latter suppression may





FIG13:DISTRIBUTIONOFPGE9-OH-PGEANDFIRACTIONSB AIN DMREVERSEH S HPLCSEPARATIONOFEMINALPL SMA.
FRACTION NUMBER
FIG 14 : DISTRIBUTION OF PGE AND IMMUNOSUPPRESSIVE
ACTIVITY IN FRACTIONS OBTAINED FROM A REVERSE PHASE
HPLC SEPARATION OF SEMINAL PLASMA.
(B:) Adherent cell depleted PBMC were incubated with 51Cr
loaded K562, and fractions were used at an equivalent
of 2% SP(v/v) in culture. Values are expressed as the %
of the control response which was 43.7% slCr release.
(E:T ratio = 25:1.) Standard deviations are not given, but
were <15%
(C:) PBMC were cultured for 90 hours with 5ug/ml PHA
and fractions used at an equivalent of 2% SP (v/v) in culture.
Values are expressed as a % of the control responsewhich was




3.2.4 Delipldatfon of Seminal Plasma by Absorption Chromatography
Reverse phase HPLC chromatography studies further suggested the
Involvement of E-series prostaglandins In seminal plasma mediated
Immunosuppression. The next study therefore Involved removal of these
molecules and assessing If any Inhibitory activity remained. A seminal
plasma pool was delIpidated and the eluate measured for prostaglandin
content and Immunological activity.
Delipldatlon extracted over 99% of the PGE from the seminal plasma
sample (the final concentration was 12.4 ng/ml). This procedure also
removed two thirds of the SP mediated suppression In the
lymphoproI Iterative assay (Table 13 A), and virtually all the
suppressive activity In the NK cell assay (Figure 13 B).
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* SP (v/v) CPM ± SD * SUPPRESSION OF
IN CULTURE CONTROL VALUE
0 22596 ±3831
2* SP 4871 ± 761 78.5
2* DLSP 16828 ± 3393 25.6
TABLE 13 A. SUPPRESSION OF PHA INDUCED LYMPHOPROLIFERATI ON BY
SEMINAL PLASMA AND DEL IPI DATED SEMINAL PLASMA.
The 90 hour lymphoprolIferative response to 1.25 ug/ml PHA was





















TABLE 13 B. SUPPRESSION OF NK CELL MEDIATED CYTOTOXICITY BY
SEMINAL PLASMA AND DELIPIDATED SEMINAL PLASMA.
The E:T ratio was 25:1 and total release 3926 cpm.
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3.2.5 Cystic Fibrosis Seminal Plasma Samples
A natural deficiency of prostaglandins in the ejaculate is
recorded in cystic fibrosis patients (Bendvold et a 1. 1986) due
to an absence of seminal vesicles (Holsclaw et a 1. 1971).
Samples from three cystic fibrosis patients (courtesy of Dr.
Raeburn) were radioimmunoassayed for PGE. Patients 1, 2 and 3 had
concentrations of 19.2, 55.3, and 17.9 ng/ml PGE in their seminal
fluid compared to 4.34 jug/ml in the normal pool. The suppressive
activity of the patient samples were compared with a normal pool
in the lymphoproliferatIve assay to a suboptimal concentration of
PHA (1.25 ug/ml) and in the natural killer cell assay (Figure 15).
At a concentration of (v/v) in culture, no differences in
suppressive ability of patient samples and the normal pool could
be detected in the proliferation assay (Figure 15 A). However, at a
lower concentration of SP (0.25$), samples from the cystics were
far less Inhibitory than the normal pool.
In the NK cell assay, the suppressive ability of patient samples
was far less than that of the normal pool at both concentrations
used (4% and (Figure 15 B).
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CF123,,SP , 1%V/V0.25%4%/1 FIG15:ACOMPARISONFTHESUPPRESSIVEEFFECTSNLYMPHOP OLI ERATIONNDNKE L ACTIVITYOFSEM NALPLASMAFROO LNORMMENDTH EECYST C FIBROSISPATIENT . (A)PBMCwereculturedfo90h sith1.25ug/PHAand0.25%SP(v/v).Resultr expresseda%ofthcontrolr sponsewithoutSPhicha228791009(cpmlsd). (B)Adherentc lldepl t dPBMCw reincubai h5floadedK562ellspd1o4%(v/v) SP.Resultsarexpressed%ofcontrolre ponsewithouthicha43.7%Cr lea E:Tratio= .25:1.
3.2.6 Ion Exchange Chromatography of Seminal Plasma
Early dialysis experiments had suggested that prostaglandins
could bind to seminal proteins. To investigate this, a SP pool was
desalted by Sephadex gel filtration and the excluded protein was
run on a DEAE ion exhange column along with a tritiated PGE tracer.
The results confirmed that prostaglandin E bound protein (Figure
16). Two peaks of PGE were located between fractions 2 to 4 and
fractions 6 to 12. The PGE tracer eluted between fractions 6 to 10.
Analysis of protein content of the fractions revealed a peak in
fraction 1 which fell off at fraction 4, and remained at a steady
low level to fraction 18.
Fractions were run in the NK cell assay and fractions 2 to 12
were found to have suppressive activity with a peak at fraction 4
and fraction 7 to 12 (Figure 17 B).
In the lymphoproliferative assay to 1.25 jjg/ml PHA, fractions 1
to 11 suppressed prolIferation, with peak activity occurring In
fractions 1 to 4 and 8 to 11 (Figure 17 C).
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1«1—■—I 2468102468 FRACTIONNUMBER.
FIG16THEDISTRIBUTIONOFPROTEIN.GANDRI IAT DT AC RIFRACTIONSOB AINM DESALTEDS MINALPLASMAA PLERUOEAHP CCOLUMN.
FRACTION NUMBER
FIG 17 : DISTRIBUTION OF PGE AND IMMUNOSUPPRESSIVE
ACTIVITY IN FRACTIONS FROM A DESALTED SEMINAL
PLASMA POOL RUN ON A DEAE HPLC COLUMN.
(B.)Adherent cell depleted PBMC were incubated with 51 Cr
loaded K562 cells and fractions were used at a equivalent
of 2%SP(v/v) in culture. Values are expressed 51
as a % of the control response which was 24.8% Cr
release. (E:T ratio = 25:1.) Standard deviationsare not given,
but were < 15%.
(C.)PBMC were cultured for 90 hours with 2.5 jug/ml
PHA and fractions used at an equivalent of 2% SP (v/v)
in culture. Values are expressed as a % of the control
response which was 22596 i 4031 (cpm i sd). Standard
deviations are not given, but were < 15%
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3.3 IMMUNOSUPPRESSIVE PROPERTIES OF MAJOR SEMINAL PLASMA COMPONENTS
The complexity of human seminal plasma precluded study of all Its
components. Characterisation studies had suggested that the Inhibitory
activity of the secretion was of a low molecular weight, and much of
this was contributed by the E-series prostaglandins. In this section,
purified preparations of three low molecular weight components of semen
with documented Immunological properties were studied. These were the
4
prostaglandins, ionic zinc and the polyamine spermidine.
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3.3.1 The Prostaglandins
Ihfi effect o± standard prostaglandin preparations £a
lymphoproliferation.
The 90 hour lymphoproliferative response to 1.25, 5.0 and 20.0
-5 -9
jjg/ml PHA was examined In the presence of a wide range (10 to 10 M)
of PGE2 concentrations (Figure 18). PGE suppressed proliferation in
a dose dependent manner, but these suppressive effects decreased as
mitogen concentration Increased. The immunological properties of PGE^
19-OH-PGE.j and 19-OH-PGF .j were also compared in the lymphoprol iferative
assay using a suboptimal (2.5 jug/ml) concentration of PHA (Figure 19).
PGE strongly inhibited pro Iiferation at all concentrations tested (10 8
to 10"9 M), as did 19-OH-PGE at 10"6 and 1O-7 M. At 10~8 and 10-9 M
19-OH-PGE slightly increased proliferation (< 20%), as did 19-OH-PGF at
-6 -9
all concentrations tested (10 to 10 M). The small stimulatory
effect of 19-OH-PGF (<10$) was not related to its concentration in
culture. The average PGE content of seminal plasma samples used
-5
throughout the study was approximately 1 x 10 M (19-OH-PGE was not
analysed).
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PROSTAGLANDIN CONCENTRATION Iff XM
FIG 18 :THE EFFECT OF PGE.ON LYMPHOPROLIFERATION.
PBMC were cultured for 90 hours with 1.25( • ), 5.0( )
or 20( ■ )ug/ml PHA and medium alone or 10 *5- 10 *9 M
PGE2. Values are expressed as the % suppression of the control
culture in the absence of PGE . Control responses in cpm ±sd were
42452 54 at 1.25ug/ml PHA ; 42111 ± 187 at 5ug/ml PHA; and
39330 ± 1373 at 20 jug/ml PHA.
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PROSTGLANDIN IN [] 10"XM
FIG 19 : A COMPARISON OF THE EFFECTS OF PGE, .19-OH-PGE
AND 19-QH-PGF ON LYMPHOPROLIFERATION.
PBMC were cultured for 90 hours with 2.5ug/ml PHA and
10-*- 10"1 M PGE ( • ), 19-OH-PGE ( A) or
19-OH-PGF ( ■ ). Results are expressed as the % suppression
or the % stimulation of the control culture in the absence of PG .
This was 233111 491 (cpmisd).
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ReversibiIity Q± suppression
Peripheral blood cells were prelncuba+ed wl+h 10~6 M PGE for 4
hours at 37°C, washed well and then cultured with various
concentrations of PHA (Table 14). Results suggest that PGE£ mediated
suppression was fully reversible as proliferative values of
prostaglandin pretreated cultures were equal to those of the control
eel Is.
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± 765 8408 ± 14
± 3360 35137 ± 2862
± 3744 26799 ± 1653
TABLE 14. REVERSIBILITY OF PGE~ MEDIATED SUPPRESSION.
PBMC were pre Incubated with medium or 10~® M PGE£ for 4
hours at 37°C, washed x 3 and then cultured for 90 hours with
1.25, 5.0 or 10.0 jug/ml PHA.
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Expression £± lymphocyte receptors In presence C± prostaglandins
The effect of prostaglandin preparations on induction of the
IL—2 and transferrin receptors and possible changes In the CD4 and
CD8 positive populations were examined. PBMC were cultured for 60
hours with suboptimai concentrations of PHA, and cells were stained
using an indirect immunofIuorescent technique, and analysed using
the flow cytometer.
-5 -7
PGE2(10 to 10 M) and seminal plasma (1 and 2% v/v) suppressed
the induction of IL—2 and transferrin receptors In a dose dependent
manner, and the extent of suppression was similar for both receptors
(Table 15).
This decrease in IL—2 receptor expression was accompanied with
a decrease in proliferation (Figure 20). Suppression by PGE (10 6and
-9
10 M) and SP (1$ v/v) was more effective at 2.5 xig/ml PHA than
10.0 jjg/ml; in fact at the higher PHA concentration suppression of
-9
receptor expression and proliferation by 10 M PGE could not be
detected.
A comparative study of PG^' 19-OH-PGE^, 19-OH-PGF^ and SP was
made by measuring the induction of IL—2 receptors and number of CD4
and CD8 positive cells in cultures stimulated with a suboptimai
(2.5 ug/ml) concentration of PHA (Table 16). PGE was the strongest
inhibitor of IL—2 receptor expression. 19-OH-PGE inhibited
expression by 10^, but 19-OH-PGF had no effect. The proportion of
cells in culture expressing the CD4 and CD8 antigens remained
relatively constant in all conditions. The exception was a low CD8
value observed in the PGE treated cells.
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TEST
j OEMS POSITIVE a SUPPRESSION OF CONTROL IN BRACKETS)
IL-2 RECEPTOR TRANSFERRIN-RECEPTOR
UNSTIMULATED CONTROL 4.8 8.1
plus 2 ug/ml PHA:
CONTROL 44.4 24.2
1$ SP (v/v) 14.5 (67.4) 11 .2 (53.8)
2% SP (v/v) 8.9 (79.9) 9.4 (61.2)
PGE2 10~5 M 27.8 (37.4) 16.5 (31.9)
PGE2 10~6 M 32.1 (27.7) 20.0 (15.0)
PGE2 10"7 M 38.6 (13.1) 21 .2 (12.3)
TABLE 15. EXPRESSION OF IL-2 AND TRANSFERRIN RECEPTORS. AND THE EFFECT
OF SEMINAL PLASMA AND PGE .
PBMC were cultured for 60 hours with 2.0 ug/ml PHA and seminal plasma
or PGE„. The % of cells in fresh PBMC positive for were IL-2




























































































FIG 20 ; THE EFFECT OF SEMINAL PLASMA AND PGE;QN
LYMPHOCYTE PROLIFERATION AND IL-2R EXPRESSION
PBMC were cultured for 60 hours with 2.5 ug/ml
PHA (A.) or 10 ug/ml PHA (B.), and medium alone,
2%SP (v/v) or 10 " Sr 10 " m PGE. The solid bars
represent proliferation values and hatched bars IL-2R
expression. Ther% positive cells in fresh PBMC




































TABLE16.COMPARISONOFTHEEFFECTSEMINAIPAS .GF19-OH-PGFAN19-OH-PGFO1 -2RECE TORCD4.AND COBEXPRESSION.•XX P8MCwereculturedfo60h rswi h2.5jug/mlPHA,andmediualone,1%S(v/v)or10M̂PGE.,19-OH-PGE.or 19-OH-PGF..Thebracket dfigur sathev lu sexpress dath%suppressionofthcont olrede orexpres ion.Th% ofcellsp sitiveforIL-2R,CD4,and8InfreshPBMCwere3.3,3.0and12 9respectiv ly.
Addition q± recombinant 1L-2
PBMC were cultured with PHA (0, 1.25, 5.0 and 10.0 >ug/ml), 10~® M
and an exogenous IL—2 source (recombinant IL-2 at 2 or 5 U/ml)
(Table 17). As reported in an earlier study, IL-2 substantially
Increased the proliferative values of control cultures with no added
mitogen, or with a sub-optimal concentration of mitogen. Addition of 2
and 5 U/ml IL-2 increased the proliferative values of PGE2 treated
cultures to an even greater extent, and no suppression was recorded.
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CPMtSD





















TABLE17.HEEFFECTOFRECOMBINANTIL-2PG „INDUCEDSUPPRESSIONLYM HOPROtERATIO . PBMCwerecultu dfo90h u sl+hHA( ,1.25,5.0and0.0^ig/ml),mediumoneGE10~6M2U/mlrlL-2.
The effect of NK eel I medIated cytotoxicity
19-OH-PGE] and 19-OH-PGF^ at concentrations between 10"^ and
10"^ M and 2% seminal plasma were tested In the NK eel I system (Table
18). PGE and 19-OH-PGE suppressed NK cell mediated killing of K562
cells in a similar dose dependent manner. A small decrease (2.5 - 10^)
in cytotoxic activity was noted in the presence of 19-OH-PGF.
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TEST NK CELL MEDIATED CYTOTOXICITY
%5]Cr RELEASE % SUPPRESSION
CONTROL 43.7 ±3.9
2% SP (v/v)
10"® M PGE?10"' M PGE,









7.9 ± 1 .0 81 .9
17.9 ± 1.2 59.0
22.2 ± 2.2 49.2
29.8 ± 1 .9 31 .8
38.1 ± 4.1 12.8
18.9 ± 2.2 56.8
28.7 ± 2.4 34.3
27.7 ± 1 .2 36.4
34.4 ± 2.9 21 .3
39.3 + 3.0 10.1
39.7 + 5.1 9.2
42.4 + 2.7 3.0
42.6 + 2.9 2.5
TABLE 18. THE EFFECT OF SEMINAL PLASMA AND STANDARD PROSTAGLANDIN
PREPARATIONS ON NK CELL MEDIATED CYTOTOXICITY.
The E:T ratio was 25:1 and total release 3319 cpm.
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3.3.2 Zinc
Ih£ effect an ±h£ lymphoproliferatlve response ±a mitogen
Zinc chloride at 10 to 10 M final dilution in culture
was examined for effects on the 90 hour proliferative response to
1.25, 5.0 and 20.0 ,ug/ml PHA (Figure 21). SP at 2% (v/v) was also
examined. All concentrations of zinc tested failed to inhibit PHA
induced lymphocyte mitogenesis. Basal proliferative values were
also unaffected by zinc (Table 19).
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FIG 21 : THE EFFECT OF ZINC ON LYMPHOPROLIFERATION.
PBMC were cultured for 90 hours with 1.25(J§ ), 5.0(^g )
or 10.0(^)tia/ml PHA and medium alone, SP 2%(v/v)





0 266 ± 53
10-5 M 280 ± 34
10"6 M 242 ± 18
10-7 M 285 ± 25
10"8 M 213 ± 57
TABLE 19. THE EFFECT QF ZINC ON BASAL PROLIFERATION.




Some studies have suggested that in bovine serum supplemented
cultures, seminal plasma mediated suppression is due to the generation
of cytotoxic molecules following the Interaction of bovine serum
polyamine oxidase with seminal polyamines (Allen and Roberts 1986,
Allen and Roberts 1987, and Vallely et a 1. 1988).
The aim of this section was therefore twofold. Firstly to
establish if polyamines could contribute to the reversible and
noncytotoxic Immunosuppression described using the conditions of this
study, that is, in a human serum supplemented culture medium.
Secondly, to establish the nature of SP mediated suppression in the
bovine serum supplemented system, and to compare this to culture made
in RPMI supplemented with human serum, or in serum free medium.
The poiyamine used throughout the study was spermidine. Although
the concentration of this in semen is ten times less than spermine (0.6
ug/ml), the reported Immunological properties are Indistinguishable
from spermine (Byrd et ai. 1977) and spermidine was also used in
the Vallely study (Vallely et al. 1988).
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Ihfi effect Q± spermidine sad iE £H lymphoproliferatlon .and. viabi1ity
PBMC were cultured for 90 hours with various concentrations of PHA
(1 .25 - 20.0 jug/ml) and 1 $ SP (v/v) or 6.0 or 12.0 ug/ml spermidine.
Culture medium was RPMI supplemented with 10$ human AB serum (Table 20
A) or 10$ fetal calf serum (Table 20 B). To assess viability, parallel
cultures were made using the same conditions, but without addition of
mitogen.
The results In human serum supplemented cultures with SP present
were similar to those described earlier; suppression was most effective
at sub-optimal PHA concentration, and there was no loss of cell
viability. In spermidine containing cultures, suppression was small
but variable (0 - 35$), and not related to PHA concentration or loss of
eel I viability.
In FCS supplemented cultures, SP equally inhibited proliferation
induced by ail concentrations of PHA. Viability testing Indicated this
was not because of cytotoxicity. Addition of spermidine to the
cultures totally prevented any pro IIferatIve response above basal
values. Some loss of cell viability was recorded In these cultures.
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TABIF20B.SUMMARYOFTHR FEXPERIMENTSEXAMININGT FFFFFOTOSP RMIDIANSEMINALPLASO1YMPHOPROIFER TIQNIN FCSSUPPLEMENTEDR MI■ PBMCwereculturedfo90h rswi hmediumalon ,IjtS(v/v)orsper idine(6.0o12pg/ l)andvariousconcent ationsPHA CultureswemadInRPMisupplementedwi h10JtFCS.
Reverslb 11tty £f suppression In E£I and human serum supplemented media
As the previous results had suggested that spermidine treatment
could induce toxicity in a proportion of the cell population,
preincubation assay was performed to investigate the reversibility
of suppression induced by SP and spermidine In the two different
media. PBMC were pretreated with 1% SP (v/v) or 12 jug/ml
spermidine for 4 hours at 37°C, washed three times and then
cultured with various concentrations of PHA for 90 hours (Figure
22).
In AB serum supplemented RPMI, PBMC pretreated with SP and
spermidine exhibited similar pro Iiferative values to control
cultures, indicating that suppression was completely reversible
(Figure 22 A). In contrast, In FCS supplemented cultures,




FIG 22 ; THE REVERSIBILITY OF SEMINAL PLASMA AND
SPERMIDINE'MEDIATED SUPPRESSION IN MEDIA
SUPPLEMENTED WITH FCS QR AB SERUM,
PBMCwere pretreated for 4 hours at 37 0 C with medium alone
(+),1% SP (v/v) (▲) or 'IZngjXifiLspermidine (•). After
washing cells were cultured with PHA for 90 hours.
Pretreatment and culture was in AB human serum (A.) or FCS
(B„) supplemented RPMI.
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A comparison £± £E mediated suppression pro Iiferation la
various media
In addition to studies made in human and foetal calf serum,
experiments were performed in NBCS supplemented medium as NBCS
interaction with SP has been reported to produce greater cytotoxic
response than with FCS (Valleley et a 1. 1988). Studies were also
made In serum free medium (HB103) to confirm that components in AB
serum were not abrogating the suppressive effects of SP in any way.
Similar patterns of suppression were observed in human serum
and In serum free medium (Figure 23 A and B). In summary this was:
a lack of inhibition of basal responses, greatest suppression at
sub- to optimal PHA concentration, and a decrease in suppression
at a post-optimal PHA dose.
Patterns of suppression were also similar in FCS and NBCS
(Figure 23 C and D), with a high degree of inhibition of prolifera¬
tion at all concentrations of PHA. At 90 hours the viability of




FIG 23 :THE EFFECT OF SEMINAL PLASMA ON
LYMPHQPRQLIFERATION IN VARIOUS MEDIA.
PBMC were cultured for 90 hours with PHA and medium alone,
2% SP (v/v) in RPMI supplemented with 10% AB serum(A.),
FCS(C.) or NBCS,(D.) or in HB103 serum free medium (B.).
Values are expressed as a % suppression of the control response
without SP. At 1.25, 5 and 10 ug/ml PHA respectively these
were : 5711, 30781 & 29787 cpm in AB serum; 3718,
17289 & 16778 cpm in HB103; 5039,16360 &15009
cpm in FCS; and 1802, 7603 & 6323 cpm in NBCS.
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NOTE
The majority of the experiments reported here were performed at





Seminal plasma is a complex mixture of components, many of which
have no ascribed role In sperm function or in the events which lead up
to fertilisation. Some of these molecules have known immunological
activity, and it Is now believed that they may play an Important role
In preventing an immune response to sperm antigens (James and Hargreave
1984, Alexander and Anderson 1987).
The aim of this study was to make an in-depth examination of the
properties of seminal plasma and Its components on Immune cell function
in vitror to contribute to our knowledge on the Interaction of the
immune and reproductive systems and the biological consequences. The
study concentrated on assessing the mechanism of immunosuppression of
whole seminal plasma, characterising the components Involved, and
finally assessing the Immunological properties of three of the major
lew molecular weight components In semen, namely prostaglandins,
polyamines and zinc.
All experimental procedures were made In a full human system
(seminal plasma, leucocytes and serum supplement), and concentrated
primarily on measuring the effects on JLa vitro parameters of
T lymphocyte and natural killer cell function.
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4.1 IMMUNOLOGICAL PROPERTIES OF WHOLE SEMINAL PLASMA
ImmunomoduI at ion of T-cells by whole seminal plasma was assessed
primarily by evaluating proliferation and expression of activation
markers after stimulation with the T-celI mitogen, phytohaemaggIutinin.
In three day cultures, immunosuppression was dependent upon the
concentration of both SP and PHA. Suppression increased with
increasing concentrations of SP, but was most effective at sub-optimal
mitogen doses. Basal values were not affected, suggesting SP was
inhibiting an event taking place during or after activation of the
cells. Lymphocyte viability of SP treated cultures was similar to
controls, and reversibility of the suppression could be achieved.
These latter observations suggest that SP was not causing suppression
of proliferation by cytopathic or cytotoxic mechanisms. The system
also statistically confirmed that the pattern of suppression was the
same with different pools of seminal plasma and with different
lymphocyte donors.
Initiation of a time course study showed that SP most effectively
suppressed proliferation when added with, or 4 hours prior to, mitogen.
Slightly smaller suppressive values were obtained on addition of SP 24
hours prior to, or 4 hours after, mitogen. Suppression could not be
demonstrated when SP was added 24 hours or more after initiation of
cultures with mitogen. This indicates that once lymphocytes are
activated they become refractory to the effects of SP.
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The decrease in suppression observed with increasing
concentrations of PHA does question whether components in SP are
competitively binding the mitogen. It is known that PHA binding is
competitively inhibited by n-acetyIgIucosamine (Kornfeld and Kornfeld
1971) and n-acetyIgaIactosamine (Fischer and Mueller 1969), and these
are almost certainly found in seminal glycoproteins and polysaccharides.
However, similar suppressive activity is noted in antigen stimulated
culture, and suppression of other immune cell functions is also noted.
In addition, this differential effect of SP In the presence of various
concentrations of mitogen is also noted with prostaglandin E, a major
constituent of semen (see below).
The clonal expansion of T lymphocytes is critically dependent upon
generation of interleukin 2 and its receptors (CantrelI and Smith
1984). Therefore, the next phase of study was to determine their
production in seminal plasma supplemented cultures. Results
obtained demonstrated that the SP mediated decrease in proliferation
was proportionate to the decrease in the number of lymphocytes
expressing IL-2 receptors, with suppression most effective in
sub-optimally stimulated cultures.
IL-2 production was subsequently measured using a biological (CTLL
line) and non-biological (RIA) method of assay. Use of the IL-2
dependent CTLL line was abandoned after SP components were found to
directly interfere with CTLL proliferation. The sensitivity of the
radioimmunoassay was very poor, and after a number of experiments, a
decision was made to discontinue use of this also. Preliminary
studies did indicate that SP inhibited IL-2 production by PHA
stimulated lymphocytes, and that SP did not interfere with the
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radioimmunoassay (data not given) but an improvement in the assay and
further experiments would be needed to verify this. The
supplementation of cultures with rlL-2 increased proliferation both
in sub-optimally stimulated control and SP treated cultures. The
proportionate increase was much greater in SP treated cultures,
however, and at the highest concentration of rlL-2 used (100 U/ml),
proliferative values of 1% SP supplemented cultures equalled those
of the controls.
The results suggest that SP components inhibit the T-celI
proliferative response to mitogen by impairing IL—2 receptor
expression. The time course of IL—2 receptor expression is known
to parallel proliferation with both induction and down regulation
playing an important role in controlling the response (CantrelI and
Smith 1984). However, as IL-2 is also known to amplify expression of
IL—2 receptors via effects on the level of mRNA, the primary
suppressive effect of SP may be at the level of IL-2 production
(Grabstein £± a 1. 1986, Reem £± a 1. 1986).
A number of other laboratories have also studied the basic
immunological properties of whole seminal plasma in the human system.
Without exception, the inhibitory effects of SP reported are directly
related to SP concentration (Stites and Erickson 1975, Lord a I.
1977, Marcus et a 1. 1987, Majumdar et al. 1982). A decrease in
suppressive activity with increased PHA concentrations was also noted
(Stites and Erickson 1975, Lord s± a I. (1977) and Majumdar £± a I.
1982). Lord et a I. (1977) also records similar patterns of response
with pokeweed mitogen and concanavalin A. Reversibility of suppression
after a one hour preincubation has also been recorded by Majumdar £±
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a I. (1982), and their time course studies record that SP mediated
suppression is only achieved when seminal plasma Is added with, or 24
hours before mitogen; proliferation values are similar to controls when
SP is added 24 or 48 hours after mitogen.
The greatest difference between this study and others made under
similar conditions, is the lack of Inhibition of the basal response
which is noted by the other groups (Stltes and Erlckson 1974, Lord
al. 1977, and Marcus ja± a 1. 1978). This may be explained by
differences in the intrinsic stimulatory capacity of different serum
supplements used. For example, studies performed in our own laboratory
indicate that FCS may contain large amounts of endotoxin, with amounts
varying widely from batch to batch. If SP only suppresses cell
activational events, use of serum with little stimulatory activity
would be unlikely to change basal values, as noted here.
Only one other study has been made on SP mediated suppression in
relation to measurement of T-cell growth factors and their receptors.
Alexander and Anderson (1987) report that SP does not contain factors
which block IL—2 activity. They conclude this is an Important
observation as IL—2 Inhibitors have been found in the decidua during
pregnancy, and have been ascribed a role in the maintenance of the
foetal allograft (CI ark et a 1. 1984).
Modulation of NK cell activity by whole seminal plasma was
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assessed by measuring chromium release from K562 target cells.
Simple studies revealed a dose-response effect of seminal plasma In
suppressing NK cell mediated cytotoxicity, but this was abrogated if
the effector cells were preincubated for 24 hours at 37°C before use in
the assay. This suggests that SP suppresses an early activational
event.
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Studies made under similar conditions have also demonstrated
dose-response effects (Tarter et al. 1986 and Vallely et a 1. 1988).
The Inability of SP to suppress pre incubated NK cells has also been
noted by S. Szymaniac (personal communication). Tarter and coworkers
(1986) also found that SP did not affect the lysability of the target
cells, and that the suppressive effect of SP was fully reversible.
Assessment of the effects of SP components on monocyte function
was made by measuring production of the monokine IL-1. Interleukin 1
Is a maturation signal for T-cells, preparing them to respond to
antigens or secondary mediator signals (Mizel 1982). Preincubation of
monocytes with SP before culture with LPS slightly Increased the
production of IL-1 above that of control cultures. The effect of
addition of seminal plasma into full-term culture with LPS could not be
assessed as the prostaglandin in the seminal fluid directly affects
mouse thymocyte proliferation (Kristensen s± a 1. 1982). In
conclusion, short term exposure of monocytes may slightly stimulate
production of IL-1, but the long term effects of SP components on
accessory cell function of monocytes remains unknown. The few previous
studies reported on the suppression of monocyte function by seminal
fluid have measured phagocytosis and oxygen consumption, and have not
been made in a full human system (Chvapil et al. 1977 and James
aJU 1983).
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4.2 THE CONTRIBUTION OF PROSTAGLAM)INS TO SEMINAL PLASMA MEDIATED
SUPPRESSION
Simple characterisation studies on seminal plasma were made by
dialysis. Suppression of T-celI proliferation to PHA was achieved by
the dialysed SP and the dialysate, although a larger proportion of the
activity was found in the dialysate. Radioimmunoassay revealed that
the dialysate was rich in PGE, but a small amount was retained in with
the higher molecular weight components. This does indicate that
prostaglandin E Is a low molecular weight factor contributing to the
observed suppression. A G200 fractionation of SP resulted In three
peaks of which the third only was associated with suppression of
proliferation and with prostaglandin E. As molecular weight marker
controls were not used, it is unclear if the prostaglandin was bound to
a low molecular weight protein, or whether other low molecular weight
components eluted with this fraction.
Seminal plasma was further characterised by reverse phase HPLC,
and the peaks of 19-OH-PGE and PGE coincided with the peaks of
suppressive activity against NK cell mediated cytotoxicity and the
lymphoprolIferative response to PHA. Delineation of the relative
contribution of the two E-type prostaglandins to suppression was
not possible, as the first peak of PGE and the single peak of-19-OH-PGE
completely overlapped each other.
Further evidence implicating prostaglandins in the observed
suppression of T-celI and NK cell function was made using prostaglandin
free seminal plasma. In the first experiment, SP was delipidated,
decreasing prostaglandin content of the sample over three hundredfold.
126
This abrogated all the suppressive activity against NK cell function,
and approximately 75% against Iymphoproliferation. In a second
experiment, prostaglandin free SP samples from cystic fibrosis patients
were compared to a normal pool of SP. No differences were found
between the pool and the patients SP when used at higher concentrations
in the proliferation assay, but when diluted further a difference
emerged between the two. In the NK cell assay, suppression by the pool
was far greater than the patients at all concentrations tested.
A number of interpretations could be made of these latter
findings. Firstly, that prostaglandin E Is the major suppressive
molecule to NK cell cytotoxicity but that a number of other prostrate
derived molecules contribute to the suppression of T-celI proliferation.
This interpretation would be In agreement with the conclusions made by
Marcus et a I. (1987), who could correlate fructose levels with NK cell
inhibitory activity but not suppressive activity on PHA induced
lymphoproliferation. Secondly, that the apparent differential effects
on NK and T-celIs may merely reflect differences In the length of the
assays. Thus, that prostaglandins only are effective in the shorter
NK cell assay, but In the proliferation assay, there Is also a
contribution from suppressive molecules with a longer time course of
action. Thirdly, although the cystic fibrosis data strongly supports
the delipidated data that other molecules besides prostaglandins
are Implicated in T-ceil suppression, the relative contribution of
prostatic or epididymal components in these cultures may be
overestimated. This Is because seminal vesicle secretions contribute
50 - 80^ of the normal ejaculate.
127
The final characterisation study was Initiated to Investigate the
possibility that prostaglandins bound to seminal proteins In the
ejaculate. Desalting of a SP sample and separation of the excluded
proteins showed that two peaks of PGE activity were retained, and these
correlated well with suppression of proliferation and NK cell mediated
cytotoxicity. This confirms that the E-series prostaglandins can bind
seminal proteins, and that these bound prostaglandins retain
Immunological activity. Whether this Is due to release of the
prostaglandin In culture or reflects activity of the complex remains to
be established. It also remains to be established If previously
described high molecular weight suppressive proteins are in fact
protein prostaglandin complexes (Prakash et a 1. 1976, Lord s± aJ, 1977).
To compare the mechanisms of action of whole seminal plasma with
pure prostaglandin preparations, a series of proliferation and NK
assays were run with PGE2, 19-OH-PGE! and 19-OH-Fj. PGE2C10"5+o
10~5 M) and 19-OH-PGE^ (10~^ +o 10~6 M) suppressed proliferation, and
were most effective at a suboptlmal stimulatory dose of mitogen.
Suppression of proliferation was accompanied by a decreased number of
cells expressing receptors for IL-2 and transferrin. 19-0H-F1 had no
effect on proliferation or receptor expression. PGE2 and mediated
suppression was reversible and could be overcome by addition
of recombinant IL-2. PGE2 and 19-0H-PGE1 (10~5 +o 10"9 M) also
Inhibited cell mediated cytotoxicity In a dose dependent manner,
but 19-OH-F.j had only a small amount of Inhibitory activity (< 10$).
These results confirm that the E series of prostaglandins are Important
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suppressors of immune cell function and that their mechanism of
action is very similar to that of whole seminal plasma.
Despite the high concentration of prostaglandins In semen and the
known immunoreguIatory properties of PGE, only two other
characterisat ion studies have been made with respect to these
molecules. In 1986 Tarter et a I. identified 19-OH-PGE^ and ^ r'ch
fractions from a HPLC separation of the acid lipid fraction of semen as
the major suppressive molecules against NK cell activity. In 1988,
Vallely et a I. demonstrated that a ric^ fraction from a
separation of seminal plasma by ion exchange chromatography also
caused suppression of NK cell cytotoxicity under certain conditions.
The contribution of prostaglandin E in Tarter's system and 19-OH-PGE
in Vallely's system is unclear, and no further studies have been
reported by either laboratory.
The differentiation and proliferation of ail leucocyte types is
regulated by a complex network of growth factors and hormones, and
evidence over the last 18 years establishes prostaglandin E as an
important participant in these processes (reviewed by Goodwin and
Ceuppens 1983, Wickremasinghe 1987).
The mechanism of action of PGE in controlling lymphocyte function
is by raising intracellular cyclic AMP (Makoul et a 1. 1985). This
elevation is mediated via activation of adenylate cyclase which is
coupled to cell surface receptors via G proteins (Nishizuka 1986).
Increased cyclic AMP levels in lymphocytes are associated with
decreased proliferation (Goodwin g± a 1. 1979), production of IL—2
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(Chouaib s± a 1. 1985), and expression of transferrin receptors
(Chouaib et a 1. 1985).
Evidence Is emerging that control of lymphocyte responses may be
through the convergence of prostaglandin E and interleukin 2 on the
adenylate cyclase system. Interleukin 2 is a positive signal for
lymphocyte differentiation and proliferation, and binding of this
growth factor to Its receptor promotes translocation of protein kinase
C to the plasma membrane and the phosphorylation of membrane
substrates including the IL—2 receptor (Farrar and Anderson 1985,
Farrar and Taguchi 1985). Basal adenylate cyclase activity and PGE£
stimulated cANP accumulation are also decreased proportionately to
Increased concentrations of exogenous IL-2 (Beckner and Farrar 1986).
Membrane studies Indicate that IL-2 effects on the adenylate cyclase
system are Indirect and mediated by protein kinase C In contrast to
which directly affects adenylate cyclase (Beckner and Farrar
1986).
In conclusion, there appears to be a potential bidirectional
modulation of lymphocyte proliferative response under the regulation of
prostaglandin E and Interleukin 2, which converges at the adenylate
cyclase system. This supports the data presented here In that E series
prostaglandins decreased T-celI proliferation, IL-2 production and IL-2
and transferrin receptor expression. As previously stated, IL-2
amplifies expression of IL-2 receptors, and similar findings have been
made on expression of transferrin receptors (Pelosl-Testa et a I.
1988). This control system Is probably Important in vIvof as a
mechanism of modulating biological responsiveness.
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Suppression of NK cell mediated cytotoxicity by PGE is also
mediated by raising intracellular cyclic AMP (Goto et a 1. 1983).
Activation of NK cells can be achieved with interleukin 2 (Trinchiera
et a 1. 1984, Seki £± a 1. 1985) and Interferon (Koren and Leung
1982). It is therefore possible that control of NK cell function could
also be made by IL—2 and PGE by a convergence of the adenylate cyclase
system.
Monocyte macrophage function is also reported to be modulated by
prostaglandin E. PGE£ can suppress la expression and Interleukin 1
production, whereas Indomethacin augments these two functions (Snyder
et al. 1982 and Kunkel a 1. 1986). The mechanism of action of PGE
In modulating la expression Is through raising intracellular cAMP
(Snyder £± al. 1982). The effect of PGE on monocytes was not
Investigated in this study, but other workers in this laboratory have
found human monocytes and rat macrophages relatively refractory to
short and long term exposure to PGE^ and SP when measuring
superoxide anion production (K. Donaldson and S. Szymanlec
personal communication). These findings therefore warrant further
Investigation.
The mechanism of action of 19-OH-PGE Is unknown, although it is
likely to be similar to PGE (Kelly, personal communication).
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4.3 THE CONTRIBUTION OF ZINC TO SEMINAL PLASMA MEDIATED SUPPRESSION
Lymphoproliterative responses to PHA were not affected by zinc
concentrations similar to those found in seminal plasma. No other
studies on the contribution of zinc to SP mediated suppression of
lymphoproliferation have been made. Zinc rich fractions from human
prostattc fluid are however, reported as suppressive to murine
peritoneal macrophage function (Chvapil et a 1. 1977).
Zinc is essential for lymphocyte proliferation and for production
of lymphokines (Chesters 1972). It is also reported as mitogenic to
murine lymphocytes, but suppressive In the presence of PHA (Berger and
Skinner 1974). A report also suggests that murine NK cell function is
Inhibited (Ferry and Donner 1984). The discrepancy between results
obtained here and those previously reported are unexplainable, unless
there Is a differential effect of zinc on murine and human leucocytes.
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4.4 THE CONTRIBUTION OF POLYAMINES TO SEMINAL PLASMA MEDIATED
SUPPRESSION
These studies help to clarify the question as to whether reported
SP mediated suppression is merely an artefact created by Interaction of
bovine serum and seminal polyamines. It is clear from the human serum
and serum free studies that suppression of Immune cell function occurs
outside a bovine supplemented system. This is supported by other
studies made In human serum supplemented cultures (Stltes and Erickson
1975, Lord et a 1. 1977, Marcus et a 1. 1978, Majumdar a 1. 1982).
Some of this may be due to spermidine itself. This has not been
reported In in vitro assays by others, but Shohat s± al. (1988)
report that low levels of spermine and spermidine in seminal plasma I
was related to Infertility, the presence of antisperm antibodies and
lack of Immunosuppressive activity.
The results do however suggest that In bovine serum supplemented
cultures, cytotoxic or cytopathic factors are generated as a result of
the interaction between serum polyamine oxidase and spermidine. Using
pure spermidine, no loss of cell viability was recorded before 48 hours
but at 90 hours a proportion of ceils were kiUed (data not shown).
Toxicity was not demonstrated with seminal plasma, but the Inability
of cells to completely recover after treatment also suggested the
generation of cytopathic molecules not present In a bovine serum free
system.
A number of studies have been undertaken to ascertain the result
of polyamlne oxidase and polyamine Interactions on eel I function and
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variable results have been reported. Byrd, Jacobs and Amoss (1977)
reported that synthetic polyamlnes were not themselves Inhibitory to
lymphoprolIferatIon In human serum supplemented cultures, but were
converted to active moieties In the presence of foetal calf serum.
This Inhibitory activity was not due to cytotoxicity and was fully
reversible. In contrast, Tabor et a I. (1964) found that a specific
amine oxidase of ruminant sera could convert spermine and spermidine
Into amlnoaldehydes which were toxic to cells In culture. Allen and
*
Roberts (1987) and Vallely et a I. (1986) also Identified loss of cell
viability after 24 hours In culture, associated with bovine serum
Interaction with spermine, spermidine and seminal plasma.
In conclusion, the combined presence of bovine serum and seminal
plasma ieads to the generation of products which are cytotoxic or
cytopathlc to cells In culture, depending on the culture system. This
is an entirely separate mechanism of cell suppression by seminal plasma
to the suppression generated In a human serum or serum free system.
Reports of Immunosuppression by SP In FCS and NBCS containing systems
must, therefore, be treated with caution.
As a final note, semen Itself does contain an Intrinsic oxidase
activity and if left to stand molecules causing cytopathtc or cytotoxic
effects could possibly be generated (WI11 lams-Ashman, personal
communication). Although toxicity was not recorded here, generation of
cytopathlc molecules could not be ruled out of this study, and may
also be a relevant suppressive mechanism In vivo.
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4.5 THE CONTRIBUTION OF OTHER SEMINAL COMPONENTS TO SUPPRESSION
Many of the other components of seminal plasma have ascribed
Immunological activity besides the prostaglandins, polyamlnes and zinc,
and these cannot be excluded from a possible role In seminal plasma
mediated Immunosuppression. They may be of particular Importance In
suppression of the function of Immune cells not looked at here, or
their activity may have a greater relative Importance In a different
specles.
135
4.6 THE IN VIVO RELEVANCE OF IN VITRO SEMINAL PLASMA MEDIATED
SUPPRESSION
Under normal circumstances, autoimmune responses to sperm antigens
are not detectable in the male. Early studies led to the belief that
the blood-test is barrier was absolute, preventing any contact of
developing spermatozoa with cells of the immune system. It is now
clear, however, that in some areas there is leakage of sperm antigens
(Tung et a 1. 1988) and active local suppression by CD8 positive cells
may prevent sensitisation (El Demiry s± a 1. 1987). It is
Inconceivable that factors in the seminal vesicles and prostate could
participate In local suppressive mechanisms, but epididymal derived
suppressive molecules have been demonstrated, and these could
constitute an Immunological back up to suppressor cells (Anderson and
Tarter 1982).
Alloimmune responses to spermatozoa do not usually occur in the
female, even though the vaginal route is adequate for immunisation
against a variety of antigens (Straus 1961, Yang and Schumaker 1979).
Furthermore, in the rabbit a vaginal leucocytosis in induced upon
insemination and phagocytosis of spermatozoa has been demonstrated
(Austin 1976, Phillips and Mahler 1975). Insemination of a second
ejaculate into a leucocyte dominated vaginal lumen showed no loss of
fecundicity, suggesting that the phagocytic function was to remove the
pool of non-fertile sperm, and possibly to 'select' fertile sperm
(Taylor £± a 1. 1982). The situation in the human is not so clear;
Pandya and Cohen (1985) have observed a leucocytosis in the cervix of
females after artificial insemination, but Wolff has not recorded this
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phenomenon after natural coitus (H. Wolff, personal communication).
If a leucocytosis does occur and polymorphs and macrophages do degrade
'unwanted' sperm, it does raise the question to the Jn vIvo relevance
of Jn vitro seminal plasma suppression. However, studies In our
laboratory have revealed that macrophages are relatively resistant to
the suppressive effects of seminal plasma and prostaglandin E in vitro.
Indicating that there may be a differential effect on cells of the
Immune response. Hence macrophages could degrade spermatozoa and
debris from the insemination site, but under similar conditions the
function of lymphocytes remained paralysed. The in vivo concentration
of prostaglandins at an Insemination site remains unknown, but
19-OH-PGE and 19-OH-PGF can still be detected In the human vagina up to
72 hours after intercourse (Sutton et a 1. 1987).
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4.7 THE CLINICAL IMPLICATIONS OF SEMINAL PLASMA MEDIATED SUPPRESSION
If the primary role of seminal plasma Is to protect
Immunologically foreign sperm from immune recognition, It follows that
certain categories of Infertility may be caused by a deficiency of key
suppressive factors In the semen. This has been demonstrated with two
of the seminal components studied in this thesis: the polyamlnes and
the prostaglandins. Decreased seminal spermine and spermidine levels
have been associated with infertility,- ant I sperm antlbodtes and
*
decreased la vitro Immunosuppression (Shohat s± al. 1988). Low
levels of prostaglandin E are found in patients who are diagnosed
with unexplained infertility (Bygdeman at al. 1970).
A number of possible immunological sequela could result from a
deficiency of seminal suppressive components. Firstly, if leucocytes
present in ejaculate derive from sites of infection they will be
preactlvated, but paralysed in function due to the high concentration
of suppressive factors present in the semen. If these factors are
missing the activated cells could initiate a graft-versus-host response
in the female tract, or secreted products of activation could cause
spermatozoa I damage. A recent study has shown that interferon and
tumor necrosis factor have an adverse affect on sperm motility
la vitro (Hill et a 1. 1987). Additionally, patients with greater
than one million/ml leucocytes were reported to have
significantly reduced semen parameters compared to those who had less
than one million/ml cells (Wolff and Anderson, 1988b). Secondly,
suppressive factors secreted by, for example, the epididymis, could
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provide a 'back up' mechanism to prevent sensltlsatIon of the male
to his own spermatozoa, and a deficiency may lead to production of
antlsperm antibodies. Thirdly, a decreased suppressive activity of SP
would allow sensltlsatI on In the female tract, possibly resulting In
production of antlsperm antibodies or killing of spermatozoa by
activated cells, each of which would result In decreased fertility.
A negative effect of a local Immunosuppression in the male and
female reproductive tract may also be the protection of micro-organisms
from Immune destruction. Impairment of the Immune response could
for example, prevent recognition and destruction by antibodies,
cytotoxic T-cells, NK cells, and phagocytosis and killing by
polymorphs and macrophages. J_a vItro Impairment of these functions
has been demonstrated repeatedly, and If these findings are relevant
in vivo. then continuous exposure to seminal plasma would aid
transmission of and Impair the host response to these organisms.
The Increasing world Incidence of AIDS makes an understanding of
transmission of HIV of particular concern. The virus has been Isolated
from seminal leucocytes (Zagury et a 1. 1984) and Is found free In
semen (Ho ja± aLu 1984). Initially, a high profile disease In
homosexuals, epidemiological study reveals that passive anal genital
Intercourse Is the lifestyle factor with the highest risk of HIV
Infection (Marmor 1985). Measurement of PGE metabolites In the blood
of rhesus macaque monkeys after rectal Insemination demonstrates
that absorption of SP components can occur (Alexander g± a I - 1986),
and similar studies In rabbits shows an Impairment in the systemic
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immune response (Richards £± a 1. 1984). I+ Is also known from in v itro
study that prostaglandin E increases HIV shedding from an Infected
T-ceiI line (Kuno et al. 1986). It Is therefore possible that semen
is not only a vehicle of transport for the virus, but that it increases
virus release from Infected cells, and increases host susceptibility to
Infection by decreasing immune cell function.
Local ImmunosurveiI lance by NK cells could also be Impaired, and
an increased susceptibility to neoplastic change result. Prostatic
cancer is the second most common neoplasm In men (McGregor and Teper
1978), and cervical cancer is prevalent In women with a high
degree of sexual activity and multiple partners (Wynder 1969). HPY
infection Is strongly associated with the risk of developing cervical
cancer (Mitchell et al. 1986) and zur Hausen (1982) has proposed that
infected Individuals may progress to cervical neoplasia by initiating
events such as concomitant HSV Infection, or heavy smoking. It is
postulated that repeated exposure to seminal plasma and the resulting
impaired Immunosurvei I lance by N8< cells may also help neoplastic change
If repeated or persistant HPV Infections are present.
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4.8 CONCLUSIONS AND FUTURE STUDIES
Many publications have reported on the immunosuppressive
properties of seminal plasma, but the complexity of the material has
hampered Identification of the factors responsible for this suppression
and few characterisation studies have been made. Studies have also
been made on cross species systems, but much of the data Is difficult
to interpret due to the use of bovine serum supplements in culture.
The data presented in this thesis clearly Illustrates that seminal
plasma components Inhibit the function of both NK cells and T
lymphocytes, and that the E series prostaglandins are responsible for a
major proportion of this suppression. Fractions rich In PGE and
19-OH-PGE suppressed cell function, removal of the prostaglandins
removed much of the suppressive activity of the seminal plasma and
the immunological properties of purified E-series prostaglandins
resembled those of whole seminal plasma.
The findings go someway in explaining the uniquely high
concentration of E-series prostaglandins in semen. Concentrations of
prostaglandin E are several log times greater than those in an
inflammatory situation (Higgs and Salmon 1979), but their presence has
not been satisfactorily explained. The interaction of seminal
prostaglandins has been frequently examined, but effects on sperm
motility are moderate, do not occur In all samples, and have not been
demonstrated with mixtures of prostaglandins as they occur in semen
(Schlegel £± a 1. 1981, Gottlieb £± a 1. 1988).
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Kelly (1988) suggests the unusually high distribution of
prostaglandins- in the semen of humans may have evolved to cope with his
unique sexual habits. In most species sexual activity is restricted by
the receptivity of the female to one part of the ovarian cycle, or
additionally, in seasonal breeders, to one part of the year. Man faces
no biological restrictions, and the prostaglandins may provide long
term protection against sensitisation of the recipient female's immune
system to semen. This hypothesis is supported by data from sub-human
primates. In the gorilla, the female usually only mates with one male,
whereas the chimpanzees and macaque monkeys Indulge in multiple matings
with the female (Kelly 1988). Although data is limited, these
behavioural patterns accord with the considerably lower levels of
prostaglandin In the gorilla compared to the chimpanzee and macaque
monkey (Kelly aJL*. 1976).
Continuation of this work will Involve the characterisation and
identification of the proteins responsible for binding seminal
prostaglandins, and the study of the immunological properties of this
complex. Further work delineating the differential effects of
prostaglandins on lymphocytes and macrophages will also be made.
Currently, a study is also underway measuring the PGE and 19-OH-PGE
concentration and Immunosuppressive activity of semen samples from
patients with unexplained Infertility, and In normal controls with
proven fertility. In a much broader context, it is essential that
further work is made on the distribution and function of Immune cells
in the male and female reproductive tracts.
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The results from this study are Important and particularly
relevant to a number of clinical situations. Further study on the
protein-prostagland In Interaction may reveal a novel immunosuppressive
agent relevant In the field of transplantation; knowledge of the
immunology of the reproductive tract and its secretions are essential
if an effective contraceptive vaccine is to be developed; and
contribution to our understanding on the transmission of HIV is
paramount with the present worldwide mortality from AIDS.
143
REFERENCES
Alexander, N.J. and Anderson, D.J. (1979) Vasectomy:
consequences of autoimmunity to sperm antigens. Fertil. Sterll.,
12:253.
Alexander, N.J. and Anderson, D.J. (1987) Immunology of semen.
FertII. Sterll.,47_d_92.
Alexander, N.J., Tarter, T.H., Ducsay, C.A., Fulgham, D.L. and
Huso, N. (1986) Rectal absorption of semen (abstract). J.
Reprod. Imaun., 10:82.
Allen, R.D. and Roberts, T.K. (1986) The relationship between
the Immunosuppressive and cytotoxic effects of human seminal
plasma. Am. J. Reprod. Immunol. Microbiol., H:59.
Allen, R.D. and Roberts, T.K. (1987) Role of spermine In the
cytotoxic effects of seminal plasma. An. J. Reprod. Imnunol.
and Microbiol., 11:4.
Anderson, D.J., Bach, D.L., Yunls, E.J., and DeWolf, W.C. (1982)
Major histocompatibility antigens are not expressed In human
epldldymal sperm. J. Imnunol., 129:452.
Anderson, D.J. and Tarter, T.M. (1982) Immunosuppressive effects
of mouse seminal plasma components in vivo and in vitro. J.
Imnunol., 125:535.
Anderson, D.J., Narayan, P., and DeWolf, W.C. (1984) Major
histocompatibility antigens are not detectable In post meiotic
human testicular germ cells. J. Imnunol., 133:1962.
Austin, C.R. (1976) Fate of spermatozoa In the female genital
tract and the problem of Induction of local antlsperm Immunity in
women. In: Development of Vaccines for Fertility Regulation.
Plenary Sessions of the Third International Symposium on
Immunology of Reproduction, Sep 21-25, 1975. WHO anon (Ed.).
Copenhagen Scrlpter 1976 p. 63.
Ayvallotls, B., Bronson, R. Rosenfeld, D., and Cooper, G., (1985)
Conception rates In couples where autoimmunity to sperm Is
detected. FertII. Star 11., 41:739
Bacetti, B., Pa 11 In I, V., and Burrlnl, A.G. (1973) The accessory
fibres of the sperm tail. I. Structure and chemical composition
of the bull "coarse fibres". Jl. Submlcr. Cy+ol., 1:237.
Bamberg, E., Weiser, M., and Desser, M. (1975) Polyamlnes In
bovine epldldymal spermatozoa. J. Reprod. FertII., 41:363.
Beckner, S.K., and Farrar, W.L. (1986) Interleukin 2 modulation
of adenylate cyclase. J. Biol. Chem., 211:3043.
144
Benvold, E., Svanborg, K., Eneroth, P., Gottlieb, C., and Bydeman, M.
(1984) The natural variations In prostaglandin concentration In
human seminal fluid and Its relation to sperm quality. Fer+II.
S+eril., 41:743.
Bendvold, E., Gottlieb, C., Svanborg, K., Gil I jam, H., Strandvik,
B., Bygdeman, M. and Eneroth, P. (1986) Absence of
prostaglandins In semen of men with cystic fibrosis Is an
indication of the contribution of the seminal vesicles. J.
Reprod. Fer+fl., Z£:311.
Berger, N.A. and Skinner, A.M. (1974) Characterisation of
lymphocyte transformation Induced by zinc Ions. J. Cell. Biol.,
£1:45.
Bischof, P., Martin-du-Pan, R., Lauber, K., GIrard, J.P., Hermann,
W.L. and Sizonenko, P.C. (1983) Human seminal plasma contains a
protein that shares physlcochemlcal, immunochemical, and
Immunosuppressive properties with pregnancy associated plasma
protein-A. J. Clin. Endocrinol. Metab., ££:359.
Biswas, S., Ferguson, K.M., Stedronska, J., Baffoe, G., Mansfield,
M.D., and Koshab, M.H. (1978) Fructose and hormone levels In
semen: their correlations with sperm counts and motility. Fertll.
Sterl!., 3(1:200.
Bouffloux, C.R. (1983) Prostatic cancer: epidemiology and etiology.
In: Cancer of the Prostate and Kidney. M. Pavona-Macaluso and P.
H. Smith (Eds.). Plenum Press, New York. p. 17.
Brendler, H. (1970) Physiology of the prostate and seminal
vesicle. In: Urology. Campbell, M.F. and Harrison, J.H. (Eds.)
W.B.Saunders, Co., Philadelphia.
Bronson, R.A., Cooper, G.W., and Rosenfeld, D.L. (1982)
Correlation between regional specificity of antisperm antibodies
to the spermatozoa surfaces and complement-mediated sperm
Immobilization. Am. J. Reprod. Immunol. Microbiol., 2:222.
Bronson, R.A., Cooper, G.W., and Rosenfeld, D.L. (1983)
Complement mediated effects of sperm head directed human
antibodies on the ability of human spermatozoa to penetrate
zona-free hamster eggs. Fertll. Sterll., 42:91.
Brooks, G.F., Lammei, C.J., Peterson, B.H., and Shites, D.P.
(1981) Human seminal plasma inhibition of antibody
complement-mediated killing and opsonisation of Neisseria
gonorrhoeae and other gram-negative organisms. J. Clin.
Invest., £1:1523.
Brcwn, P.G., Holborcw, E.J., and Glynn, L.E. (1965). The
aspermatogenic antigen in experimental allergic orchitis in guinea
pigs. Immunol., 2:255.
Brummer, H.C. and Gillespie, A. (1972) Seminal prostaglandins
and fertility. Clin. Endocrinol., 1:363.
145
Bygdeman, M., Fredricsson, B., Svanborg, K. and Samuelsson, B.
(1970) The relation between fertility and prostaglandin content of
seminal fluid in man. Fer+ll. Sterll., 21:622.
Byrd, W.J., Jacobs, D.M. and Amoss, M.S. (1977) Synthetic
polyamines added to cultures containing bovine sera reverslbly
Inhibit in vitro parameters of immunity. Nature (London),
262:621.
Cantrell, D.A. and Smith, K.A. (1984) The interleukin 2 T-celI
system: a new cell growth model. Science, 224:1512.
Centifanto, Y.M., Drylie, D.M., Deardourff, S.L., and Kaufman, H.E.
(1972) Herpes virus type 2 In the male genitourinary tract.
Science, 178:318.
Chesters, J.K. (1972) The role of zinc Ions In the transformation
of lymphocytes by phytohaemagglutlnln. Blochea J., 130:153.
Choualb, S., Welte, K., Mertelsmann, R. and Dupont, B. (1985)
Prostaglandin E„ acts at two distinct pathways of T-lymphocyte
activation: InnibIt Ion of interleukin production and
down-regulation of transferrin receptor expression. J. Immunol.,
121:1172.
Chvapll, M., Stankova, L., Bernhard, D.S., ZukoskI, C.F., and
Drach, G.W. (1977) Effects of prostatic fluid and its fraction on
some functions of peritoneal macrophages. Invest. Urol., 11:173.
Clark, D.A., Slapsys, R., Croy, B.A., Krcek, J. and Rossant, J.
(1986) Local active suppression by suppressor cells In the
decldua: a review. An. J. Reprod. Immunol., 1:78.
Cunnlngham-Rundles, S. and CunnIngham-RundIes, W.F. (1988) Zinc
modulation of Immune Response. In: Nutrition and Immunology.
Alan Llss, NY. p. 197.
Dawson, R.M.C., Mann, T., and White, I.G. (1957) GlyceryIphosphoryI-
cholIne and phosphoryIcholIne In semen and their relation to
choline. Blochen. J., 61:627.
Droller, M.J., Lindgren, J.A., Claesseln, H.A. and Perlmann, P.
(1979) Production of prostaglandin E2by bladder tumour cells In
tissue culture and a possible mechanism of lymphocyte Inhibition.
Cell. Immunol., 41:261.
El Demlry, M.I., Young, H., Elton, R.A., Hargreave, T.B., James,
K., and Chlsholm, G.D. (1986) Leucocytes In the ejaculate from
fertile and Infertile men. Br. J. Urol., 11:715.
El Demlry, M.I., Hargreave, T.B., Busuttll, A., Elton, R., James,
K., and Chisholm, G.D. (1987a) Immunocompetent eel Is In human
testis in health and disease. Fertll. Sterll., 41:470.
146
El Demlry, M.I.M. (1987b) Lymphocyte subsets and macrophages in male
genital tract in health and disease. Ph.D. Thesis, University of
Edinburgh p. 196.
El Demlry, M.I. and James, K. (1988) Lymphocyte subsets and
macrophages In the male genital tract In health and disease. A
monoclonal antibody based study. Eur. Urol., 11:226.
Eliasson, R. (1959) Studies on prostaglandin occurence, formation
and biological actions. Acta Physiol. Scand., 46 suppl. 158:75.
Eliasson, R., Posse, N. (1960) The effect of prostaglandin on the
non-pregnant human uterus la vivo. Acta Obstet. Gynecol.
Scand., 22.: 112.
Eliasson, R., and Lindholmer, C. (1971) Zinc In human seminal
plasma. Andrologie, 2:147.
Eliasson, R., Johnsen, 0., and Lindholmer, C. (1974) Effects of
seminal plasma on some functional properties of human spermatozoa.
In: Mane ini, R.E. and Martini, L. (Eds.) Male Fertility and
Sterility, Academic Press, New York, London p. 107.
Fabbri, A., Gnessi, L., Perricone, R., de Sanctis, G., Moretti,
C., de Carol Is, C., Fontana, L., Isidori, A. and Fraioli, F.
(1985) Human semen Inhibits T-rosette formation through an opiate
mediated mechanism. J. Clin. Endocrinol. Metab., £12:807.
Farmer, J.L., Gottlieb, A.A., Nishihara, T. (1986) Inhibition of
Interleukin 2 production and expression of the interleukin 2
receptor by plasma from acquired Immune deficiency syndrome
patients. Clin, I n»uno I. Inmunopath., 58:255.
Farrar, W.L. and Anderson, W.B. (1985) Interleukin 2 stimulates
association of protein kinase C with plasma membrane. Nature
(London), 215:233.
Farrar, W.L. and Taguchi, M. (1985) Interleukin 2 stimulation of
protein kinase C membrane association: evidence for IL—2 receptor
phosphorylation. Lymphokine Res., 1:87.
Ferry, F. and Donner, M. (1984) In vitro modulation of murine
natural killer cytotoxicity by zinc. Scand. J. Inmunol.,
12:435.
Filllngame, R.H., and Morris, D.R. (1973) Polyamine accumulation
during lymphocyte transformation and Its relation to the
synthesis, processing, and accumulation of ribonucleic acid.
Blochea., 12:4479.
Fisher, D.B. and Mueller, G.C. (1969) Acetyl-D-galactosamine inhibits
the early phospholipid response by lymphocytes to phytohemagluttnin
Nature (London), 221:556.
Friberg, J. (1974) A simple and sensitive micromethod for
demonstration of sperm from Infertile men and women. Acta Obstet.
Gynaecol. Scand. Suppl., 2£.:21.
147
Freundllch, B. and Avdalovlc, N. (1983) Use of gelatin-plasma
coated flasks for Isolating human peripheral blood monocytes. J.
Immunol. Meth., £2:31.
Friend, D.S. and Gllula, N.B. (1972) Variations in tight and gap
junctions in mammalian cells. J. Cell Biol., H:758.
Gearing, A.J.M., Johnstone, A.P., and Thorpe, R. (1985) Review
article. Production and assay of the InterleukIns. J. Immunol.
Meth., £1:1.
Gllula, N.B., Fawcett, D.W., Aoki, A. (1976) The Sertoli cell
ocludlng Junctions and gap junctions in mature and developing
mammalian testis. Dev. Biol., 2Q.:142.
Glater, G.B. and Anderson, D.J. (1988) Seminal plasma Inhibition of
lysis of viral-Infected target cells by natural killer cells and
activated cytotoxic T-cells. In press.
Goodwin, J.S. and Ceuppens, J. (1983) Regulation of the Immune
response by prostaglandins. J. Clin. Immunol., 1:295.
Goodwin, J.S., Messner, R.P. and Williams, R.C. (1979)
Inhibitors of T-celI mitogenesis: Effect of mitogen dose. Cell.
Immunol., 11:303.
Goto, T., Herberman, R.B., Maluish, A., and Strong, D.M. (1983)
Cyclic AMP as a mediator of prostaglandin E Induced suppression of
human natural killer cell activity. J. Immunol., 130:1350.
Gottlelb, C., Svanborg, K., Eneroth, P., and Bydeman, M. (1988)
Effect of prostaglandins on human sperm function la vitro and
seminal adenosine triphosphate concentration. Fertll. Sterll.,
42:322.
Grabsteln, K., Daver, S., Gil I Is, S., Urdai, D„, and Larsen, A.
(1986) Expression of Interleukin-2, interferon , and the IL2
receptor by human peripheral blood lymphocytes. J. Immunol,,
121:4503.
Haas, G.G. and Beer, A.E. (1986) Immunologic Influences on
reproductive biology: sperm gametogenesIs and maturation in the
male and female genital tracts. Fer+II. Sterll., 41:753.
Hamberg, M. (1976) Biosynthesis of prostaglandin E. by human
seminal vesicles. Lipids, 11:249.
Hargreave, T.B. (1982) Incidence of serum agglutinating and
Immobilizing antibodies In infertIle couples. Int. J. Fertll.,
21:90.
Heathcote, J.G., Cameron, C.H., and Dane, D.S. (1974) Hepatltls-B
antigen In saliva and semen. Lancet, 1:71.
148
Heathcote, J.G. and Washington, R.J. (1973) Analysis of the
zinc-binding protein derived from the human benign hypertrophic
prostate. J. Endocrinol., 56:421.
Heller, C.G. and Clermont, Y. (1964) Kinetics of the germinal
epithelium In man. Recent Prog. Honn. Res., 22:545.
Hendry, W.F., Morgan, H., and Stredonska, J. (1977) The clinical
significance of ant I sperm antibodies In male subfert11Ity. Br.
J. Urol., 42:757.
Hermann, W.P. (1975) Nachwels zlnkhaltiger Glykoprotelne In
mensllchen Spermaplasma. Andrologia, 2:329.
Hess, E.V. and Bernstein, I.L. (1985) The immune profile of
human seminal plasma. Imaunol. Today, £:320.
«
HIggs, G.A. and Salmon, J.A. (1979) Cyclo-oxygenase products in
carrageen in induced Inflammation. Prostaglandins, 12:737.
Hill, J.A., Halmovlcl, F., Pol Itch, J.A., and Anderson, D.J.
(1987) Effects of soluble products of activated lymphocytes and
macrophages (lymphokines and monokines) on human sperm motion
parameters. Fertil. Sterll., 42:460.
Hjort, T., Johnson, P.M. and Mori, T. (1985) An overview of the
WHO international multicentre study on antibodies to reproductive
tract antigens in the clinically defined sera. J. Reprod.
Immunol., £:359.
Ho, D.D., Schooley, R.T., Rota, T.R., Kaplan, J.C., Flynn, T.,
Salahuddln, S.Z., Gonda, M.A., HIrsch, M.S. (1984) HTLV-II In
the semen and blood of a healthy homosexual man. Science,
226:451.
Holsclaw, D.S., Perlmutter> A.D., Jock In, H. and Schwachman, H.
(1971) Genital abnormalities In male patients with cystic
fibrosis. J. Urol., 106:568.
Hulka, J.P. and Omran, K.F. (1969) The uterine cervix as a
potential local antibody secretor. Am. J. Obs+et. Gynecol.,
104:440.
Humes, J.L., Bonney, R.J., and Pel us, L. (1977) Macrophages
synthesize and release prostaglandins In response to inflammatory
stimuli. Nature (London), 262:149.
James, K. and Hargreave, T.B. (1984) Immunosuppression by
seminal plasma and its posslble clIn leal significance. Immunol.
Today, 5:357.
James, K., Harvey, J., Bradbury, A.W., Hargreave, T.B., Cull en,
R.T. and Donaldson, K. (1983) Preliminary report. The effect of
149
seminal plasma on macrophage function-a possible contributory
factor in sexually transmitted disease. Aids Res., 1:45.
James, K. and Szymaniec, S. (1985) Human seminal plasma is a
potent Inhibitor of natural killer cell activity in vitro. J.
Reprod. Imnunol., 1:61.
Jenkins, A.D., Turner, T.T. and Howard, S.S. (1978) Physiology
of the male reproductive system. Urologlcal Clinics of North
America, 1:437.
Jones, R., Brown, C.R., von Glos, K.I., and Parker, M.G. (1980)
Hormonal regulation of protein synthesis in the rat epididymis.
Characterization. of androgen-dependent and testicular
fluid-dependent protein. Blochem. J., 188:667.
Kay, J.E. and Lindsay, V.J. (1973) Polyamine synthesis during
lymphocyte activation. Exp. Cell. Res., 21:428.
Kelly, R.W., Taylor, P.L., Hearn, J.P., Short, R.V., Martin, D.E.,
and Marston, J.H. (1976) 19-hydroxy-prostaglandIn E. as a major
component of the semen of primates. Nature (London), 260:544.
Kelly, R.W. (1978) Prostaglandins In Semen: Their occurrence and
possible physiological significance. Int. J. Adrol., 1:188
Kelly, R.W., Deam, S., Cameron, M.J., and Seamark, R.F. (1984)
Measurement by radioimmunoassay of prostaglandins as their methyl
oximes. Prostaglandins LeukotrIenes Med., 21:1.
Kelly, R.W. (1988) Prostaglandins and semen. In: Prostaglandins
and Reproduction, M. Mitchell (Ed.) CRC Press, Boca Raton, Fla.
Kendall, R. and Targan, S. (1980) The dual effect of
prostaglandin and ethanol on the natural killer cytolytic process.
J. Immunol., 121:2770.
Kitada, M., Igarashi, K., Hirose, S, KItagawa, H. (1979) Inhibition
by polyamines of lipid peroxide formation In rat liver microsomes.
Blochem. Blophys. Res. Commun., 11:388.
Koren, H.S. and Leung, K.H. (1982) Modulation of human NK cells
by Interferon and prostaglandin E?. Mol. Immunol., 12:1341.
Kornfeld, R. and Kornfeld, S. (1971). The structure of a
phytohemaglutinIn receptor site from human erythrocytes to PHA
reactivity. J. Biol. Chem., 211:2536.
Krampltz, G. and Doepfmer, R. (1962) Determination of free amino
acids In human ejaculate by ion-exchange chromatography. Nature
(London), 121:684.
150
Kremer, J. and Jager, S. (1980) Characteristics of
anti-spermatozoa I antibodies responsible for the shaking
phenomenon with special regard to Immunoglobulin class and antigen
reactive sites. Int. J. Androl., 1:143.
Kristensen, F., Walker, C., Betters, F., Joncourf, F. and De
Week, A.L. (1982) Assessment of IL-1 and IL-2 effects on cycling
and noncycling murine thymocytes. Cell. Immunol., 24:140.
Kunkel, S.L., Chensue, S.W. and Phan, S.H. (1986) Prostaglandins
as endogenous mediators of Interleukin 1 production. J.
Immunol., 156:186.
Kuno, S., Ueno, R., Hayaishi, 0., Nakashlma, H., Harada, S., and
Yamamoto, N. (1986) Prostaglandin E2, a seminal constituent,
facilitates the replication of acquired immune deficiency syndrome
virus Jn vitro. Proc. NY Acad. Scl., 51:3487.
Labib, R.S. and Tomasi, T.B. (1981) Enzymatic oxidation of
polyamines. Relationship to Immunosuppressive properties. Euro. J.
Immunol., 11:266.
Lang, D.J. and Kummer, J.F. (1972) Demonstration of
cytomegalovirus In semen. N. Eng. J. Med., 281:756.
Lanier, L.L. and Phillips, J.M. (1988) What are natural killer
cells? I SI Atlas of Science: Immunology.
LIndholmer, C. and Eliasson, R. (1974) In vitro release and
uptake of zinc and magnesium by human spermatozoa. Int. J.





S., Tomasi, T.B., and
localisation of G, A,
human female genital
Tourville, D.R. (1970)
U secretory piece and
tract. Contraception,
London, S.N., Haney, A.F., and Weinberg, J.B. (1985) Macrophages
and infertility - enhancement of human macrophage-mediated sperm
killing by antisperm antibodies. Fertll. Sterll., 41:274.
Lord, E.M., Sensabaugh, G.F. and Stites, D.P. (1977)
Immunosuppressive activity of human seminal plasma. I. Inhibitor
of la vitro lymphocyte activation. J. Immunol., 118:1704.
Lozzio, C.B. and Lozzio, B.B. (1975) Human chronic myelogenous
leukaemia cell line with positive Philadelphia chromosome. Blood,
41:321.
Mackenzie, A.R., Hall, T., and Whitmore, W.F. (1962) Zinc content
of expressed human prostatic fluid. Nature (London), 193:72.
Majumdar, S., Bapna, B.C., Mapa, M.K., Gupta, A.N., Devi, P.K.
and Subrahmanyam, D. (1982) Effect of seminal plasma and its
fractions on in vitro blastogenic response to mitogen. Int. J.
Fertll., 21:224.
151
Makoul, G.T., Robinson, D.R., Bhalla, A.K. and Glimcher, L.J.
(1985) Prostaglandin E2 Inhibits the activation of cloned T-cell
hybridomas. J. Immunol., 154:2645.
Mandelbaum, S.L., Diamond, M.P., and de Cherney, A.M. (1984) The
impact of antisperm antibodies on human infertility. J. Urol.,
12£:1.
Mandelbaum, S.L., Diamond, M.P., and de Cherney, A.M. (1987)
Relationship of antisperm antibodies to oocyte fertilisation and
cleavage In In vitro fertilisation. Fer+II. Sterll., 4Z:644.
Mann, T. (1946) Studies on the metabolism of semen. 3. Fructose as a
normal constituent of seminal plasma. Site of formation and
function of fructose in semen. Biochem. J., 40.:481
Mann, T. (1964) The biochemistry of semen and of the male
reproductive tract. Methuen, London Second Edition.
Mann, T. and Lutwak-Mann, C. (Eds.). (1984) Male reproductive
function and semen. Themes and trends in physiology, biochemistry
and Investigative urology. Springer Verlag, BerIin-HeI del berg-NY.
Marcus, Z.H., Freisheim, J.H. and Houk, J.L. (1978) Suppression
of eel I-mediated immune response by human spermatozoa and
fractions Isolated from human seminal plasma. Clin. Immunol.
Iuaunopathol., 2:318.
Marcus, Z.H., Lunenfeld, B., Weissenberg, R., and Lewin, L.M.
(1987) Immunosuppressant material in human seminal fluid.
Inhibition of blast transformation and of NK activity by seminal
fluid from patients of a male Infertility clinic. Gynecol.
Obstet. Invest'., 22.: 54.
Marmor, M. (1985) Epidemic kaposis sarcoma and sexual practices
among male homosexuals. In: AIDS: The Epidemic of Kaposis Sarcoma
and Opportunistic Infection, A.E. Friedman-Klein and G.G.
Labenstein (Eds.) Masson Publishing, New York. p. 291.
Mary, D., Aussel, C., Ferrua, B. and Fehlmann, M. (1987)
Regulation of interIeukin-2 synthesis by cAMP in human T-cells.
J. Immunol., 159:1179.
Mathur, S., Baker, E.R., Williamson, H.O., Derrick, F.C., Teague,
K.J., and Fudenberg, H.H. (1981) Clinical sIgnIfIcance of sperm
antibodies in Infertility. Fertll. S+erll., 2&:486.
McGregor, J.E. and Teper, S. (1978) Mortality from carcinoma of the
cervix uteri in Britain. Lancet, _LL:774.
McNeal, J.E. (1981) The zonal anatomy of the prostate. Prostate,
1:35.
152
Meisels, A. and Fort In, A. (1976) Condyloma+ous lesions of the
cervix and vagina. I. Cytological patterns. Acta Cytol.,
2Q:505.
Middleditch, B.S. (1975) PGA: fact or artifact? Prostaglandins,
S: 409.
Mitchell, H., Drake, M. and Medley, G. (1986) Prospective
evaluation of risk of cervical cancer after cytological evidence
of human papillomavirus infection. Lancet, 1:573.
Mizel, S.B. (1982) lnterleukln-1 and T-celI activation. Immunol.
Rev., £3.:51.
Moghissi, K.S. (1970) Human fallopian tube fluid. I. Protein
Composition. Fertll. Sterll., 21:821.
Mukherjee, D.C., Agrawal, A.K., Manjunath, R. and Mukherjee, A.B.
(1983) Suppression of epididymal sperm antigenicity in the rabbit
by uteroglobuI in and transglutaminase in vitro. Science, 219:989.
Nishizuka, Y. (1986) Studies and perspectives of protein kinase
C. Science, 233:305.
Ogra, P.L., Yamanaka, T. and Losonsky, G.A. (1981) Local
immunologic defenses in the genital tract. In: Reproductive
Immunology. Alan Liss, NY. p. 381.
Oppenheim, J.J. and Gery, I. (1982) lnterleukln-1 is more than an
Interleukin. Immunol. Today, 1:113.
Paetkau, V., Miles, G., Gerhart, S. and Monticon, E. (1976)
Proliferation of murine thymic lymphocytes in vitro is mediated by
the concanavalin A induced release of a lymphoklne (costimulator).
J. Immunol., UL2:1320.
Palladino, M.A. and Welte, K. (1984) Interleukin regulation o.f
the immune system (IRIS) in male homosexuals with AIDS syndrome.
Ann. NY. Acad., 437:535.
Pandya, I.J. and Cohen, J. (1985) The leukocytic reaction of the
human uterine cervix to spermatozoa. Fer+II. Sterll., 42:417.
Parks, D.R., Bryan, V.M., 01, V.T., and Hertzenberg, L.A. (1979)
Antigen specific identification and cloning of hybridomas with a
fluorescent activated cell sorter (FACS). Proc. Nat. Acad.
Self., USA 12:1962.
Parrish, R.F., Goodpasture, J.C., Zaneveld, L.J.D., Polakoski, K.L.
(1979) Pol yam Ine inhibition of the conversion of human proacrosin
to acrosin. J. Biol. Chem., 253:8428.
153
Pelosi-Testa, E., Samoggia, P., Giannella, G., Montesoro, E.,
Caravita, T., Salvo, G., Camagna, A., Isacchi, G., Tes+a, U., and
Peschle, C. (1988) Mechanisms underlying T lymphocyte activation:
mitogen initiates and IL—2 amplifies the expression of transferrin
receptors via intracellular iron level. Immunol., 64:275.
Phillips, D.M. and Mahler, S. (1975) Migration of leucocyte and
phagocytosis In rabbit vagina. J. Cell. Biol., £L:334a
(abstract number 667).
PItout, M.J. and Jordaan, J.H. (1976) Partial purification of an
ant I-mitogenic factor from human semen. Int. J. Biochem.,
1:149.
Prakash, C., Coutinho, A. and Moller, G. (1976) Inhibition of la
vitro Immune responses by a fraction from seminal plasma. Scand.
J. Immunol., 6:77.
Prakash, C. (1981) Etiology of Immune Infertility. In:
Reproductive Immunology. Alan LIss, Inc., New York. p. 403.
Reem, G.H. and Yeh, N.H. (1984) Interleukin 2 regulates
expression of Its receptor and synthesis of gamma interferon by
human T-lymphocytes. Science, 225:429.
Richards, J.M., Bedford, J.M., and Witkin, S.S. (1984) Rectal
insemination modifies Immune responses In rabbits. Science,
221:390.
Ritchie, A.W.S., Hargreave, T.B., James, K. and Chisholm, G.D.
(1984) Intraepithelial lymphocytes in the normal epididymis: a
mechanism for tolerance to sperm autoantigens: Br. J. Urol.,
-56:79.
Romrell, L.J. and 0f Rand, M.G. (1978) Capping and
uItrastructuraI localisation of sperm surface isoantigens during
spermatogenesis. Dev. Biol., 63:76.
Ross, L.S. (1983) Diagnosis and treatment of Infertile men: a
clinical perspective. J. Urol., 150:847.
Rumke, P. (1974) The origin of Immunoglobulins in semen. Clin.
Exp. InnunoI., 11:287.
Rumke, P. and Hellinger, G. (1959) Autoantibodies against
spermatozoa In sterile men. Am. J. Clin. Pathol., 22:357.
Rumke, P., Van Amstel, N., Messer, E.N. and Bezemer, P.D. (1974)
Prognosis of fertility of men with sperm agglutinins In the sperm.
Pert!I. S+eril., 26:393.
Sarada, S. and Yoshida, 0. (1985) Zinc concentrations and total
amount of zinc In seminal plasma of infertile men with special
reference to prostatic secretory function.Hinyokika Kiyo, 21:1971.
154
Schlegel, W., Rotemund, S., Farber, G. and Nieschlag, E. (1981)
The Influence of prostaglandins on sperm motility.
Prostaglandins, 21:87.
Sekl, H., Ueno, Y., Taga, K. (1985) Mode of in vitro
augmentation of natural killer cell activity by recombinant human
interleukln 2: a comparative study of Leu I 1+ and Leu I I- cell
populations In cord blood and adult peripheral blood. J.
Innunoi., 135:2551 .
Shohat, B., Maayan, R., Zukerman, Z. and Kaufman, H. (1988)
Correlation between immunosuppressive activity of seminal plasma,
antisperm antibodies and spermine levels In couples with
unexplained activity. Presented at the Annual Symposium of the
American Society for the Immunology of Reproduction, Portland,
Maine, June 1988.
Sixeby, J.W., Lemon, S.M. and Pagano, J.S. (1986) A second site
for Epstein-Barr virus shedding: the uterine cervix. Lancet,
JL1:1122.
Snyder, D.S., Beller, D.I. and Unanue, E.R. (1982)
Prostaglandins modulate macrophage la expression. Nature
(London), 299:165.
Stankova, L., Drach, G.W., Hicks, T., ZukoskI, C.F. and Chvapil,
M. (1976) Regulation of some functions of granulocytes by zinc of
the prostatic fluid and prostate tissue. J. Lab. Clin. Med.,
M:640.
Stites, D.P. and Erlckson, R.P. (1975) Suppressive effect of
seminal plasma on lymphocyte activation. Nature (London),
251:727.
Straus, E.K. (1961) Occurence of antibody in human vaginal mucus.
Proc. Soc. Exp. Biol. Med., 1Q6:6A.
Sutton, J.G., Kelly, R.W. and Morris, B.A. (1987) Evaluation of
the 19-OH analogues of prostaglandins E. and E„, F. and F« as
specific markers for the identification of numan semen in Body
fluid mixtures. Forensic. Sci. int., 32:103.
Swerdloff, R.S., Overstreet, J.W., Sokol, R.Z. and Rajfer, J. (1985)
Infertility in the male. Ann. Int. Med., 105:906.
Tabor, C.W., Tabor, H. and Bachrach, U. (1964) Identification of
the amlnoaldehydes produced by the oxidation of spermine and
spermidine with purified plasma amine oxidase. J. Biol. Chen.,
222.:2194.
Tarter, T.H., Cunningham-Rundles, S. and Kolde, S.S. (1986)
Suppression of natural killer cell activity by human seminal
plasma in vItro: Identification of 19-OH-PGE as the suppressor
factor. J. Innunoi., 156:2862.
155
Taylor, N.J. (1982) Investigation of sperm-induced cervical
leucocytosis by a double mating study in rabbits. J. Reprod.
Ferti IM:157.
Tea, N.T., Grenier, J., and Scholler, R. (1976) Steroid hormones
in human semen. In: Hubinot, P.O. and L'Hermite, M. (Eds.).
Sperm Action. K-arger, Basel (Prog. Reprod. Biol., vol. 1. p. 107).
Templeton, A.A., Cooper, I. and Kelly, R.W. (1978) Prostaglandin
concentrations In the semen of fertile man. J. Reprod. Fer+II.,
52:147.
Thomas, I.K. and Erickson, K.K. (1984) Seminal plasma inhibits
lymphocyte response to T dependent and independent antigens in
vitro. Immunology, 52:721.
Til den, A.B. and Balch, C.M. (1982) A comparison of PGE- effects
on human suppressor cell function and Interleukin 2 function. J.
Immunol., 129:2469.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S.C., Seehra, J.,
London, L. and Perussia, B. (1984) Response of resting human
peripheral blood natural killer cells to interleukin-2. J. Exp.
Med., 165.: 1147.
Tung, K.S.K., Yule, T.D., and Mahl-Brown, C.A. (1988) Recent
advances in testicular autoimmunity. Presented at the First
Workshop on Biochemical Aspects on the Immunopathology of
Reproduction, Rome, November 1988.
Turner, M.J., White, J.O. and Soutter, W.P. (1987) Human seminal
plasma inhibits the lymphocyte response to Epstein-Barr Virus.
Immunol. Today, 5:170.
Urry, R.L. (1981) Pathophysiological principles of male infertility.
Urology Clinics of North America, 5:3.
Vallely, P.J. and Rees, R.C. (1986) Seminal plasma suppression
of human lymphocyte responses in vitro requires the presence of
bovine serum factors. Clin. Exp. Immunol., 66,:181.
Vallely, P.J., Sharrard, R.M., and Rees, R.C. (1988) The
Identification of factors in seminal plasma responsible for
suppression of natural killer cell activity. Immunol., 53.:451.
Vercammen, C. and Ceuppens, J.L. (1987) PGE- inhibits human T
cell proliferation after cross I inking of The CD3-TI complex by
directly affecting T-cells at an early step of the activation
process. Cell. Immunol., 104:24.
Von Euler, U.S. (1936) On the specific vaso-dilating and plain
muscle stimulating substances from accessory genital glands in man
and certain animals (prostaglandin and vesIgland In). J. Physiol.
(London), 55:213.
156
Walker, C., Krlstensen, F., Bet+ens, F. and de Week, A.L. (1983)
Lymphokine regulation of activated (G1) lymphocytes. I.
Prostaglandin E~ Induced Inhibition of interleukin 2 production.
J. Immunol., 130;1770.
Wickremasinghe, R.G. (1988) The role of prostaglandins in the
regulation of cell proliferation. Prostaglandins Leukotrienes and
Essential Fatty Acids; Reviews, 11:171.
W!11 lams-Ashman, H.G., Corti, A., and Tadollni, B. (1976) On the
development of specific inhibitors of animal polyamlne
biosynthetlc enzymes. Ital. J. Blochem., 21:1.
Wi11iams-Ashman, H.G. and Lockwood, D.M. (1970) Role of
polyamines in reproductive physiology and sex hormone action.
Ann. NT Acad. Scl., 111:882.
WII I lams-Ashman, H.G. and Canellakis, Z.N. (1979) Polyamines in
mammalian biology and medicine. Perspect. Biol. Med., 22:421.
Witkln, S.S., Richards, S.J.M., Bongiovanni, A.M. and Zellkovsky,
G. (1983) An IgG-Fc binding protein in seminal fluid. Am. J.
Reprod. Immunol., 1:23.
Wolff, H. and Anderson, D. (1988a) ImmunohIstologIc characterisation
and quantitation of leukocyte subpopuI at ions in human semen.
Fer+ll. Ster11., 42:497.
Wolff, H. and Anderson, D. (1988b) Leukocytes In semen: their
role in male Infertility. Presented at the First Workshop on
Biochemical Aspects on * the Immunopathology of Reproduction.
November 1988, Rome.
Wynder, E.L. (1969) Epidemiology of carcinoma in situ of the cervix.
Obstet. Gynaecol. Surv., 21:697.
Yang, S. and Schumacher, G.F.B. (1977) Immune response after
vaginal application of antigens in the rhesus monkey. Fertll.
SterII., 22:314.
Zagury, D., Bernard, J., Lelbovltch, J., Safai, B., Groopman,
J.E., Feldman, M., Sarngadharan, M.G. and Gallo, R.C. (1984)
HTLV-I11 in cells cultured from semen of two patients with AIDS.
Science, 226;449.
Zaneveld, L.J.D., Tauber, P.F., Port, C., Propplnc, D. and
Schumacher, G.F.B. (1974) Scanning electro microscopy of the
human, guinea-pig and rhesus monkey seminal coagulum. J. Reprod.
Fertll., 42:223.
zur Hausen, H. (1982) Human genital cancer: synergism between two
virus Infections or synergism between a virus infection and an


















4. Boehringer Manheim Corporation Ltd.
Bell Lane
Lewes
East Sussex BH7 1LG
5. Corning Medical Ltd.
Ha I stead
Essex C09 2DX













9. Gel man Sciences Inc.

























Mi Iton Keynes NK9 3HP
15. Scottish Antibody Production Unit


























AB AB blood group positive
B eel 1 Bursa derived lymphocyte
CMV Cytomegalovirus
CPM Counts per minute
Con A Concanava1 in A
DEAE Diethy1 amino ethy1 ce11u1ose
DNA Deoxyribonucleic acid
DNP-F 2-4-dinitropheny1-L-1ysine-fico11
EBV Epstein Barr Virus
EDTA Ethylenediaminetetra acetic acid
FCS Foetal calf serum
HB103 HB103 serum free medium
HBSS Hanks balanced salt solution
HIV Human immunodeficiency virus
HLA-DR Human leucocyte antigen class II
HPLC High pressure liquid chromatography
HPV Human papilloma virus
HSV Herpes simplex virus
IL-1 Interleukin 1
IL-2 Interleukin 2




MLR Mixed lymphocyte reaction
NBCS New born calf serum
ND Not done
NK eel I Natural ki1ler eel 1
NRS Normal rabbit serum
NS Not significant
PBS Phosphate buffered saline
PBMC Peripheral blood mononuclear cells
PHA Phytohaemag1utinin
PGE Prostaglandin E
19-OH-PGE Nineteen hydroxy prostaglandin E
19-OH-PGF Nineteen hydroxy prostaglandin F
PGF Prostaglandin F
PMA Phorbol myristate acetate
PWM Pokeweed mitogen
R M Rabbit antimouse
RIA Radioimmunoassay
RNA Ribonucleic acid
RPMI RPMI cell culture medium 1640
SD Standard deviation
SP Seminal plasma
TBS Tris buffered saline





Journal of Reproductive Immunology, 12 (1987) 191—200
Elsevier Scientific Publishers Ireland Ltd.
191
JRI 00509
Human seminal plasma suppresses lymphocyte
responses in vitro in serum-free
medium
Stanislaw Szymaniec", Alison J. Quayleb, T.B. Hargreaveb
and Keith Jamesb
"Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, UL Czerska, 53-114 Wroclaw
(Poland) and ''Department of Surgery, University of Edinburgh Medical School, Teviot Place,
Edinburgh, EG8 9AG (Scotland)
(Accepted for publication 9 September 1987)
Summary
The in vitro immunosuppressive properties of human seminal plasma have
been re-investigated in serum-free medium in view of recent suggestions that the
previously observed effects might be dependent on the presence of exogenous
serum co-factors present in the culture media. The present studies reveal that low
concentrations of seminal plasma can inhibit the ability of peripheral blood
leukocytes to lyse K562 target cells in the absence of fetal calf or new-born calf
serum. These inhibitory effects could be achieved by pre-incubating the effector
cells in seminal plasma at 37 °C prior to use in the natural killer cell assay or by
incorporating it into the assay system. Additional studies revealed that human
seminal plasma could also inhibit the proliferative response of peripheral blood
lymphocytes to phytohaemagglutinin in serum-free HB103 medium. These effects
were most marked and consistent if the seminal plasma was present throughout
the period of culture. Overall, these studies indicate that the previously reported
suppressive effects of human seminal plasma in these systems cannot be entirely
attributable to cytotoxic factors generated by exogenous serum components.
Key words: seminal plasma; immunosuppression; in vitro assays; serum-
free medium.
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Introduction
There have been many reports showing that human seminal plasma can
impair the activity of most of the cells of the immune system and also
interfere with the generation and activity of a number of the soluble
factors involved in the defence against infection (see James and
Hargreave, 1984). This has led to the suggestion that while the main
purpose of immunosuppressive components in seminal plasma may be to
limit autoimmune responses to differentiation antigens on sperm,
excessive exposure might also predispose to a number of problems of
increasing clinical importance, including prostatitis, epididymitis,
malignancies of the urogenital tract and sexually transmitted diseases,
including AIDS (e.g. James et al., 1983; James and Hargreave, 1984;
McClean et al., 1983; Rees et al., 1986; Tarter et al., 1986).
Recently, however, there have been reports that the ability of human
seminal plasma to suppress certain in vitro responses, namely mitogen-
induced lymphocyte transformation and natural killer cell activity, is
dependent upon the presence in the culture media of bovine serum (Rees
and Vallely, 1986). This has led to the suggestion that the
immunosuppression observed in these systems is due to factors produced
by the interaction of polyamine oxidases in bovine serum with spermine, a
major component of seminal plasma. These factors include oxidised
spermidine itself (Rees and Vallely, 1986; Allen and Roberts, 1986a,b)
and its highly toxic degradation product, acrolein (Allen and Roberts,
1986a,b).
While the ability of the above products to inhibit certain lymphocyte
responses in vitro is beyond doubt (e.g. Byrd et al., 1977; Gaugas and
Dewey, 1978; Williamson, 1984) the suggestion that certain of the
observed immunosuppressive effects of human seminal plasma are due to
the action of serum co-factors of bovine origin are of considerable
importance as they challenge the possible biological relevance of most of
the previous studies in this area. We therefore felt it was important to
perform further studies to establish if the in vitro immunosuppressive
effects of human seminal plasma were dependent upon the interaction
with bovine serum factors. The results of this study clearly indicate that
the ability of seminal plasma to inhibit the response of peripheral
lymphocytes to phytohaemagglutinin and their ability to lyse K562 target
cells is not crucially dependent upon the presence of exogenous serum co-
factors.
Materials and methods
The semen samples were obtained from routine laboratory specimens
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provided by donors attending the male infertility clinic run by our
department. After liquefaction the semen samples were centrifuged at
1000 x g for 10 min to remove spermatozoa. Samples were either tested
individually (see Table 1) or about 20 samples pooled. The individual
samples and pools were sterilised by passage through a Hemming filter
and stored at — 20°C until used.
The peripheral blood leukocyte preparations used were derived from
fresh whole blood obtained with consent from healthy laboratory staff or
routine blood donors. Blood was collected into 10 ml sterile blood
collection tubes containing 0.1 ml of a 15% (w/v) solution of EDTA
(Monojet, Sherwood Medical, St. Louis, MO, U.S.A.). Leukocyte
separations were performed on lymphocyte separation medium (Flow
Laboratories, Irvine, U.K.). The cells obtained were washed (X3) with
Hank's balanced salt solution and resuspended to the required cell density
in RPMI-1640 containing either 10% (v/v) heat-inactivated (56 °C for 30
min) fetal calf serum or new-born calf serum or in HB103 serum-free
medium (New England Nuclear, Stevenage, U.K.). The HB103 medium is
a modified RPMI-1640 basal medium supplemented with purified human
albumin (Cohn Fraction V) and transferrin and also contains selenium
and phosphoethanolamine. The total protein content is less than 730 pg/
ml. For commercial reasons, precise details of composition are
unavailable but it is highly unlikely that this product exhibits polyamine
oxidase activity. It should also be noted that when used in the
transformation assays the above media were also supplemented with 2
mm L-glutamine, 100 Iu penicillin/ml, 100 pg streptomycin/ml and 5 X
10~5 M mercaptoethanol.
Adherent cell-depleted effector cells for use in the NK cell assay were
obtained by further incubation of the above preparations in 75 cm2 plastic
flasks for 20 min at 37 °C.
Full details of the basic NK cell assay used, including the growth and
51Cr-labelling of the K562 target cells, the incubation conditions and the
procedure for determining specific chromium release have been described
elsewhere (James and Szymaniec, 1985). Further details on pre-incubation
conditions, effector target ratios used and the concentration of seminal
plasma employed are recorded in the results section.
Mitogen-induced lymphocyte proliferation studies were performed with
a wide range of concentrations (0.3—40 pg/ml) of phytohaemagglutinin
(Sigma, Poole, U.K.). The cultures which were performed in triplicate on
96-well round-bottomed microtitre plates, contained 1 x 105 cells in 100
pi of serum-free or serum-containing media, 20 pi of mitogen solution and
20 pi of human seminal plasma or media. The final concentration of
seminal plasma in culture was 1% (v/v). Following 72 h incubation at
37 °C the cultures were pulsed with 1 pCi/ml tritiated thymidine
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(Amersham International, Amersham, U.K.) and harvested 18 h later on
a Skatron semi-automatic harvester (Skatron, Lier, Norway). The discs
were suspended in scintillant and counted on a p scintillometer. Further
details on the pre-incubation of lymphocytes are desribed below.
Cell viability was assessed using the vital dye ethidum bromide acridine
orange (Parks et al., 1979).
Results
In our initial studies in serum-free media we examined the inhibitory
effects of human seminal plasma from 10 different donors on the lysis of
K562 target cells by peripheral blood leukocytes, the seminal plasma being
present throughout the 4-h assay period. These studies clearly demon¬
strated that every sample of seminal plasma examined was capable of in¬
hibiting natural killer cell activity in HB103 serum-free medium (see Table
1).
Additional studies revealed that these inhibitory effects in serum-free
media could be achieved with a range of concentrations of seminal
plasma, there being some suggestion however that with low doses the ef¬
fects were more marked in the presence of FCS (Fig. 1).
TABLE 1
The effect of human seminal plasma" on NK cell activity in serum-free medium.
Experiment Donor % Inhibition




Ab 3 45.5 73.4
4 67.3 73.2
5 74.6 71.4
Mean ± S.D. 57.5 ± 13.0" 73.9 ± 7.3
6 79.8 29.6
7 86.4 81.0
Bc 8 91.9 99.5
9 92.2 82.8
10 85.2 73.7
Mean ± S.D. 87.1 ± 4.6 73.3 ± 23.4
"1% v/v.
bEffector/target ratio, 12:1. Maximum release 39.1%.
"Effector/target ratio, 30 : 1. Maximum release 61.1%.










FINAL CONCENTRATION OF SEMINAL PLASMA (7.V0L)
Fig. 1. The effect of different doses of human seminal plasma on natural killer cell activity in serum-
free media. Note that effective inhibition is achieved in serum-free media with all doses of seminal
plasma. The serum used in these experiments was FCS.
Other experiments were performed to determine the influence of var¬
ious pre-incubation procedures on the immunosuppressive properties of
human seminal plasma in serum-free systems. In these studies the effector
leukocytes were pre-incubated at various temperatures and for varying
0 15 0 15
FINAL CONCENTRATION OF SEMINAL PLASMA (7.VOL)
Fig. 2. The influence of pre-incubation temperature on the inhibitory effects of human seminal
plasma in serum-free media (HB103). Note that prior treatment of peripheral blood leukocytes in
human seminal plasma at 37 °C in the absence of bovine serum components drastically impairs natu¬
ral killer cell activity while treatment at 0°C does not.
TABLE2 Theeff ctofhumanseminalplasma"hytohaemagglutininbinducedlymphocytetrans ormations ru -freeedium(HB103).N t ti ilar inhibitoryeffectsw reseenharangeofmito ndos dp ripheralbllym h yt sfr mnu b rn r . Experiment"1%Inhibitionobserved"following 1hpre-treatmentinContinuoustr atm nti HB103mediumRPMI+10%HB103mediumI10P I FCSNBCSNBCS 13.32 531 9699 .85 2069.19357.01 3014.46.788 09 . MeanS.D.4 4±6 332.026 21 93 78 .50 18 475 ■1%v/v. "5fig/mlPHA. "Percentinhibitiowithr fer ncetostimulationobservednPHAstimulatedcul urw thoutus minalplasm . "Experimentsdonn3separa eoccasionswithp ripheralbl odlym hocyt sfros gled r.
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10
Fig. 3. The effect of human seminal plasma on PHA-induced lymphocyte transformation in serum-
free and serum-containing media. Note that human seminal plasma (1% v/v) effectively suppresses
the proliferative response to a wide range of doses of phytohaemagglutinin in both serum-free
(HB103) and serum-containing media (FCS and NBCS).
NO HSP HSP THROUGHOUT PERCENT SUPPRESSION
BY HSP
periods of time in 1% and 5% (v/v) human seminal plasma in serum-free
(HB103) medium. The cells were then extensively washed in serum-free
medium prior to testing in the standard K562 lysis assay without the addi¬
tion of further seminal plasma. It is apparent from Fig. 2 that the ability
of human seminal plasma to inhibit natural killer cell activity is drastically
influenced by the temperature of pre-incubation. Thus pre-incubation of
effector cells at 0°C for 16 h had little effect on their lytic ability when
subsequently tested in the standard NK assay. In contrast, pre-incubation
at 37 °C resulted in complete ablation of their activity. Additional studies
revealed that similar inhibitory effects could be achieved in serum-free
medium by pre-incubation at 37°C for much shorter periods, namely 1—4 h.
Extensive studies on the effect of human seminal plasma on
phytohaemagglutinin-induced lymphocyte proliferation gave results in
broad agreement with the above, indicating that marked inhibition could
be achieved in the absence of bovine serum components. The results of
three separate experiments on lymphocytes from a single donor are sum¬
marised in Table 2 while those obtained in one such experiment are illus¬
trated in greater detail in Fig. 3. Throughout these studies it has been
apparent that the inhibition achieved in all three media is more dramatic
and reproducible when human seminal plasma is present throughout the
period of culture. It should also be noted that inhibitory effects in FIB 103
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medium have been observed with a wide range of doses of mitogen.
Furthermore, the suppression observed in both HB103 and FCS contain¬
ing media was usually from a higher control level.
The cytotoxic effects of human seminal plasma were investigated using
peripheral blood lymphocytes from six donors (3 male, 3 female). The
lymphocytes were incubated for 92 h at 37°C in HB103, or in RPMI-1640
supplemented with 10% FCS, NBCS or autologous plasma, in the presence
or absence of 1% human seminal plasma. With the exception of the
NBCS-containing cultures, human seminal plasma had little effect on cell
survival. In almost all cases survival and viability were similar to that
observed in controls with viabilities in most instances exceeding 90%. In
contrast, in the presence of NBCS, HSP appeared to be extremely toxic
for lymphocytes with few cells surviving culture for 92 h in 4 out of 6 of
the donors tested.
Discussion
In the current studies we have demonstrated that human seminal
plasma is capable of impairing the activity of cells of the immune system
in HB103 medium which contains no bovine serum components. The res¬
ponses inhibited included NK cell mediated lysis of K562 target cells and
mitogen-induced lymphocyte proliferation. These results indicate that the
inhibitory effects observed in certain of these in vitro models, by our¬
selves and others, cannot be attributable solely to the interaction of exo¬
genous bovine serum co-factors with human seminal plasma components
such as spermine (Rees and Vallely, 1986; Vallely and Rees, 1986).
At the present time we do not have a satisfactory explanation of the
differences between our results in HB103 medium and those previously
reported by Vallely and Rees (1986). It is however conceivable that it
might be partly due to differences in experimental protocols. In this
connection it is interesting to note that Vallely and Rees (1986) incubated
their effector cells at 37 °C for 18 h prior to use in the NK cell assay. In
our hands this leads to enhanced NK cell activity and a markedly reduced
susceptibility to inhibition by HSP in the presence of fetal calf serum
(Quayle et al., 1987). Further studies in identical experimental models
should help resolve this matter.
While our results in HB103 medium are at variance with those pre¬
viously reported we accept that in certain experimental models the immu¬
nosuppressive properties of human seminal plasma may be attributable to
the generation of oxidised spermine (Vallely and Rees, 1986; Rees and
Vallely, 1986) and its toxic degradation product acrolein (Allen and Rob¬
erts, 1986). Indeed, our own cytoxic studies would suggest that culture of
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lymphocytes for 48 h or more in HSP in newborn calf serum containing
media can result in their death. In contrast, however, little or no cell
death was observed in either serum-free or FCS-containing media. It is
our contention that a variety of factors and mechanisms are involved and
as previously emphasised these may vary from system to system (see
James and Hargreave, 1984). Of special interest as far as the NK cell sys¬
tem is concerned are recent reports indicating that the inhibitory effects of
human seminal plasma can be directly attributed to 19-hydroxylated E
prostaglandins (Tarter et al., 1986). The present studies further support
the view that the inhibitory effects of human seminal plasma on human
peripheral blood leukocytes cannot be entirely attributable to cytotoxicity.
In the first place, prolonged incubation (92 h) of these cells in inhibiting
concentrations of HSP in both serum-free and FCS or autologous plasma
containing media resulted in little cell death. In view of these results we
find it difficult to believe that the inhibitory effects noted in the relatively
short term NK cell model can be attributed to the killing of the effector
cells, unless they are particularly susceptible. However, in view of our ob¬
servations that the NK cell activity of peripheral blood leukocytes
incubated at 37 °C for 18 h is not readily inhibited by human seminal
plasma (Quayle et al., 1987), we feel this is not the case unless this proce¬
dure induces phenotypic changes which render the cells refractory.
Nevertheless, we would concede that the peripheral blood lymphocytes of
certain individuals might be particularly sensitive to seminal plasma,
especially if the latter contains antibodies which might cross-react with
lymphocytes.
Although differences in immunosuppressive effects of HSP have been
noted in serum-free media they do not detract from the possible clinical
importance of previous reports in this field but emphasise the need for
further studies. The relevance or otherwise of bovine serum co-factors in
different experimental systems will only become fully apparent when in¬
vestigations are performed with purified seminal plasma components and
as their mode of action becomes understood. In this connection it is inter¬
esting to note that our recent studies indicate that human seminal plasma
may inhibit mitogen induced lymphocyte proliferation by impairing the
generation of IL-2 receptors (Quayle et al., 1987).
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Immunosuppression by seminal prostaglandins
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SUMMARY
In this paper we report studies undertaken to determine the contribution of seminal prostaglandins to
some of the known immunosuppressive properties of human seminal plasma. Initial studies revealed
that fractions of seminal plasma enriched in E series prostaglandins, obtained by reverse phase
chromatography, had a pronounced inhibitory effect on the PHA-induced proliferation ofperipheral
blood lymphocytes and on the NK-cell-mediated lysis ofK562 target cells. Additional investigations
revealed that similar inhibitory effects could be achieved with purified PGE2 (10~6 to 10~9 m) and
19-OH PGE| (10 6 to 10 7 m), both of which are present in uniquely high concentrations in human
seminal plasma. In contrast, 19-OH PGF| which is found in lower concentrations in semen was
slightly stimulatory in proliferative assays and had no effect on NK-cell-mediated cytotoxicity.
Removal of the seminal prostaglandins by absorption chromatography resulted in a dramatic
decrease in immune suppressive activity. Further studies with fractions obtained by ion-exchange
HPLC of desalted seminal plasma indicated that prostaglandins complexed with seminal proteins,
and these too were immunosuppressive. The possible relevance of these results to sexually
transmitted disease is discussed.
Keywords prostaglandin E seminal plasma AIDS
INTRODUCTION
Seminal-plasma-mediated immunosuppression is well docu¬
mented and is believed to prevent sensitization of the female to
spermatozoa after coitus (Stites & Erickson, 1975; James &
Hargreave, 1984; Alexander & Anderson, 1987). The complex¬
ity of seminal plasma has hampered the identification of the
factor(s) responsible for this suppression and few characteriza¬
tion studies have been reported.
Semen contains four main prostaglandins (PGs) all ofwhich
are of the E series; PGE,, PGE2, 19-OH PGE, and 19-OH PGE2,
with up to 2 x 10~4m PGE and even higher levels of 19-OH PGE
(Templeton, Cooper & Kelly, 1978). The hydroxylated prosta¬
glandins are only found in appreciable concentrations in
primate semen (Kelly et al., 1976).
Prostaglandin E is a well known immunoregulatory
molecule (Goodwin & Ceuppens, 1983; Wickremasinghe, 1988),
but 19-OH PGE has only been reported as an immunosuppres¬
sant in a single study (Tarter, Cunningham-Rundles & Koide,
1987). Since the two previous reports implicating prosta¬
glandins as possible immunosuppressive factors in semen have
not distinguished between 19-OHPGE and PGE (Tarter et al.,
1987; Vallely, Sharrard & Rees, 1988), we have evaluated the
contribution of these two types of prostaglandin to mitogcn-
Correspondence: A. J. Quayle, Department of Surgery, The Medical
School, Teviot Place, Edinburgh, EH8 9AG, UK.
induced lymphoproliferation and NK-cell-mediated cytotoxi¬
city using reverse-phase fractionated semen and standard
prostaglandin preparations. We have also examined the asso¬
ciation of prostaglandins in semen with protein components, an
observation not previously reported. It is our belief that these
findings help explain the known in vitro immunosuppressive
effects of seminal plasma and, as emphasized previously, may be




Semen samples obtained from patients attending the infertility
clinic at theWesternGeneral Hospital,were centrifuged at 1000 g
for 10 min to remove spermatozoa and cells, and frozen at
— 20 °C within 4 h of receipt. Before use samples were thawed
and a pool of approximately 30 donors was made. The pool was
centrifuged at 80000 g for 15 min and the precipitate was
discarded.
Reverse phase chromatography
Twenty millilitres of the seminal plasma pool was separated by
reverse phase chromatography on a 15x300 mm CI8 30 pu
silica column (Waters, Harrow, UK) with a linear gradient of
acetonitrile in water from 0-80%. Sixty 4 ml fractions were
collected over a 4 h period. A 0-7 ml aliquot of each fraction was
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removed to determine UV absorbance and 0-1 ml was diluted to
11 ml with a methyloximating solution and assayed by
radioimmunoassay for PGE. The remainder of the fractions
were freeze-dried and reconstituted with RPMI-1640 (Gibco,
Glasgow, UK). Aliquots were frozen at —20 °C until use.
Anion exchange chromatography
A fraction (2-5ml) of the seminal plasma pool was loaded onto a
PD10 Sephadex G25 column (Pharmacia, Uppsala, Sweden)
which had previously been washed with 20 ml water. The
excluded protein was collected in 3-5 ml water and 2-0 ml of this
eluate together with 2-5 pCi of a PGE2 tracer (Amersham Int.,
Amersham, UK) was injected into a 7-5 x 75 mm DEAE 5PW
HPLC column (Waters). The column was equilibrated with
20 mm ammonium formate (pH 7-6) (buffer A) and eluted at
3 ml/min with a gradient to 100% of buffer B (10 m ammonium
formate). Protein distribution was determined by UV absorp¬
tion at 280 nM and 2-min fractions were collected. Distribution
of labelled PGE was assessed by scintillation counting. The PGE
content of each fraction was determined by mixing 200 pi
aliquots of each fraction with methyloximating solution and
measuring after suitable dilution in the PGE2 radioimmuno¬
assay. The remainder of each fraction was freeze-dried and
reconstituted with RPMI-1640 (Gibco). Aliquots were frozen at
— 20°C until use.
Delipidation of semen by absorption chromatography
Two millilitres of seminal plasma was delipidated by passage
through a CI8 reverse-phase cartridge (Seppak, Waters) which
had been primed with methanol. The eluate was found to have
negligible PGE and 19-OH PGE levels and was stored at — 20 °C
until use.
Radioimmunoassay ( RIA )
Radioimmunoassays were performed on PGs protected as the
methyloximes, using an approach described previously where
the antisera were raised against the methyloximated PGE (both
E and 19-OHE) and methyloximated standards were used to
create the standard curves (Kelly et al., 1984). For the 19-OH
PGE assay the PG used to raise the antiserum was extracted
from human semen and the antiserum cross-reacted equally
with 19-OH PGE] and 19-OH PGE2. The cross-reactivity
against PGE2 and PGE] was less than 1 % although there was
appreciable (5%) cross-reactivity with 19-OH PGF. This latter
was not a problem given the far lower amounts of 19-OH PGF
found in semen (Templeton et al., 1978). In the PGE2 assay the
cross-reactivity against PGE, was 26% and against 19-OH
PGE| it was 1%. The tracers used were a 125I-labelled peptide
coupled through proline to PGE2 methyloxime for the assay,
and a similar conjugate with tyrosine methyl ester for the 19-OH
PGE methyl oxime assay. Separation of bound and free tracer
was achieved by magnetic separation of second antibody
coupled to magnetic latex particles (Amerlex, Amersham
International).
Peripheral blood mononuclear cells (PBMC)
Blood samples were obtained with consent from laboratory
staff. Blood was collected into EDTA, and PBMC isolated by
gradient centrifugation on lymphocyte separation medium
(Flow Labs, Irvine, UK). The cells obtained were washed three
times with HBSS (Gibco) and resuspended in RPMI-1640
Fraction number
Fig. 1. Distribution of PGE, 19-OH PGE and inhibitory activity to NK
cell cytotoxicity and lymphoproliferation in fractions from reverse-
phase-separated HSP.
supplemented with 10% human AB serum (Sigma, Poole), 2 mm
l-glutamine, 100 iu/ml penicillin, 100 /ig/ml streptomycin and
5 x 10~5m mercaptoethanol.
Prostaglandin standards
PGE2 was obtained from Sigma and 19-OH PGE] and 19-OH
PGF] from Cayman Chemicals (Ann Arbor, Michigan, USA).
Lymphoproliferations
Cells were adjusted to 1 x 106/ml and 0-1 ml aliquots dispensed
in triplicate in 96-well round-bottomed plates. PHA (Sigma)
(0125 to 20 /tg/ml), and medium alone, RPMI diluted HSP.
fractions or PG standards were added in 20 pi. The cultures were
pulsed after 72 h with 1 /tCi/well of 'H-thymidine (Amersham)
and harvested 18 h later on a Skatron cell harvester. Incorpor¬
ated thymidine was measured in a scintillation counter.
NK cell assay
NK cell activity was assessed by measuring the lysis of
5lCr-labelled K562 target cells by adherent-cell-depleted PBMC.
The method has been described elsewhere (James & Szymaniec,
1985). An effector target cell ratio of 25 :1 was used.
RESULTS
Reverse phase chromatography
Radioimmunoassay of the fractions obtained from the CI8
reverse phase HPLC revealed two peaks of prostaglandin E
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Fraction number
Fig. 2. Distribution ofPGE-likematerial, protein and inhibitory activity
to NK cell cytotoxicity and lymphoproliferation in fractions from a
desalted HSP pool run on a DEAE HPLC column.
activity between fractions 26-34 and fractions 38-46 (Fig. la).
Radioimmunoassay demonstrated that 19-OH PGE eluted
almost totally in the first peak (Fig. la). However, the composi¬
tion of the first peak of E-like material is almost certainly
heterogeneous and possible contributing components are dis¬
cussed below. The broad peak shape due to large particle size
and a wide column was an unavoidable aspect of the chrom¬
atography of whole seminal plasma. In both the NK cell
(Fig. lb) and lymphocyte transformation (Fig. lc) assays,
suppression of cell function correlated with the two peaks of
prostaglandin activity. The interim fractions (35-37) had no
effect in the NK cell assay and were slightly stimulatory in the
proliferative assay. An initial assay (data not shown) has
revealed 19-OH PGF activity in these fractions but this extends
also to the higher fractions. All anti-proliferative effects of these
reverse phase fractions, ion-exchange fractions and pure prep¬
arations were most effective at sub-optimal PHA doses, a
phenomenon noted previously by other workers (Goodwin &
Ceuppens, 1974). The results presented are those obtained with
a suboptimal PHA concentration for the particular donor.
Table I. The effect of seminal plasma and standard PG preparations on
lymphoproliferation and NK cell activity
PBMC response NK-cell-mediated
Prostaglandin to 2-5 /rg/ml PHA cytotoxicity
concentration ([3H]-TdR uptake, ct/min)* (% 51Cr release)*
Control 2331 1 (100 0) 43-7 (100-0)
hsp 2% (v/v) 3260 (140) 7-9 (18-1)
10~6m pge2 7144 (30 6) 17-9 (41 0)
10 7m pge2 8248 (35-4) 22-2 (50-8)
10 8m pge2 12 158 (52-2) 29-8 (68-2)
10~9m pge2 16138 (69 3) 38-1 (87-2)
10~6m 19-oh pge, 9341 (401) 18-9 (43-2)
10"7m 19-oh pge, 17771 (76-2) 28-7 (65-7)
10 8m 19-oh pge, 27 559 (118-2) 27-8 (63-6)
10~9m 19-oh pge, 27 541 (118-2) 34-4 (78-7)
10~6m 19-oh pgf, 25 303 (108-5) 39-3 (89-9)
10 7m 19-oh pgf, 24463 (104-9) 39-7 (90-8)
10 8m 19-oh pgf, 24454 (104-9) 42-4 (97-0)
10~9m 19-oh pgf, 23827 (102-2) 42-6 (97-5)
* Standard deviations were below 15% of the mean value, and are
not given.
Numbers in parentheses are percentage of response observed
compared to the control culture (100%) set up in the absence of PG or
HSP.
Table 2. A comparison of immunosuppression by seminal plasma and
delipidated (DL) seminal plasma
PBMC response to NK-cell-mediated
1-25 /rg/ml PHA cytotoxicity
Seminal plasma (3H-TdR uptake, ct/min)* (% MCr release)*
Control 22 596 (100-0) 24-8 (100-0)
HSP 0-5% (v/v) ND 18-9 (76-2)
HSP 2% (v/v) 4871 (21-6) 9-4 (37-9)
HSP (DL) 0-5% (v/v) ND 24-3 (98-0)
HSP (DL) 2% (v/v) 16 828 (74-5) 22-7 (91-5)
* Standard deviations were below 15% of the mean value, and are
not given.
Numbers in parentheses are percentage of response observed
compared to the control culture (100%) set up in the absence of HSP.
ND not done.
Ion exchange chromatography
The low molecular weight of prostaglandins (approximately
350 Daltons) would suggest that all such components would be
lost in the desalting step. However, separation of the excluded
proteins from a Sephadex G25 column on a DEAE HPLC
column, and subsequent RIA of the fractions demonstrated two
peaks of PGE-like activity between fractions 2-4 and 6-12
(Fig. 2a). The PGE2 tracer labelled with tritium was detected
between fractions 6-11 with a peak at fraction 7, indicating that
radiolabeled PG did not necessarily co-elute with the radio-
immunoassayable PG.
Suppression of both NK cell activity and lymphocyte
proliferation correlated with PGE like activity (Fig. 2b & 2c).
The small peak of suppressive activity (< 10%) in fractions 15-
390 A. J. Quayle et al.
17 has not so far been explained. The results from this procedure
clearly demonstrate that prostaglandins of the E series bind to
seminal proteins, and that such complexes are actively suppres¬
sive.
Standard preparations ofprostaglandins
In an attempt to establish further the contributions of the
prostaglandins to the immunosuppressive properties of human
seminal plasma, studies were performed with purified prepara¬
tions. Three standard preparations of prostaglandins were used
in the two assays; PGE2, 19-OH PGE, and 19-OH PHFi, which
is found in lower concentrations in human semen.
The proliferative response of PBMC to a suboptimal
concentration of mitogen (Table 1) was suppressed by all
concentrations of PGE2 (ICE6 to 10~9m) and the two higher
concentrations (ICE6 and I(E7m) of 19-OH PGEi; 19-OHF, was
slightly stimulatory. These effects were reduced at optimal PHA
concentrations (results not given). PGE2 and 19-OH PGEi also
suppressed NK-cell-mediated lysis of K562 target cells at all
concentrations used (ICE6 to KE'm), while 19-OH PGF[ had a
small (< 10%) inhibitory effect at 10~6 and 10~7 m (Table 1).
Whole seminal plasma (PGE level 4-34 ^g/ml), when used in
culture at 2% (V/V), suppressed NK cell and lymphocyte
function by approximately 80%. Further support for the
immunosuppressive role of seminal prostaglandins was
obtained using prostaglandin-depleted seminal plasma (PGE
level 12-4 ng/ml). Seminal plasma delipidated by passage
through a lipid extraction column retained a proportion of
suppressive activity against lymphoproliferation (approxima¬
tely 25%), but was ineffective against NK-cell-mediated-cyto-
toxicity (Table 2).
DISCUSSION
Seminal plasma is reported to suppress the in-vitro responses of
T and B lymphocytes, NK cells, neutrophils, and cells of the
monocyte-macrophage lineage, and to interfere with comple¬
ment activation (James & Hargreave, 1984; Alexander &
Anderson, 1987). Although there is a paucity of studies isolating
and examining the character of the active substances, suggested
mediators of this suppression include zinc and zinc/peptide
complexes (Chvapil et al., 1977; Stankova et al., 1976), trans¬
glutaminase (Mukherjee et al., 1983), Fc binding protein
(Witkin et al., 1983), pregnancy associated protein A (Bischof et
al., 1982) and other unspecified high molecular weight proteins
(Prakash, Coutinho & Moller, 1976; Lord. Sensabaugh & Stites,
et al., 1977) as well as prostaglandins (Tarter et al., 1986; Vallely
et al., 1988).
The studies presented here clearly implicate prostaglandins
E and 19-OHE as major contributors to seminal-plasma-
induced suppression ofT cell responses to mitogen and NK-cell-
mediated cytotoxicity. This confirms recent reports that seminal
prostaglandins may inhibit NK-cell-mediated cytotoxicity (Tar¬
ter etal., 1986; Vallely et al., 1988) and has extended their initial
observations in a number ofways by clearly demonstrating that
both PGE and 19-OH PGE individually can suppress NK-cell-
mediated cytotoxicity, that they also inhibit lymphoprolifera¬
tion and that a substantial amount of the inhibitory effect of
human seminal plasma may be due to protein bound prosta¬
glandins. In this study the protein-prostaglandin complex may
contribute to the composition of the first peak of the reverse-
phase chromatography (Fig. 1), as both immunosuppressive
activity and PGE-like material eluted ahead of the 19-OH PGE
peak and this area of the chromatogram corresponded with the
tail of the protein elution (data not shown).
The degree to which PGs account for all the immunosup¬
pressive activity in semen is the subject of further research, but
delipidated seminal plasma samples failed to inhibit the NK cell
activity and only exerted a small effect on lymphocyte prolifer¬
ation. These results suggest that prostaglandins might be
entirely responsible for the inhibitory effects observed in the NK
cell assay but that additional factors could contribute to the
inhibition of lymphocyte proliferation. Furthermore our studies
have suggested that prostaglandins bind to seminal protein(s), a
phenomenon not previously reported. Preparations of these
bound prostaglandins also show immunological activity; this
may be due to the release of the prostaglandin or may reflect
activity of the complex itself. The presence of the prostaglandin-
protein complexes leads us to speculate that the suppression
attributed in earlier studies to proteins was actually due to
prostaglandin-protein complexes.
These observed immunosuppressive effects appear to be
specific to the E series since we show 19-OH PGF to be inactive
(Table 1). Studies of synthetic prostaglandins show that PGE
and 19-OH PGE have comparable activity in the NK cell assays
but PGE ismore effective at suppressing the PBMC proliferative
response to mitogen.
PGE is produced by many cells, including macrophages, but
not lymphocytes. The action of PGE in controlling cell function
is by a paracrine mechanism raising intracellular cAMP con¬
centrations through receptors coupled to adenyl cyclase via G
proteins (Smith et al. 1987). Earlier studies demonstrated
suppression ofNK activity and ofT cell proliferation, lympho-
kine production and cytotoxicity (Goodwin & Ceuppens, 1974).
More recently PGE has been shown primarily to exert its anti¬
proliferative effects through inhibition of IL-2 production
(Walker et al., 1983, Mary etal., 1987; Vercammen & Ceuppens,
1987). The expression of receptors for IL-2 (Vercammen &
Ceuppens, 1987) and transferrin (Chouaib et al., 1987) may also
be inhibited. In our laboratory whole seminal plasma and
standard PGE preparations have been found to suppress IL-2 R
expression (Quayle et al., 1987) and IL-2 production (unpub¬
lished data).
The presence of prostaglandins in semen, many log con¬
centrations above those found in peripheral blood or in an
inflammatory situation (Higgs & Salmon, 1979), has attracted
interest and speculation, but their presence has not been
satisfactorily explained. The interaction of the seminal prosta¬
glandins with spermatozoa has been examined frequently
(Schlegel et al., 1981; Gottlieb et al., 1988), but effects on sperm
motility are moderate, do not occur in all samples, and have not
been demonstrated with mixtures of prostaglandins as they
occur in semen. In addition an action on sperm is not obviously
compatible with the species distribution of the seminal PGs. The
physiological relevance of prostaglandin-mediated suppression
of immune responses in the female is attractive as high
prostaglandin concentrations would be necessary to ensure total
paralysis of sensitization. There is also evidence to suggest that
some men with unexplained infertility have low seminal prosta¬
glandin levels (Bygdeman et al., 1970).
We believe that seminal plasma immunosuppression may
also be a co-factor in the etiology or pathogenesis of a number of
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genito-urinary tract diseases. Sexually transmitted bacteria such
as TV. gonorrhoea and viruses such as herpes, papillomavirus and
HIV are causing increasing morbidity and mortality and it is
imperative thatmore is understood about factors involved in the
transmission and establishment of these infections. HIV for
example has been a high profile disease in homosexual men and
epidemiological evidence has shown that passive anal inter¬
course is the lifestyle factor with the greatest risk of infection
(Marmor, 1985). Animal studies have shown that PGE2 meta¬
bolites peak in blood after rectal insemination of semen
(Alexander et al., 1986) and the same procedure suppresses
systemic immune responses (Richards, Bedford & Witkins,
1984). Furthermore, studies in vitro have demonstrated that the
MT4 T cell line infected with HIV produces 2-5 times more virus
than control cells when exposed to 1-7 jtg/ml PGE2, which is a
concentration far lower than that in semen (Kuno et al., 1986).
We anticipate that further studies will help elucidate the role of
seminal prostaglandins in disease and also improve our under¬
standing of reproductive processes.
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